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ABSTRACT 
 
Ferrocene-peptide conjugates represent a hybrid area between organometallic 
chemistry and biochemistry. In these bioconjugates, the ferrocene (Fc) moiety can 
serve as molecular scaffold, chromophore, sensitive probe, biological marker, redox 
active site, etc. Disubstituted Fc systems, in which both cyclopentadienyl rings are 
substituted, provide influence over the supramolecular structure of the assemblies, 
and serve as starting materials for the design of electronic biomaterials. Recently, 1'-
amino-ferrocene-1-carboxylic acid (Fca) and 1,1'-diaminoferrocene Fc[NH2]2 were 
recognized as useful tools in bioorganometallic chemistry. This work sketches some 
novel preparative and structural aspects of Fc-peptide conjugates and explores their 
applications as biosensors and as polymeric materials.  
First, I demonstrated that Fca invariably induces a turn-like structure, which is 
stable in solution and the solid state. The obtained results showed different behaviour for 
Fca peptides depending on the chirality and position of the attached amino acid. The 
axial chirality of the Fca is completely dependent on the chirality of the first amino acid 
attached to the amino terminal of the Fca group. 
Second, I was able to develop a surface based sensor for the electrochemical 
detection of papain based on Fc-peptide conjugates. The idea was to place a surface-
bound redox probe in close proximity to the electrode surface. In addition, the redox-
active Fca label will be part of the recognition site but will not interfere with the 
recognition process. My sensor provides an attractive alternative for the electrochemical 
detection of non-labelled non-redox active proteins, which under current detection 
schemes remains a significant challenge. 
 ii
This work represents a truly important proof of concept for establishing this 
novel bioorganometallic approach for the electrochemical detection of important 
biological targets. 
Last, I was successful in developing a very convenient method to synthesize 1,1'-
bis(tert-butoxycarbonylamino)ferrocene as a stable derivative of Fc[NH2]2. This new 
synthetic approach has circumvented the problems encountered with the explosive 
diazide usually used as a precursor in the conventional synthons of Fc[NH2]2. Building 
on this achievement, a series of novel peptide-like oligomeric and polymeric ferrocenyl-
amides were synthesized and fully characterized. The electrochemical investigations on 
these polymers suggested unresolved or no electronic interaction between the ferrocene 
groups in all systems. These results may reveal the influence of the amide groups on 
suppressing the electronic interaction between the iron centers in my polymers.   
Thus, my systematic work on Fc-peptide conjugates lays solid foundations in the 
fields of structural control, biosensors, and material science. 
 
  
 iii
ACKNOWLEDGEMENTS 
I would like to acknowledge everybody who showed interest in my work and 
supported me during this Ph.D. work. I would like to sincerely thank my supervisor, 
professor H.-B. Kraatz, for his patience, support, guidance and faith in me in the 
course of this study. His suggestions and constructive criticisms were extremely 
useful and necessary in the successful completion of this work. 
 I would like to thank with gratitude my Advisory Committee members: Dr. D. 
Ward, Dr. D. Sanders and Dr K. Mitchell for helping me in various ways during this 
project.  
My appreciation also goes to Dr. Gabriele Schatte, Saskatchewan Structural 
Science Center, for Crystallographic data collections and solving the structures. The 
assistance given by Dr. K. Brown in performing NMR experiments and collecting 
mass spectral data by Mr. K. Thoms are really appreciated.  
            I sincerely thank the past and present members of our group for their help and 
suggestions in different stages during this work. 
  Financial support from NSERC, Department of Chemistry and University of 
Saskatchewan is gratefully acknowledged. 
 
 
 
 
 
 
 iv
DEDICATION 
 
 This work is dedicated to my parents and my wife Kareman for their 
encouragement, supplications, and faith in me. 
 
 
 
 
 
 
 
 
 
 
 
 
 v
 
TABLE OF CONTENT 
 
Page 
No. 
Permission to Use………………………………………………………………. i 
 
Abstract…………………………………………………………………………. ii 
 
Acknowledgments………………………………………………………………. iv 
 
Dedication……………………………………………………………………….. v 
 
Table of Content………………………………………………………………… vi 
 
List of Figures…………………………………………………………………… xiii 
 
List of Schemes…………………………………………………………………. xviii 
 
List of Tables……………………………………………………………………. xxi 
 
List of Abbreviations…………………………………………………………… xxiii 
 
Chapter 1. General Introduction..…….………………………………………. 1 
     1.1. Preparation of Ferrocene Peptides Conjugates……………….................. 3 
 
        1.1.1. 1,1'-Ferrocenedicarboxylic Acid Conjugates………………………... 4 
 
        1.1.2. 1'-Aminoferrocene-1-Carboxylic Acid Conjugates……………….. 7 
 
        1.1.3. 1,1'-Diaminoferrocene  Conjugate…………………………………... 11 
 
    1.2. Structural Studies of Ferrocene-Peptide Conjugates…………………...... 13 
 
        1.2.1. General Features……………………………………………….......... 13 
       
        1.2.2. Hydrogen Bonding Properties of Disubstituted Ferrocene Peptide 
Conjugates…………………………………………………………………. 15 
   
     1.3. Oligomeric and Polymeric Ferrocene Amides…………………………...  25 
     
     1.4. Objectives and Motivation………………………………………………. 34 
 
    1.5. References………………………………………………………………… 38 
 
Chapter 2. Rearrangement of the Active Ester Intermediate During HOBt 
/EDC Amide Coupling............................................................................................. 42 
 vi
 
     2.0. Connecting Text…………………………………………………….......... 42 
 
     2.2. Introduction…………………………………............................................ 43 
 
     2.2. Results and Discussion ………………………………………………..... 44 
        2.2.1 Synthesis and Characterization............................................................. 44 
     
        2.2.2. Crystal Structures of Compounds 2 and 3…………………………… 48 
        2.2.3. Electrochemistry................................................................................... 56 
     2.3. Conclusion................................................................................................... 57 
     2.4. Experimental Section.................................................................................. 57 
 
        2.4.1. General Procedure................................................................................. 57 
 
         2.4.2. Preparation of (Benzotriazol-1-yl)-1'-tButylcarbamato Ferrocene-1-
Carboxylate (2) and (Benzotriazole-1-N-oxide-3-yl)-1'-tButylcarbamato 
Ferrocene-1-Carboxylate (3).......................................................................... 58 
           
            2.4.2.1 Characterization of  Compound 2................................................... 59 
            
           2.4.2.2. Characterization of  Compound 3................................................... 59 
           
        2.4.3. Attempted Coupling of (Benzotriazole-1-N-oxide-3-yl)-1'-tButyl-
carbamato Ferrocene-1-Carboxylate................................................................ 60 
          
        2.4.4. Electrochemical Measurements............................................................. 60 
          
        2.4.5. X-ray Crystallography………………………………………………... 61 
     
     2.5. References..................................................................................................... 63 
 
Chapter 3 Helically Chiral alanine Peptides Containing 1'-aminoferrocene-
1-carboxylic acid subunit as turn inducer …………………………………… 64 
 
     3.0. Connecting Text………………………………………………………….. 64 
 
     3.1. Introduction………………………………………………………………… 65 
 
     3.2. Results and Discussions…………………………………………………… 66 
         
        3.2.1. Synthesis and Characterization ………………………………………. 66 
  
 vii
        3.2.2. X-Ray Crystallography ………………………………………………. 71 
         
        3.2.3. CD-Spectroscopy ………………………………………………….. 75 
        
         3.2.4. Electrochemistry ……………………………………………………… 77 
      
        3.3. Conclusions ……………………………………………………………… 78 
 
     3.4. Experimental Section …………………………………………………….. 80 
 
        3.4.1. General Procedure…………………………………………………….. 80 
     
        3.4.2. General Synthesis of the Ferrocene Dipeptides 2 and 3 …………….. 82 
        
        3.4.2.1. Boc-Fca-Ala-OMe (2)……………………………………………… 82 
    
        3.4.2.2. Boc-Fca-D-Ala-OMe (3)..................................................................... 83 
         
        3.4.3. Synthesis of Boc-D-Ala-Fca-Ala-OMe (4)……………………………. 84 
 
        3.4.4. Synthesis of Boc-Ala-Fca-D-Ala-OMe (5)…………………………..... 85 
         
        3.4.5. Synthesis of Boc-Ala-Fca-Ala-D-Ala-OMe (6)……………………….. 86 
         
        3.4.6. Synthesis of Boc-Ala-Fca-D-Ala-D-Ala-OMe (7)…………………….. 87 
        
        3.4.7. Synthesis of Boc-D-Ala-Ala-Fca-Ala-D-Ala-OMe (8)......................... 88 
     
        3.4.8. Synthesis of Boc-Ala-Ala-Fca-D-Ala-D-Ala-OMe (9)......................... 89 
      
     3.5. References ……………………………………………………………….. 91 
 
Chapter 4 A Bioorganometallic Approach for the Electrochemical 
Detection of Proteins: A Study on the Interaction of Ferrocene-Peptide 
Conjugates with Papain in Solution and on Au Surfaces…………………... 93 
 
     4.0. Connecting Text……………………………….......................................... 93 
 
     4.1. Introduction………………………………………………………………. 94 
 
     4.2. Results and Discussion…………………………………………………… 97 
 
        4.2.1. Synthesis............................................................................................... 97 
         
        4.2.2. Inhibition Studies…………………………………………………….. 100 
 
        4.2.3. SPR Imaging…………………………………………………………. 103 
 viii
 
        4.2.4. Electrochemistry……………………………………………………… 107 
     
     4.3. Conclusion………………………………………………………………... 112 
 
     4.4. Experimental Section…………………………………………………….. 122 
 
        4.4.1. Synthesis of Boc-Fca-Gly-Gly-Tyr(Bz)-Arg(NO2)-OMe (2)………... 114 
 
        4.4.2. Synthesis of Thc-Fca-Gly-Gly-Tyr(Bz)-Arg(NO2)-OMe (3)………… 115 
 
        4.4.3. Synthesis of Thc-Fca-Gly-Gly-Tyr(Bz)-Arg(NO2)-OH (4)………….. 116 
 
        4.4.4. Synthesis of Boc-Arg(Mtr)-Tyr-OMe (5) …………………………… 117 
 
        4.4.5. Synthesis of Boc-Gly-Gly-Arg(Mtr)-Tyr-OMe (6) …………………. 118 
 
        4.4.6. Synthesis of Boc-Fca-Gly-Gly-Arg(Mtr)-Tyr-OMe (7)……………… 120 
 
        4.4.7. Synthesis of Thc-Fca-Gly-Gly-Arg(Mtr)-Tyr-OMe (8)……………… 121 
 
        4.4.8. Synthesis of Thc-Fca-Gly-Gly-Arg(Mtr)-Tyr-OH (9)……………….. 122 
 
        4.4.9. Synthesis of Thc-Fca-Gly-Gly-Arg-Tyr-OH (10)……………………. 123 
         
        4.4.10. Papain Inhibition Studies……………………………………………. 125 
 
        4.4.11. Preparation of Peptide Arrays………………………………………. 126 
 
        4.4.12. Real-Time SPR Imaging Studies…………………………………… 127 
         
        4.4.13. Surface Electrochemistry…………………………………………… 127 
 
     4.5. References………………………………………………………………... 129 
      
     4.7. Supplemental Material…………………………………………………… 131 
 
Chapter 5. Synthesis and Electrochemical Investigation of Oligomeric 
Ferrocene Amides: Towards Ferrocene Polyamides…………………….. 135 
 
     5.0. Connecting Text………………………………………………………….. 135 
 
     5.1. Introduction………………………………………………………………. 136 
 
     5.2 Results and Discussion................................................................................ 138 
         
        5.2.1. Synthesis .............................................................................................. 138 
 ix
 
        5.2.2. Electrochemistry……………………………………………………… 143 
 
        5.2.3. Ultraviolet/Visible Spectroscopy…………………………………….. 146 
 
     5.3. Conclusion………………………………………………………………... 147 
 
     5.4. Experimental……………………………………………………………... 148 
 
        5.4.1. General Procedure……………………………………………………. 148 
 
        5.4.2. Preparation of 1'-methoxycarbonyl ferrocene-1-carbonyl chloride (7)…… 149 
 
        5.4.3. Preparation of MeOOC-[Fc-NHCO]2-Fc-COOMe (8)......................... 149 
 
        5.4.4. Preparation of BocNH-[Fc-NHCO]2-Fc-NHBoc (10).......................... 150 
 
        5.4.5. Preparation of Ferrocene-1,1'-dicarbonylchloride (11)………………. 151 
 
        5.4.6. Synthesis and Characterization of Oligo- and Poly-Ferrocene Peptides….. 152 
 
           5.4.6.1. Characterization of Compound 12…………………………………. 152 
            
           5.4.6.2. Characterization of Compound 13…………………………………. 153 
            
           5.4.6.3. Characterization of Compound 14…………………………………. 153 
 
           5.4.6.4. Characterization of the Polyferrocene Peptide 15............................. 153 
      
     5.5. References………………………………………………………………..... 154 
 
     5.6. Supplemental Material…………………………………………………… 156 
 
Chapter 6. Synthesis and Electrochemical Investigation of Oligomeric and 
Polymeric Ferrocenyl-Amides Having Cyclohexylene, Phenylene and Lysyl 
Spacers…………………………………………………………………………… 158 
 
     6.0. Connecting Text……………………………………………………………. 158 
 
     6.1. Introduction………………………………………………………………… 159 
 
     6.2. Results and Discussions…………………………………………………… 162 
 
        6.2.1. Synthesis and Characterization ……………………………………….. 162 
 
        6.2.2. Electrochemistry……………………………………………………… 171 
  
 x
     6.3. Conclusion……………………………………………………………….. 176 
 
     6.4. Experimental……………………………………………………………... 177 
 
        6.4.1. General Procedure……………………………………………………. 177 
 
        6.4.2. Preparation of Bis-(1'-Methoxycarbonylferrocenyl-1'-Amide)-1,4-
Terephthaloyl (3)…………………………………...……………………… 178 
 
        6.4.3. Preparation of 1,4-Cyclohexyldicarboxylic Chloride (4)……………. 179 
 
        6.4.4. Preparation of Bis-(1’-Methoxycarbonylferrocenyl-1’-Amide)-1,4 
Cyclohexyldicarbonyl (5) …………………………………………………… 179 
 
        6.4.5. Polycondensation of 1,1'-bis(Boc-amino)Ferrocene and Terephthaloyl 
Chloride ……………………………………………………......................... 180 
 
           6.4.5.1. Characterization of Compound 7………………………………… 181 
 
           6.4.5.2.Characterization of Compound 8…………………………………. 181 
 
           6.4.5.3. Characterization of Compound 9………………………………… 181 
 
           6.4.5.4. Characterization of Polymer 10………………………………….. 182 
         
        6.4.6. Polycondensation of 1,1’-bis(Boc-amino)Ferrocene and 1,4-
Cyclohexyldi- Carboxylic Chloride. ………………………………………. 182 
 
           6.4.6.1. Characterization of Compound 11……………………………….. 183 
 
           6.4.6.2. Characterization of Compound 12……………………………….. 183 
 
        6.4.7. Preparation of 1, n’-bis(Lys(Boc)-OMe)Ferrocene (14)…………….. 183 
 
        6.4.8. Reaction of Compound 14 and Ferrocenediacid Chloride…………… 184 
 
        6.4.9. Electrochemical Measurements………………………………………. 185 
 
     6.4. References………………………………………………………………... 186 
 
Chapter 7. General Conclusion……….………………………………………... 188 
      
     7.1. Ferrocene-Peptide Conjugates…………………………………………… 188 
      
     7.2. Applications in Biosensors ………………………………………………. 190 
     
     7.3. Application in Material Science…………………………………………. 191 
 xi
      
     7.4. Final Remarks and Future Directions……………………………………. 194 
      
     7.5. References................................................................................................... 195 
 
Appendixes. ……………………………………………………………………….. 197 
 
     A.  Copyright Permissions from the Journals publishers………………………. 197 
 
        A.1. Wiely-VCH……………………………………………………………... 197 
 
        A.2. Springer…………………………………………………………………. 199 
 
     B. Permission of Co-Author……………………………………………………. 200 
 
 
 
 
 xii
 
LIST OF FIGURES 
 
Page 
No. 
 
Figure 1.1. a) Molecular drawing of compound Fc[Gly-OEt]2 42 showing the 
1,3'-substitution of the Fc group; (b) molecular drawing of the 
centrosymmetric Fc[Gly-OH]2 43 showing the 1,2'-substitution and the typical 
H-bonding pattern……………………………………………………………… 16 
 
Figure 1.2. Molecular structure of 1,1'-Fc-prolinylmethylester 45 and 1,1'-Fc-
bis(alanylprolinylesters) 46a…………………………………………………… 17 
Figure 1.3.  Molecular structure of Fc-[L-Ala-L-Pro-OEt]2  46b and Fc-(D-
Ala-D-Pro-OEt)2 46b-D……………………………………………………….. 17 
 
Figure 1.4. 1,2'-substituted Fc systems showing the two different 
conformations of the amino acid substitutents: a) Conformation A: drawing of 
the molecular structure for Fc[Gly-NH2]2 44 showing the two C=O pointing 
outwards, allowing the formation of interstrand H-bonding between the two 
amide C=O and N-H; b) Conformation B: drawing of the molecular structure 
of Fc[Phe-OMe]2 48, showing one of the C=O pointing inwards the other 
pointing outwards, resulting in the formation of only a single H-
bond……………………………………………………………………………. 19 
 
Figure 1.5. Molecular structure of the macrocyclic Fc[Gly-CSA]2 (17) 
showing the intra- and intermolecular H-bonding interactions. The molecule 
has two diastereomers in the asymmetric unit…………..................................... 20 
 
Figure 1.6. a) Structural drawing of dimethyl-1',1'-ureylenedi (1-
ferrocenecarboxylate) 24  ; b) the crystal packing showing the intermolecular 
hydrogen bonding pattern. Redrawn from the original crystal structure.……… 21 
 
Figure 1.7. X-ray structure of the first Fca peptide conjugate 29 showing two 
intra-molecular hydrogen bonds. Selected hydrogen bond distances (Ǻ) and 
angles (°): N1–O52 2.812(3), N51–O2 2.914(3), N1–H1N–O52 169(3), H51–
H51N–O2 157(3)................................................................................................ 22 
 
Figure 1.8. X-ray structure of [BocNH(C5H4)Fe(C5H4)C(O)NHCH2CH2S]2 43 
(A) showing two intra-molecular hydrogen bonds. Selected hydrogen bond 
distances (Ǻ) and angles (°) N1–O3 2.849(3) and N4–O2 2.989(3) Å. (B) 1,5' 
conformation of  Fc1. (C) 1,1' conformation of Fc2 with respect to the 
orientation of the substituents………………………………………………….. 23 
 
Figure 1.9. Structure  of 1,1'-bis(tert-butoxycarbonylamino)ferrocene 40 
showing three rotamers having the two substituents at different rotational 
angles with respect to the Cp-Fe-Cp vector with an approximate 1,2' (70º) and 
1,3' (144º, 180º) conformation. All three rotamers are linked via 
intermolecular N(H)•••O=C bonding…………………………………………... 
 
 
 
 
 
24 
 xiii
Figure 1.10. a) Molecular structure of the diferrocenyl peptide 56 in the solid 
state, b) hydrogen bonding pattern in the solid state………………………...… 30 
 
Figure 2.1. Ortep drawing of compound 2 (30% probability).  H atoms 
omitted for clarity. Side-on view and view down the Cp-Fe-Cp axis to 
visualize the 1,2’-conformation of the Fc group………………………………. 49 
 
Figure 2.2. Ortep drawing of compound 3 (30% probability). H atoms omitted 
for clarity. Side-view and view down the Cp-Fe-Cp axis to show the 1,1'-
conformation of the Fc system…………………………………………………. 50 
 
Figure 2.3. Packing diagrams for compounds 2 and 3........................................ 52 
 
Figure 2.4. Temperature dependence of the chemical shifts for NH signals of 
compounds 2 (●,○) , 3. (■,□) in CDCl3. (○,□)-open shapes indicate 1 mM; ( 
●,■)-solid shapes indicate 50 mM…………………………………………… 54 
 
Figure 2.5. Variable temperature 1H-NMR spectra of 2 (50 mM, CHCl3) in a 
region of 215 – 308 K…………………………………………………………... 55 
 
Figure 2.6. Variable temperature 1H-NMR spectra of  3 (50 mM, CDCl3)…… 55 
 
Figure 2.7. Electrochemical study of compounds 2 and 3 in CH3CN/ 0.1 M 
TBAP: A shows the cyclic voltammetry at a scan rate of 100 mV/s (∆Ep for 
the Fc/Fc+ couple under identical conditions was 68 ±5 mV); B shows the 
differential pulse voltammetry at a scan rate 10 mV/s. for 2:  DPV, Ep = 643 ± 
5 mV; for 3, Ep = 566 ± 5 mV…………………………………………………. 56 
 
Figure 3.1. The ferrocene-derived peptide conjugates. Arrows point from the 
C to the N terminals……………………………………………………………. 66 
 
Figure 3.2. Possible H-bonding pattern in 2. The numbering scheme is 
presented for conformer A, for the specification of ring size in the H-boded 
species. The pattern D has no intra-molecular H-bonds and could exsit in 
equilibrium with an “open isomer……………………………………………… 72 
 
Figure 3.3. Crystal structure of 2 showing a L,M-configuration with one 
hydrogen bond…………………………………………………………………. 72 
 
Figure 3.4. Crystal structure of 3 showing a D,P-configuration with one 
hydrogen bond……………………………………………………………….. 73 
 
Figure 3.5. Crystal packing of 2, view down the b axis………………………..  73 
 
Figure 3.6. Tilt angle θ is the dihedral angle between the two Cp rings; ω is 
the dihedral angle between the two ring-bound substituents: C(ipso) - 
 
 
 
 xiv
Cp(centroid) - Cp(centroid) - C(ipso); β is the dihedral angle between the Cp 
ring and the –NHR (βNH) or –COR´ (βCO) substituent…………………………. 
 
74 
 
Figure 3.7. CD spectra (CH3CN) of the dipeptides 2 and 3…………………… 76 
 
Figure 3.8. CD spectra (CH3CN) of the tripeptides 4 and 5…………………... 77 
 
Figure 4.1. 1H-NMR of peptides 4, 9, and 10. * (D5)DMSO trace at δ2.50, 
water trace at δ3.33…………………………………………………………… 100 
 
Figure 4.2. Proposed structure of peptide 10 interacting with the binding site 
of papain. The initial enzyme-inhibitor structure was modeled in the VEGA 
ZZ 2.0.5 program based on the papain structure 1PE6 studied by Yamamoto 
et al. The papain-peptide complex model was constructed by replacing the 
inhibitor in structure 1PE6 with peptide 10 as the chosen inhibitor in our case. 
The initial geometry of peptide 10 and papain-peptide complex were modeled 
by energy minimization using molecular mechanics calculation method (MM) 
in Spartan. The enzyme-inhibitor complex distances were in good agreement 
with x-ray crystallographic studies…………………………………………….. 103 
 
Figure 4.3. SPR imaging measurements showing the interaction of papain 
(150 nM) with surface-bound Fca-peptide conjugates 4, 9, and 10 and a 
decanethiol control. Papain was dissolved in a buffer solution (0.1 M sodium 
phosphate pH 6.2, 2.5 mM EDTA, 300 µM DTT, and 30% DMSO, 23 °C. (A) 
SPR difference image resulting from subtraction of the buffer image from the 
ones obtained after interaction with papain; (B) The line profile, taken across 
the difference images, shows significant differences in the ∆%R for 
measurements taken in the absence and presence of papain………………….... 105 
 
Figure 4.4. Plot of ∆%R versus time for the interaction of papain with thin 
films of Fca-peptide conjugate 10 on gold. The concentration of papain was 
increased from 25 – 200 nM………………………………………………...…. 106 
 
Figure 4.5. Plot of γ versus papain concentration for conjugate 10 obtained 
from fitting the adsorption curves to Eq 4.2. The linear slope corresponds to 
the adsorption rate constant ka = 1.75 ± 0.05 x 105 M-1 s1 and the y-intercept 
corresponds to the desorption rate constant  kd = 2.90 ± 0.05 x 10-2 s-1……….. 107 
 
Figure 4.6. Cyclic voltammogram of 25 µm diameter gold microelectrodes 
modified with a mixed film of Fca-peptide 10 and decanethiol in the presence 
of increasing concentrations of papain (The arrow direction indicates a signal 
decrease and shift to higher potential with increasing the concentration from 0 
to 200 nM. Enzyme activation buffer (0.1 M sodium phosphate pH 6.2, 2.5 
mM EDTA, 300 µM DTT, and 30% DMSO, 23◦C) with 2M NaClO4. Scan 
rate of 10 Vs-1, Pt counter, Ag/AgCl reference………………………………… 
 
 
 
 
 
 
 
109 
 
Figure 4.7. A plot of the formal potential (E°) vs papain concentration………. 110 
 xv
 
Figure 4.8. QCM measurement of papain adsorption on films of Fca-peptide 
conjugate 10 on gold covered AT-cut type crystals. Papain activation buffer: 
0.1 M sodium phosphate pH 6.2, 2.5 mM EDTA, 300 µM DTT, and 30% 
DMSO, 23°C with 2.0 M NaClO4………………………..…………………….. 111 
 
Figure 4.S1. HPLC trace of peptide 10………………………………………... 131 
 
Figure 4.S2. Michaelis-Menten plot, with an inset Lineweaver-Burk plot. 
Michaelis-Menten constant (Km) was determined by non linier regression fit 
of the concentration velocity curve using Michaelis-Menten equation {V= 
Vmax [S]/(Km+[S]). The Km value was determined by monitoring the total 
papain-catalyzed hydrolysis of Z-Phe-Arg-NHNp in the absence of the 
inhibitors and at high initial concentration of the substrate. The fitting was 
performed using GraphPad Prism version 4.03 for Windows, GraphPad 
Software, San Diego California USA………………………………………….. 131 
 
Figure 4.S3. Plot of the rates of hydrolysis of Z-Phe-Arg-NHNp versus 
concentrations of Fca-peptide 9 (upper) and Fca-peptide 10 (lower) 
monitoring of the papain-catalyzed hydrolysis of Z-Phe-Arg-NHNp (90 µM) 
in the presence of increasing concentrations of the Fca-peptide conjugate (0.1 
M sodium phosphate pH 6.2, 2.5 mM EDTA, 300 µM DTT, and 30% DMSO, 
23◦C). The reaction was initiated by addition of the enzyme. Data were 
obtained by measuring the absorption at λ = 405 nm. The linear dependence 
shown in the Dixon plot (inset) indicates competitive inhibition. Nonlinear 
regression gave an apparent inhibition constant Ki' = (1 + [S]/Km)Ki = 
639.1±1.1µM for conjugate 9 and 210 ± 1.4 µM for conjugate 10. A Michaelis 
constant Km = 980 ± 26 µM was determined separately according to the 
Michaelis-Menten equation……………………………………………………. 132 
 
Figure 4.S4. Substrate-papain subsites according to Schechter and Berger,  S2 
and S3 pockets consist of Val-133, Val-157 and Asp 158 and of Tyr61, Gly-66 
and Tyr-67 residues of papain, respectively…………………………………… 133 
 
Figure 4.S5: Curve fitting for the adsorption curves obtained for various 
concentrations of peptide 10, fitted using Equation (4.2)…………………….. 133 
 
Figure 4.S6. Representative figure describing the dilution studies of the 
peptide 10 films. The diluted films were characterized by observing their 
blocking effect on the electrochemical response of the Ru(NH3)63+/2+ redox 
probe. The reversible redox behavior was observed on bare gold electrode 
with E1/2 = -0.16 V vs Ag/AgCl has almost disappeared that may implies a 
fully covered surface…………………………………………………………… 134 
 
Figure 4.S7. Control QCM measurement demonstrating a comparison between the 
binding efficiency of peptides 10 and 4 to papain. The inset shows only peptide 4, which 
was used as a control. The peptide films were formed on gold covered AT-cut type 
 
 
 
 
 xvi
crystals. Papain activation buffer: 0.1 M sodium phosphate pH 6.2, 2.5 mM EDTA, 300 
µM DTT, and 30% DMSO, 23°C with 2.0 M NaClO4………………………………. 
 
134 
 
Figure 5.1. The 1H-NMR pattern of compounds 8 and 10 in CDCl3: * residual 
peak of CHCl3 ………………………………………………………………….  139 
 
Figure 5.2. IR spectra  of (a) BocNH-Fc-NHCO-Fc-COOMe (12) and (b) 
MeOOC-Fc-CONH-Fc-NHCO-Fc-COOMe (8) in CHCl3 solution……………. 
 
 
141 
 
Figure 5.3. 1H-NMR spectra in CDCl3 of ferroceneamide oligomers, 12-14 in 
CDCl3. * residual peak of CHCl3………………………………………………. 142 
 
Figure 5.4: Cyclic voltammetry of compounds 8 and 10 in CH2Cl2. All 
solutions contain 0.1 mM of the compounds and 0.1 M TBAP. GCE vs. 
Ag/AgCl. Scan rate = 100 mV/s. The E1/2 of the Fc/Fc+ couple under the 
experimental conditions was 448(±5) mV (vs. Ag/AgCl)……………………... 144 
 
Figure 5.5. Cyclic voltammetry (CV) (left) and differential pulse voltammetry 
(DPV) (right) of compounds 12-14 in CH2CL2. All solutions contain 0.1 mM 
of the compounds and 0.1 M TBAP. GCE vs. Ag/AgCl. Scan rate = 0.1 v/s…. 145 
 
Figure 5.6. Electronic spectra of the triferrocenes 8 and 10 (left) and the ferrocene 
amide oligomers 12-14. All concentrations were 0.1 mM in CH2Cl2……………… 147 
 
Figure 6.1. Intensity size distributions of 0.1 mM of polymer 10 in DMSO 
measured by dynamic light scattering at 23°C………………………………… 164 
 
Figure 6.2. IR spectra (KBr) of the oligomers 7-9 and the polymer 10……….. 166 
 
Figure 6.3. 1H-NMR spectra in DMSO-d6 of the polymer 10………………… 166 
 
Figure 6.4. Selected regions from FT-IR spectra (KBr) of the oligomers 11 
and 12…………………………………………………………………………... 167 
 
Figure 6.5. FT-IR spectra of compounds 14 and 15 recorded as KBr disk…… 169 
 
Figure 6.6. Intensity size distributions of 0.1 mM of polymer 15 in H2O 
measured by dynamic light scattering at 23°C.………………………………... 169 
 
Figure 6.7. CD spectra of compounds 14 and 15  (1 mM in CH3CN).……….. 170 
 
Figure 6.8. Cyclic voltammetry (left) and differential pulse voltammetry 
(right) of compounds 3, 5, 7-9 in CH3CN. All solutions contain 0.1 mM of the 
compounds and 0.1 M TBAP. GCE vs. Ag/AgCl. Scan rate = 100 mV/s. The 
E1/2 of the ferrocene/ferrocenium redox couple under the experimental 
conditions was 449(±5) mV (vs. Ag/AgCl)………………….………………… 173 
  
 xvii
Figure 6.9. Cyclic voltammetry (left) and differential pulse voltammetry 
(right) of deposited film of the polymer 10 on glassy carbon electrode. All 
solutions contain 0.1 M TBAP in CH3CN. GCE vs. Ag/AgCl. Scan rate = 100 
mV/s. The E1/2 of the ferrocene/ferrocenium+ couple under the experimental 
conditions was 449(±5) mV (vs. Ag/AgCl)……………………….………….. 
 
 
 
 
174 
 
Figure 6.10. Cyclic voltammetry (left) and differential pulse voltammetry 
(right) of compounds 11 and 12 in CH3CN. All solutions contain 0.1 mM of 
the compounds and 0.1 M TBAP. GCE vs. Ag/AgCl. Scan rate = 100 mV/s. 
The E1/2 of the Ferrocene/Ferrocene+ couple under the experimental 
conditions was 449(±5) mV (vs. Ag/AgCl)……………………………………. 
 
 
 
 
 
175 
 
Figure 6.11. Cyclic voltammetry (left) and differential pulse voltammetry 
(right) of compounds 14 and 15 in CH3CN. All solutions contain 0.1 mM of 
the compounds and 0.1 M TBAP. GCE vs. Ag/AgCl. Scan rate = 100 mV/s. 
The E1/2 of the Ferrocene/Ferrocene+ couple under the experimental 
conditions was 449(±5) mV (vs. Ag/AgCl)……………………………………. 176 
 
 
 
 
 xviii
 
LIST OF SCHEMES 
 
Page 
No. 
 
Scheme 1.1.  Synthesis of ferrocenoyl amino acid esters (5) via the acid 
chloride and active ester methods: (i) (COCl)2 or SOCl2; (ii) carbodiimide 
such as DCC or EDC, HOBt; (iii) carbodiimide such as DCC or EDC, HOSu 
and (iv) peptide or amino acid and base……………………...………………... 4 
 
Scheme 1.2.  Synthesis of 1,1'-bispeptide Fc derivatives peptides 7 – 13 via 
the HOBt/EDC protocol: (i) HOBt, EDC, CH2Cl2, H-Pron-OMe (n = 1-4)…… 5 
 
Scheme 1.3. Unusual synthesis of Fc[Val-OMe]2 15 from the Li salt of CP-
Val-OMe 14 formed by the addition of isocyanate: (i) FeCl2, THF, 60°C, 7d; 
(ii) FeCl2/CpLi,  50 °C,  THF, 7d. …………………………………………… 6 
 
Scheme 1.4. Synthesis of redox active cyclopeptides : (i) EDC, HOBt, 
CH2Cl2; (ii) (CSA)2• 2HCl, CH2Cl2; (iii) a) Boc-amino acid CSA dimer, TFA; 
b) Et3N, CH2Cl2; (iv) dilution…………………………………………….......... 7 
 
Scheme 1.5. Synthesis of Boc-protected 1'-aminoferrocene-1-carboxylic acid. 
(i) t-BuOH, reflux for 4 hours (ii) NaOH/H2O, MeOH (iii) TFA/CH2Cl2…….. 8 
 
Scheme 1.6. Synthesis of Fc amino acid hydrochloride 27 according to 
Heinze: (i) N-acetylation with Ac2O, (ii) selective Friedel-Crafts acylation 
with 2,6-dichlorobenzoyl chloride at the unsubstituted Cp ring; (iii) base 
hydrolysis; (iv) removal of the acetyl protection group with hydrochloric 
acid……………………………………………………………………………... 9 
 
Scheme 1.7. Synthesis of the tetrapeptide Boc-Ala-Fca-Ala-Ala-OMe 29 
derived from  1'-Boc-aminoferrocene-1-carboxylic (Fca) 23a: (i) + H-Ala-
Ala-OMe, EDC/HOBt; (ii) HCl(g)/ AcOEt; + Boc-Ala-OH,EDC/HOBt…….. 
10 
 
 
 
Scheme 1.8. (a) Reaction of 38b with the alkylating reagents to form 
compounds 30-33 (b) synthesis of compound 34 from 23a according to Khan 
et al. (i) EtOH (ii) Saturated NaHCO3 (iii) HOBt, EDC (iv) Cystamine, Et3N. . 11 
 
Scheme 1.9. Arnold’s synthesis of 1,1'-diaminoferrocene involving the 
explosive diazidoferrocene: (i) C2H2Br4, Et2O, (ii) NaN3, CuI, EtOH/H2O, (iii) 
H2, Pd/C, MeOH………………………………………………………………. 12 
 
Scheme 1.10. Synthesis of 1,1-bis(Boc-amino)ferrocene 40 via 1,1-
bis(carbonylazido) Fc 39, and its amino acid derivatives with L-Ala (41a) and 
D-Ala (41b). (i) Reflux in t-BuOH, 80 °C, 8 h; (ii) a) TFA, b) TEA, c) Boc-
Ala-OH activated by EDC/HOBt………………………………………………. 12 
 
 
 
 
 xix
Scheme 1.11.  Torsion angles in Fc-amino acids and peptides: θ = Cp bent 
and β = twist between amide and Cp planes…………………………………… 
 
14 
 
Scheme 1.12. Some of the possible orientation of the amino acid and peptide 
substituents. Structure a) is the most commonly found structural motif having 
the two C=O anti orientation…………………………………………………. 18 
 
Scheme 1.13. Synthesis of the methylsiloxane polymer [-Si-(CH3)2-(CH2)3-
NHC(O)-Fc-C(O)NH(CH2)3Si(CH3)2O-]n 50 having Fc in the backbone of the 
polymer chain………………………………………………………………….. 26 
 
Scheme 1.14. Synthesis of cyclopeptides 51 and 52 by condensation of 1,1'-
ferrocenyldicarbonyl chloride and bifunctional cystein derivatives…………… 26 
 
Scheme 1.15. Synthesis of  some Fc-containing aromatic polyamides 53…... 27 
 
Scheme 1.16. Preparation of some Fc-based poly(amide ether amide)s 54…… 28 
 
Scheme 1.17. Structure of the organometallic Fc-polypeptide proposed by 
Nakamura……………………………………………………………………..... 29 
 
Scheme 1.18.  Coupling of ferrocenoyl benzotriazole ester 55 with 
aminoferrocene 24 to give the diferrocenyl diamide 56; (i) THF, 12 h.. ……… 29 
 
Scheme 1.19. Synthesis of P- and M-helical foldamers from the conjugates of 
Fca with L- and D-alanine resulted in the formation of the oligomers 57-64 
and the polymer 65……………………………………………….…………….. 31 
 
Scheme 1.20. Synthesis of elastomeric polyamides 67 and 68 from 1,1'-bis(β-
aminoethyl) Fc 66 and diacid chlorides. (i) Cl-CO-R-CO-Cl; (ii) OCN-R'-
NCO.................................................................................................................... 32 
 
Scheme 1.21. Cyclization of 70 forming macrocyclic oligopeptides 71-73: (i) 
H2, Pd/C(5%),MeOH (ii) 7-azabenzotriazol-1-yloxytris(pyrrolidino) 
phosphonium hexafluoro phosphate (PyAOP), Dipea, DMF............................. 33 
 
Scheme 1.22. Schematic representation summarizes the objectives of the 
study described in this thesis…………………………………………………. 34 
 
Scheme 2.1. Two isolated products 1-(1-benzotriazolato)-1'-tbutylcarbamato 
ferrocene 2 and N-oxide 1-(3-benzotriazole-1-N-oxide)-1'-tbutylcarbamato 
ferrocene 3 resulted form the activation of 1'-tbutylcarbamato-1-ferrocene- 
carboxylic acid 1.................................................................................................. 45 
 
Scheme 3.1. Syntheses of Fca peptides. (a) 1 M NaOH; (b) 1. EDC/HOBt or 
HBTU/HOBt, CH2Cl2, 2. H-(Aaa)x-OMe·HCl/NEt3, CH2Cl2; (c) HCl (gas)/EtOAc or 
TFA; (d) 1. EDC/HOBt or HBTU/HOBt, CH2Cl2, 2. Boc-(Aaa)y-OH/NEt3, CH2Cl2.... 67 
 xx
 
Scheme 4.1. Schematic representation of some of the common 
electrochemical biosensor systems (A-C) and the new proposed system 
making use of an ferrocene-peptide conjugate (D): (A) The redox active probe 
in solution and the target protein blocks its interaction with the surface. (B) In 
the electrochemical immunoassay (EIA) a protein binds to a surface-bound 
capture probe followed by binding labelled antibody. (C) Conformational 
changes take place upon binding of a target DNA to a single stranded capture 
DNA. Changes in the distance between the redox label and the surface alter 
the electrochemical behaviour of the system. (D) Bioorganometallic capture 
probe: protein binding is detected by monitoring the electrochemical 
properties before and after protein binding......................................................... 96 
 
Scheme 4.2 Synthesis of Fca-peptide conjugate 4. (i) TFA/CH2Cl2; Boc-Fca-
OBt; Et3N, CH2Cl2 (ii) TFA/CH2Cl2; ThcOH, EDC/HOBt; Et3N, CH2Cl2  (iii) 
NaOH/CH3OH/H2O………………………………………………………….. 98 
 
Scheme 4.3. Synthesis of Fca-peptide conjugates 7-10. (i) TFA/CH2Cl2; 
EDC/HOBt; Et3N,/CH2Cl2 (ii) TFA/CH2Cl2; Boc-Fca-OBt; Et3N,/CH2Cl2 
(iii)TFA/CH2Cl2; ThcOH/EDC/HOBt; Et3N,/CH2Cl2  (iv) NaOH/CH3OH, (v) 
TFA/thioanisol/CH2Cl2………………………………………………………… 99 
 
Scheme 5.1. Synthesis of compounds 8 and 10 (i) a) TFA, CH2Cl2; b) Et3N/ THF…. 138 
 
Scheme 5.2. Synthesis of compounds 8, 12-14 and of polymer 15. (i) a) TFA, 
CH2Cl2; b) Et3N/THF........................................................................................... 140 
 
Scheme 5.3.  Representation of the two oxidation steps of compounds 8 and 10. …. 144 
 
Scheme 6.1. Schematic overview of the synthesis of compounds 3 and 5 from 
ferrocene amino acid derivative 1 and terephthaloyl chloride (2) and 1,4-
cyclohexyldicarboxylic chloride (4)…………………………………………. 162 
 
Scheme 6.2. Schematic overview of the synthesis of compounds 7 – 12 from 
the ferrocene diamine derivative 6 and terephthaloyl chloride (2) and 1,4-
cyclohexyldicarboxylic chloride (4)…………………………………………. 163 
 
Scheme 6.4. Schematic overview of the synthesis of compounds 14 and 15. (i) 
Et3N, CH2Cl2, 0 °C, H-Lys(Boc)-OMe; (ii) a) TFA, CH2Cl2 , b) Et3N, CH2Cl2, 
c) Fc[CO-Cl]2………………………………………………………………… 168 
 
 xxi
 
LIST OF TABLES 
 
Page 
No. 
 
Table 1.1. Some common structural parameters for disubstituted ferrocenoyl 
amino acids and peptides……………………………………………………… 14 
 
Table 2.1. Spectroscopic characterization of compounds 2 and 3…………… 46 
 
Table 2.2. Relevant bond distances (Å) and angles (º) for 2 and 3…………… 47 
 
Table 2.3. Torsions angles (º) for 2 and 3………………………………….. 51 
 
Table 2.4. X-ray crystallographic data of complexes 2 and 3…………………. 62 
 
Table 3.1. Chemical shifts of the amino-protons of Fca-peptides. and standard 
numbering scheme.............................................................................................. 68 
 
Table 3.2. Selected parameters in the crystal structures of 2 and 3. ………… 75 
 
Table 3.3. Solution electrochemical results for compounds 2-9. Conditions: 1 
mM in MeCN; glassy carbon working electrode (BAS), Pt counter, Ag/AgCl 
reference, 0.1 M TBAP; E in mV and Ip in µA; errors in the measured 
potentials are ± 5 mV from five independent measurements………………….. 78 
 
Table 4.1. Inhibition constant Ki of the Fc-peptide conjugates 4, 9, and 10 and 
some literature compounds…………………………………………………….. 101 
 
Table 5.1. Half-wave potential of tri-ferrocene analogues 8 and 10 and oligo-
ferrocene peptides 12-14 in CH2Cl2 (0.1 M TBAP. GCE vs. Ag/AgCl. Scan 
rate = 0.1 V/s). ………………………………………………………………... 146 
 
Table 5.2: UV-vis data for compounds 8, 10 and 12-14 in CH2Cl2…………… 147 
 
Table 5.S1. Summary of selected 1H-NMR spectroscopic data for compounds 
9, 11-15, chemical shifts in ppm……………………………………………… 156 
 
Table 5.S2.  Summary of selected IR (KBr, cm-1) spectroscopic data for 
compounds 8, 10, 12-15……………………………………………………… 156 
 
Table 5.S3. Some characterization and Physical properties of compounds 8, 
10, 12-15……………………………………………………………………... 157 
 
Table 6.1. Selected IR spectral data (KBr, cm-1) for compounds 7-10. ……… 165 
 
Table 6.2. Solution electrochemical results for compounds 3, 5, 7-12, and 14 and 15..... 172 
 xxii
 
LIST OF ABBREVIATIONS 
A absorption 
Å angstrom 
Ala  alanine 
Arg  arginine 
Asn  aspartine 
Asp aspartic acid 
Boc t-butyloxycarbonyl 
BOP benzotriazol-1-yl-N-oxy-tris(dimethylamino)-phosphonium 
hexafluoro-phosphate 
Bz benzyl 
CD circular dichroism 
COSY correlation spectroscopy 
Cp cyclopentadiene 
CSA cystamine 
CV cyclic voltammetry 
Cys  cystein 
DCC dicyclohexyl-carbodiimide 
DCM dichloromethane 
DLS Dynamic light scatternic 
DMSO dimethylsulfoxide 
DPV differential pulse voltammetry  
DTT ±-threo-1,4-dimercapto-2,3-butanediol. L-1,4-dithiothreitol 
E0 standard potential 
E1/2 half-wave potential 
EDC 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
EDTA ethylenediamminetetraacetate 
Et ethyl 
EtOAc ethylacetate 
FAB fast atom bombardment 
Fc ferrocene 
Fca 1-amino-1'-ferrocene carboxylic acid 
FTIR fourier transform infrared spectroscopy 
Gln  glutamine 
Glu glutamic acid 
Gly  glycine 
HBTU O-(benzotriazole-1-yl)-N,N,N’,N’-tetramethylurionium hexafluorophosphate 
 xxiii
His  histidine 
HMBC heteronuclear multiple bond correlation spectroscopy 
HOBt hydroxybenzotriazole 
HOSu 1-hydroxysuccinimide  
HPLC high performance liquid chromatography 
HRMS high resolution mass spectrometry 
Hz hertz 
Ile  Isoleucine 
j coupling constant 
K kelvin 
Ki inhibition constant 
Ki' apparent inhibition constant 
Km Michaelis-Menten constant 
Leu leucine 
LRMS low resolution mass spectrometry 
Lys lysine 
m milli 
Me methyl 
MeOH methanol 
Met  methionine 
min. minute 
ml millilitre 
mM millimolar 
mmol millimole 
mol mole 
MS mass spectrometry 
MW molecular weight 
NMR nuclear magnetic resonance 
Phe  phenylalanine 
ppb parts per billion 
ppm parts per million 
Pro  proline 
r t room temperature 
Ser  serin 
SPPS solid phase peptide synthesis  
SPR surface plasmon resonance 
Thc thiostic acid 
 xxiv
THF tetrahydrofuran 
TFA trifluro acetic acid 
Thr  threonine 
TOCSY total correlation spectroscopy 
Trp  triptophan 
Tyr  tyrosine 
UV ultra violet 
Val  valine 
ε extinction coefficient 
∆Εp potential peak separation 
∆Τ change of temperature 
∆δ change of chemical shift 
δ chemical shift 
λ Wavelength 
 xxv
CHAPTER 1 
 
GENERAL INTRODUCTION 
 
 
The field of bioorganometallic chemistry, which is a hybrid area between 
biochemistry and organometallic chemistry has rapidly matured and has gained great 
interest over the past two decades and has allowed for the design of  new organometallic 
bioconjugates which can be engaged in many important fields such as molecular 
recognition, biosensors, bioelectronics, and catalysis.[1-6] In addition, by choosing the 
appropriate organometallic group and peptide sequences it may be possible to control 
the supramolecular self-organization. Considerable efforts have focused on utilizing 
ferrocene (Fc) building blocks in supramolecular chemistry. These systems have been 
exploited as molecular scaffolds to control the organization of peptides secondary 
structures in order to have a better understanding of the factors affecting protein 
structure and stability, and to facilitate the rational design of useful drugs.[7-13]  
Peptide-derived bioconjugates occupy a special position in that they offer the 
potential for biomolecular recognition and enable probing of biological processes.[14, 15] 
These systems are also of a more fundamental interest for the construction of well- 
defined scaffolds. The assembly of amino acids and peptides into extended 
supramolecular three-dimensional structures is controlled by the hydrogen bonding 
between individual molecules.[16, 17] The desire to control the properties of such 
assemblies has led to a considerable body of work focused on the design of secondary 
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structural elements,[18, 19] and on the design of new peptidic materials, ranging from 
peptide nanotubes[20-24] to peptide hydrogels.[25-27] Bioorganometallic peptide conjugates 
have allowed additional control over the structural properties by choosing the 
appropriate organometallic group. Fc is particularly useful in this regard.[28-32] 
Disubstituted Fc systems in which both cyclopentadienyl rings are substituted have 
allowed influence over the supramolecular structure of the assemblies by controlling the 
Cp-twist, as well as providing a starting point for the design of electronic 
biomaterials.[33] Recently, the artificial amino acid 1'-amino-ferrocene-1-carboxylic acid 
(Fca) was recognized as a useful tool in bioorganometallic chemistry. A series of 
peptides incorporating Fca have been synthesized by using solution phase methods.[34-
36]  Initial investigations show that Fca imposes specific secondary-structural elements 
onto the peptide.[34-36] Fca derivatives have also been employed as transition state 
analogues for formation of catalytic antibodies.[37] Electrochemical sensing of 
bimolecular interactions is one of the important applications of Fc chemistry.  Our 
group has been interested in studying the interaction of Fc-peptide conjugates with 
papain. This interaction was readily monitored electrochemically.[38]  
The following sections will provide an overview over the recent advances into 
the preparative and structural aspects of Fc-peptide conjugates. In particular, the focus 
is on the use of disubstituted Fc systems as templates in an effort to control the 
secondary structure, and the recent efforts of incorporating disubstituted Fc into oligo- 
and polyamides. 
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1.1. Preparation of Ferrocene Peptides Conjugates 
Amide coupling methods provided the most extensively explored way to couple 
the Fc moiety to amino acids and peptides. The preparation of Fc-peptide conjugates 
was achieved by coupling of a Fc-carboxylic acid and the terminal amino group of the 
amino acid. The pre-activation of the carboxylic group is important in order to achieve 
efficient synthesis under mild conditions. Different activation strategies include the 
“acid chloride” ,  “active ester”, and the oxazolone methods were developed.[39] The 
“acid chloride” method provides a fast and convenient rout for labeling peptides, which 
makes use of the reaction between Fc-acid chloride, prepared from Fc-carboxylic acid, 
and amino acids or peptides having an available amino terminus. Different organic 
bases can be used for capturing the formed HCl. The “active ester” method is based on 
the formation of an often-isolable Fc-CO-active ester. A variety of activating ester 
groups were used such as N-hydroxybenzotriazole (HOBt), 2-(1H-7-azabenzotriazol-1-
yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate (HATU), and 1-
hydroxysuccinimide (HOSu).  
These active esters can be used ether as stoichiometric Fc delivery reagent, as an 
intermediate in one pot reaction or used during solid phase peptide synthesis (SPPS). 
The Fc-CO-esters then react with the desired amino acid or peptide to give rise to Fc-
conjugate 5 (see Scheme 1.1). This effective method has led to the preparation of a 
number of mono- and disubstituted Fc-peptide derivatives. Up to now, a large number 
of mono- and disubstituted Fc-peptide conjugates of defined structure have been 
reported. Some excellent comprehensive reviews on Fc-peptide conjugates were 
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published recently and can be used as a valuable source of references.[40, 41] The 
following section focuses on the bioorganometallic conjugates containing disubstituted Fc.   
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Scheme 1.1.  Synthesis of ferrocenoyl amino acid esters (5) via the acid chloride and 
active ester methods: (i) (COCl)2 or SOCl2; (ii) carbodiimide such as DCC or EDC, 
HOBt; (iii) carbodiimide such as DCC or EDC, HOSu and (iv) peptide or amino acid 
and base. 
 
1.1.1. 1,1'-Ferrocenedicarboxylic Acid Conjugates 
A large number of bisamino acid and bispeptide substituted Fc-conjugates were 
synthesized by employing 1,1'-ferrocenedicarboxylic acid, Fc[COOH]2 6 as starting 
material.  
Fc-active esters, initially employed by Degani and Heller for coupling the Fc-
group to  the ε-amino group of lysines in proteins,[42, 43] were successfully employed in 
the synthesis of symmetrical Fc-peptide-cystamines having two Fc groups linked to the 
two terminal amino groups. A series of 1,1'-oligoprolinoyl-Fc(s) 7-10 were obtained 
from Fc[COOH]2 6, HOBt, EDC, and a series of oligoproline esters (Scheme 1.2).[44, 45]  
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The proline derivative 7 was first obtained by Herrick via the acid chloride route.[46]  
Importantly, this route also offers a way to introduce site differentiation between the 
two cyclopentadienyl (Cp) rings and in essence allows the formation of Fc-peptide 
conjugates, in which two different peptides can be attached to the two Cp rings. Using 
only one equivalent of peptide ester, ring-differentiated 1-oligoprolinoyl-1'-OBt-Fc 
derivatives 11-13 were obtained. This class of compounds is a convenient starting 
material for the synthesis of asymmetrically substituted ferrocenoyl derivatives, which 
may potentially have applications in proteomics and protein sensing. Erker and co-
workers reported an unusual procedure for the synthesis of Fc[Val-OMe]2 15 from two 
equivalents of the Li-salt of a Cp-Val-OMe-conjugate with anhydrous FeCl2 in THF 
(Scheme 1.3).[47] 
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Scheme 1.2.  Synthesis of 1,1'-bispeptide Fc derivatives peptides 7 – 13 via the 
HOBt/EDC protocol: (i) HOBt, EDC, CH2Cl2, H-Pron-OMe (n = 1-4). 
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Scheme 1.3. Unusual synthesis of Fc[Val-OMe]2 15 from the Li salt of CP-Val-OMe 14 
formed by the addition of isocyanate: (i) FeCl2, THF, 60°C, 7d; (ii) FeCl2/CpLi,  50 °C,  
THF, 7d.  
 
Using the same procedure, the Fc-peptide macrocycles 25-29 were obtained in 
low to moderate yields by the reaction of Fc[COOH]2 6 with the appropriate amino 
acid-cystamine conjugates in the presence of carbodiimide and HOBt under high 
dilution conditions (Scheme 1.4). At concentrations above 2 mM in Fc[COOH]2 6 the 
yields were decreased significantly, as expected for the synthesis of macrocycles. 
Cheng reported on the synthesis of the related Fc-peptide-cystine-macrocycles using the 
acid chloride method starting from Fc-dicarboxylic acid chloride Fc(COCl)2 30.  In 
addition to the desired systems, a series of dimeric Fc-macrocycles was obtained (see 
Scheme 1.14).[48] Interestingly, the cystine macrocycles were able to coordinate alkali 
ions very effectively.  Another series of such Fc-peptide conjugates were prepared by 
incorporating Gly, Ala, Val, and Leu. The cystamine disulfide was used as anchor 
group for the preparation of Fc-peptide films on gold substrates and their subsequent 
investigations of the electron transfer properties from the Fc group through the peptide 
spacer to the gold surface.[49]  
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Scheme 1.4. Synthesis of redox active cyclopeptides : (i) EDC, HOBt, CH2Cl2; (ii) 
(CSA)2• 2HCl, CH2Cl2; (iii) a) Boc-amino acid CSA dimer, TFA; b) Et3N, CH2Cl2; (iv) 
dilution 
 
Importantly, a fascinating macromolecular assembly can be produced by 
expansion of the ring by additional amino acids, in which the peptide macrocycles 
associate into “pseudo-β-barrels”.[13] Fc[Gly-Val-CSA]2 21 has Gly as the first amino 
acid to be attached to the Fc group, giving maximum flexibility to the podant peptide 
chains, followed by Val, an amino acid with very high propensity to form β-sheets.[50]  
 
1.1.2. 1'-Aminoferrocene-1-Carboxylic Acid Conjugates 
While extensive studies have been focusing on Fc[COOH]2 derivatives, fewer 
reports have utilized 1'-aminoferrocene-1-carboxylic acid (Fca) as starting material for 
making Fca-peptide conjugates. Modifying Fc with an amino group was always difficult 
and the product was often considered as unstable and sensitive to air and water. 
Nevertheless, different synthetic routes were described in an attempt to obtain Fca. In 
several of these synthetic procedures 1-bromo-1'-dilitioferrocene has been used as a key 
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precursor.[51-53] The resulting compound can be considered as promising monomer for 
the formation of the peptide-like Fc backbone polymers. However, the material is 
readily oxidizable and easily contaminated with butylated byproducts.[53]  
Recently, Rapić and coworkers reported an alternative synthetic approach to 
full-protected derivative of Fca 23 as shown in Scheme 1.5. The compound showed 
good stability and can be readily coupled to amino acids and peptides in mild 
conditions. The removal of the protecting groups can be achieved easily to give the 
desired precursor. For example, deprotection of ester group can be performed by base 
hydrolysis in aqueous medium, and the Boc group can be removed by treatment with 
acid.[54]  During the synthesis, the symmetrical Fc-substituted urea, dimethyl 1',1'-
ureylenedi(1-ferrocenecarboxylate) 24 was formed as a by-product (Scheme 1.5).[55] 
The Fc groups linked through a urea group, which upon deprotection maybe used in 
condensation reactions.  
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+
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23b
(iii)
 
Scheme 1.5. Synthesis of Boc-protected 1'-aminoferrocene-1-carboxylic acid. (i) t-
BuOH, reflux for 4 hours (ii) NaOH/H2O, MeOH (iii) TFA/CH2Cl2. 
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Another convenient synthetic route starting from Fc to give the hydrochloride 
salt of Fca  27 was described by Heinze and coworkers.[56] Scheme 1.6 summarizes the 
reaction sequence. The key material in this synthesis was 1-aminoferrocene 24, 
prepared from N-ferrocenylphthalimide. However, this route requires the synthesis of 1-
haloferrocene or Fc boronic acid as precursors of N-ferrocenylphthalimide. In addition, 
the reaction is accompanied by the formation of biferrocenes due to a copper-mediated C-
C coupling reaction, even in the presence of excess phthalimide.[57-59]  
 
Fe
NHAc
Fe
NH2
(iv)
Fe
NHAc
COOH
Fe
NH2 . HCl
COOH
(i) (iii)(ii)
24 25 26
27  
Scheme 1.6. Synthesis of Fc amino acid hydrochloride 27 according to Heinze: (i) N-
acetylation with Ac2O, (ii) selective Friedel-Crafts acylation with 2,6-dichlorobenzoyl 
chloride at the unsubstituted Cp ring; (iii) base hydrolysis; (iv) removal of the acetyl 
protection group with hydrochloric acid.  
 
The first attempt for the preparation of  Fca-peptide conjugate Boc-Ala-Fca-Ala-
Ala-OMe 29 was reported by Rapić and Metzler-Nolte and is shown in Scheme 1.7.[35]  
They employed EDC/HOBt coupling protocol, starting from Fca derivative 23a and 
coupled H-Ala-Ala-OMe to the C-terminal followed by coupling Boc-Ala-OH to the N-
terminal.   
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 Fe
O
N
O
Me
H
N
Me
H
OMe
O
N
Me
O
NHBoc
H
Fe
O
N
O
Me
H
N
Me
H
OMe
O
Fe
NHBoc NHBoc
(i)
(ii), (iii)
23a 28
29
O
OH
 
Scheme 1.7. Synthesis of the tetrapeptide Boc-Ala-Fca-Ala-Ala-OMe 29 derived from  
1'-Boc-aminoferrocene-1-carboxylic (Fca) 23a: (i) + H-Ala-Ala-OMe, EDC/HOBt; 
(ii) HCl(g)/ AcOEt; + Boc-Ala-OH, EDC/HOBt. 
 
Kraatz reported on the reactivity of Fca derivative 23b with different alkylating 
agents such as EtSCH2CH2Cl and (CN)(EtO)2P(O) which serve as chemical warfare 
agents mimic.[60] The successful preparation of compounds 30-33 has led to the novel 
idea of exploiting Fca as a redox active precursor towards developing an 
electrochemical sensor for the detection of chemical warfare agents. Summary of 
alkylation reactions of the amino group of 23b is described in Scheme 1.8. This study 
was extended by preparing the cystamine conjugate of Fca which was then anchored to 
the gold surface in order to carry out surface reactions with simulants for chemical 
warfare agents.[61]  
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 (i), (ii)
Fe
COOMe
NHR
30 : R = Me
31 : R = Et
32 : R = CH2CH2SEt
33 : R = P (O)(OEt)2
Fe
BocHN
Fe
NHBoc
S
S
O
O
(iii), (iv)
34
a
b
Fe
NHBoc
23a
O
OMe
Fe
NH2
23b
O
OMe
Fe
NHBoc
23a
O
OH
 
Scheme 1.8. (a) Reaction of 38b with the alkylating reagents to form compounds 30-33 
(b) synthesis of compound 34 from 23a according to Khan et al. [60, 61] (i) EtOH (ii) 
Saturated NaHCO3 (iii) HOBt, EDC (iv) Cystamine, Et3N.  
 
1.1. 3. 1,1'-Diaminoferrocene  Conjugates 
Over the past decade or so, little efforts have been made to synthesize Fc-amine 
compounds.[62-64]  None of these methods appeared attractive because of poor overall 
yield and inconvenient reaction conditions.  Since 1961, the first attempt to prepare 1,1'-
diaminoferrocene 38 made by Knox et al,[65] very few studies have attempted to develop 
an improved synthetic route because of the explosive nature of the diazoferocene 
intermediate, also the products were unstable and very sensitive  to air.[66] Therefore, 
peptide derivatives of 1,1'-diaminoferrocene were completely absent from the literature 
until recent date. An improved high-yield synthesis of diaminoferrocene was described 
by Arnold and coworkers.[66]  They started from diazioferrocene using a modified 
Nesmeyanov procedure (Scheme 1.9). Catalytic reduction of the diazide with H2-Pd/C 
in MeOH resulted in the formation of diaminoferrocene. Removal of the Pd/C catalyst 
and crystallization at -30 °C afforded diaminoferrocene in a good yield. However, an 
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extreme care should be exercised when handling solid diazidoferrocene, as it tends to 
explode if heated rapidly above 56 °C .[66] 
 
Fe
Br
Br
Fe
N3
N3
Fe
Li
Li
(i) (ii) (iii) Fe
NH2
NH2
35 36 37 38  
Scheme 1.9. Arnold’s synthesis of 1,1'-diaminoferrocene involving the explosive 
diazidoferrocene: (i) C2H2Br4, Et2O, (ii) NaN3, CuI, EtOH/H2O, (iii) H2, Pd/C, MeOH 
 
Most recently, we have described a convenient synthon for 1,1'-.bis(tert-
butoxycarbonylamino)ferrocene 40 as a stable Boc-protected form of 1,1'-
diaminoferrocene 38. This new synthetic approach has circumvented the problems 
encountered with the explosive diazide as described in Scheme 1.10. First, 1,1'-
Bis(carbonylazido)ferrocene 39 was synthesized from Fc[COOH]2 6 by treatment with 
ethyl chloroformate, followed by reaction with sodium azide. The resulting 
carbonylazido 1,1 -Bis(carbonylazido)ferrocene 39 is then reacted with tert-butanol to 
give 1,1'-bis(tert-butoxycarbonylamino)ferrocene 40.[67]  
Fe
NHBoc
NHBoc
Fe
CON3
CON3
(i)
39 40
Fe
H
N * NHBoc
Me
O
N
H *Me
O
NHBoc
*    L-Ala: 41a
      D-Ala: 41b
(ii)
 
Scheme 1.10. Synthesis of 1,1-bis(Boc-amino)ferrocene 40 via 1,1-bis(carbonylazido) 
Fc 39, and its amino acid derivatives with L-Ala (41a) and D-Ala (41b). (i) Reflux in t-
BuOH, 80 °C, 8 h; (ii) a) TFA, b) TEA, c) Boc-Ala-OH activated by EDC/HOBt.[67] 
 
The compatibility of the bis-Boc derivative with the peptide synthesis protocol 
was successfully proved by the preparation of its first amino acid conjugates. The 
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syntheses of the L-Ala and D-Ala conjugates, 1,1'-bis(tert-butoxycarbonyl-L-alanine-
amido)Fc (41a) and 1,1'-bis(tert-butoxycarbonyl-D-alanine-amido)Fc (41b) were 
readily achieved after deprotection of the amino group, followed by coupling with the 
corresponding Ala derivatives in the presence of a carbodiimide under inert atmosphere, 
to prevent the oxidation of the diaminoferrocene formed in situ.  
 
1.2. Structural Studies of Ferrocene-Peptide Conjugates 
In the structure of Fc the two Cp rings are separated by about 3.3Å, a distance 
suitable for forming a hydrogen bonding network for the attached peptide strands as 
observed in β-sheets. That gives Fc the ability to act as organometallic scaffold with a 
central reverse-turn unit. Moreover, by choosing the appropriate molecular assemblies 
and by utilizing chiral centers and H-bonding sites of conjugated peptide chains, it was 
possible to design highly ordered supramolecular systems. From these points of view, a 
variety of Fc–peptide bioconjugates have been designed to obtain a peptidomimetic 
basis for protein folding and to construct highly ordered molecular assemblies. 
 
1.2.1. General Features 
Some pertinent structural features for some Fc-amino acids and Fc-peptide 
conjugates are summarized in Table 1.1. In general, the two Cp rings of most 
structurally investigated Fc-amides are virtually co-planar[68] with a small angle θ and 
co-planarity between the amide and Cp planes (β) as defined in Scheme 1.11. In many 
cases, the two Cp rings are eclipsed. 
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 Fe
Fe
O
N
H
θ
β
R
 
Scheme 1.11.  Torsion angles in Fc-amino acids and peptides: θ = Cp bent and β = twist 
between amide and Cp planes 
 
 
Table 1.1. Some common structural parameters for disubstituted ferrocenoyl amino 
acids and peptides 
 
Compound d(C-C) <(O-C-N) θ β d(C=O) Ref. 
Fc[Gly-CSA]2 (17) 1.238(4) 
1.235(5) 
1.482(5) 
1.477(6) 
122.6(4) 
122.9(4) 
< 1 
 
 [9] 
Fc[Gly-Val-CSA]2 (21) 1.243(4) 
1.243(4) 
1.490(5) 
1.483(5) 
123.2(3) 
122.8(4) < 1 
 [13] 
Fc[Gly-OEt]2 (42) 1.235(5) 
1.230(4) 
1.482(5) 
1.487(5) 
121.1(3) 
121.2(3) 1.8 
14.1 
15.2 
[69] 
Fc[Gly-OH]2 (43) 1.246(2) 1.472(3) 121.1(2) 0.9 2.9 [69] 
Fc[Gly-NH2]2 (44) 1.238(5) 1.478(5) 121.9(4) 0.1 6 [70] 
Fc[Pro-OMe]2 (45) 1.219(11) 
1.227(11) 
1.515(14) 
1.481(14) 
129.2(9) 
120.1(9) < 1 
 [46] 
Fc[AlaPro-OMe]2 (46a) 1.219(7) 1.506(9) 121.7(7) 0.53 3.77, 5.64 [71] 
Fc[AlaPro-OEt]2 (46b) 1.222(7) 1.478(8) 121.7 (6) 2.45 5.27 [72] 
Fc[AlaPro-OPr]2 (46c) 1.220(1) 1.47(1) 119.0(1) 1.75 1.70, 4.38 [73] 
Fc[AlaPro-OBz]2 (46d) 1.22(1) 1.51(1) 121.0(1) 2.60 2.64, 2.84 [73] 
Fc[Val-OMe]2 (47) 1.222(4) 1.488(5) 122.4(3)   [47] 
Fc[Phe-OMe]2 (48) 1.238(5) 
1.232(6) 
1.492(7) 
1.498(7) 
121.7(4) 
123.0(5) 4.7 
31.4, 15.1 [74] 
 
The group attached to Fc moiety has a significant influence on the co-planarity 
of the Cp and amide planes. Steric interactions of the substituents with adjacent 
molecules may result in a loss of coplanarity of the Cp rings. Generally, the twist angle 
between the Cp and amide planes will increase with increasing size of the substituent 
(see Scheme 1.11), which will result in poor electronic coupling between Cp and amide 
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for large twist angles. In general, for all ferrocenoyl amino acids and peptides, the Cp 
bent angle is less than 1 - 4.5°, which is relatively small. However, extending the 
peptide sequence will result in increasing the angle due to the relief of steric 
pressures.[68]   
The distances from the carbonyl carbon to the Cp rings for all structurally 
characterized Fc-peptides are well within established bond distances for a normal C-C 
single bond in Fc-amides (range d(C-C) = 1.43 – 1.507 Å).[68] Furthermore, the amide 
C(O)-N group is planar in all Fc-amino acids and –peptides and the carbonyl C=O 
distances compare well with simple Fc-amides. Similarly, the bond distances and angles 
of the Fc-moiety itself are well within established parameters for Fc derivatives.[68] 
With some exceptions in which larger twist angles are realized, the small cp-amide 
twists for most Fc-peptides allowed for significant electronic interaction between the π-
systems of the Cp and the amide group, which will be discussed in the following 
section.  
 
  
1.2.2. Hydrogen Bonding Properties of Disubstituted Ferrocene Peptide Conjugates 
All Fc-peptides exhibit a fascinating array of intermolecular H-bonding 
interactions, which result in an ordered packing of the molecules in the solid state. It 
was observed in all structures investigated to date that the Fc-group does not interfere 
with the intrinsic ability of the peptides to assemble into larger aggregates via 
intermolecular H-bonding. The crystal structure of the two compounds Fc[Gly-OEt]2 42 
and Fc[Gly-OH]2  43 are of particular interest where they display two completely 
different substitutional patterns as well as different H-bonding patterns (Figure 1.1).[69]  
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 NH
R
O NH
R
O
O
NH
R
O
N
H
R
 
 
Figure 1.1. a) Molecular drawing of compound Fc[Gly-OEt]2 42 showing the 1,3'-
substitution of the Fc group; (b) molecular drawing of the centrosymmetric Fc[Gly-
OH]2 43 showing the 1,2'-substitution and the typical H-bonding pattern. Redrawn from 
Ref. [69] 
 
In the case of Fc[Gly-OEt]2 42, a 1,3'-substitution pattern is observed, which results in 
the formation of intermolecular H-bonding exclusively. Interestingly, the amide group 
on the other Cp ring is not involved in H-bonding and is well separated from other 
molecules (ca. 4 Å).  This H-bonding pattern is reminiscent of that reported by 
Gallagher, Kenny and Hirao[71, 75, 76] with alternating up-down orientation of the 
individual H-bonded molecules. On the other hand, the free acid Fc[Gly-OH]2 43 adopts 
C2 symmetry with a 1,2'-conformation which allows the formation of strong 
intramolecular H-bonding between the two podand substitutents (N…O(2A) and 
O(2)…N(A) = 2.875(3) Å). This pattern provides a rigid framework, in which the amide 
twist is reduced considerably (β = 1.8º) (see Table 1.1, Scheme 1.11). Mingos et al 
described a related amide Fc[Gly-NH2]2 44,[70] which was engages in intermolecular 
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interactions with adjacent molecules. Different 1,1'-disubstituted Fc-peptides, such as 
Fc[Pro-OMe]2 45 and Fc[Ala-Pro-OMe]2 46a were reported by Herrick and Hirao.[46, 71]  
 
Fe
N
O
C
OMe
O
N
OC
MeO
O
N
C
OMe
Fe
O
N
O
Me
H O
N
C
OMe
O
N
O
Me
H O
45 46a  
Figure 1.2. Molecular structure of 1,1'-Fc-prolinylmethylester 45 and 1,1'-Fc-
bis(alanylprolinylesters) 46a. 
 
A series of related disubstituted Fc-dipeptides was studied by Hirao and 
coworkers.[71-73]  It was shown that only intramolecular H-bonding is present in the C2 
symmetrical molecules Fc[Ala-Pro-OR]2 (46a-d)  forcing the two Cp rings into a 1,2'-
conformation which has been observed frequently in other disubstituted Fc systems. 
Two strong intramolecular H-bonding interactions are present between the C=O of Ala 
of the Cp ring and the amide NH of Ala of another strand on the Cp' ring giving 
d(O…HN) distances of 1.88 and 2.15 Å (Figure 1.3). 
 
O
N
H
O
N
EtO
O
O
N
H
O
N
EtO
O
Fe
O
N
H
O
N
EtO
O
O
N
H
O
N
EtO
O
Fe
46b 46b-D  
 
Figure 1.3.  Molecular structure of Fc-[L-Ala-L-Pro-OEt]2  46b and Fc-(D-Ala-D-Pro-
OEt)2 46b-D.[72] 
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It was found that the strong intramolecular H-bonding is the dominant factor, 
forcing the two amide planes to be co-planar to their respective Cp ring. In addition, the 
size of the peptide has very little effect on the structure. Changing the ester substituent 
in this series of compounds has virtually no effect on their molecular conformation.[72] 
Importantly, the intramolecular H-bonding is preserved in solution. Despite the lack of 
intermolecular H-bonding, these molecules assemble in a chirality-directed self-
assembly into helical structures.  The helicity of the super-structure depends on the 
chirality of the podant peptide. The L-Ala-L-Pro podant peptide chain will result in a 
helical arrangement, with the podant D-Ala-D-Pro giving the exact mirror image (Figure 
1.3). Both helices have a pitch height of >14 Å and a distance between the Fc groups of 
approximately 4.5 Å. The related GlyPro and ProGly systems form related 
supramolecular arrangements in which intramolecular H-bonding determines the 
structure of the assembly.[77] Importantly, the helical chirality of the Fc core itself is 
preserved in solution. 
 
HN
R
O
a b c
O
H
N
R
HN
R
O
O
HN
RO
O
HN
R
NH
R
 
Scheme 1.12. Some of the possible orientations of the amino acid and peptide 
substituents. Structure a) is the most commonly found structural motif having the two 
C=O anti orientation. 
 
In 1,2'-substituted Fc derivative, the two peptide substituents can adopt three 
different orientations with respect to each other shown in Scheme 1.12. The two Fc-CO 
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groups on the two Cp rings are pointing away from each other (A) allowing the 
remaining peptide chain to engage in intramolecular H-bonding interactions between 
the Fc-amide N-H and the amino acid or peptide carbonyl groups, resulting in the 
formation of two interstrand H-bonds. This is the typical “Herrick pattern”, commonly 
observed in disubstituted Fc-peptide conjugates. For example, in Mingos' Fc[Gly-NH2]2 
44 two H-bonds are formed with N···O distances of 2.88 Å.[70] However, for the 
sterically more demanding isopropyl substituent in Erker's Fc[Val-OMe]2 47, only very 
long N···O contacts of 3.247 Å are established. Metzler-Nolte[74]  described the only 
case in which isomer B is observed. In Fc[Phe-OMe]2 48, one of the carbonyl groups 
points inwards towards the amide group of the other amino acid substituent. As a 
consequence, only a single inter-strand C=O···H-N H-bond is formed with a N···O 
contact of 2.832 Å.                              
 
 
A B 
Figure 1.4. 1,2'-substituted Fc systems showing the two different conformations of the 
amino acid substitutents: a) Conformation A: drawing of the molecular structure for 
Fc[Gly-NH2]2 44 showing the two C=O pointing outwards, allowing the formation of 
interstrand H-bonding between the two amide C=O and N-H; b) Conformation B: 
drawing of the molecular structure of Fc[Phe-OMe]2 48, showing one of the C=O 
pointing inwards the other pointing outwards, resulting in the formation of only a single 
H-bond. Redrawn from Refs.[70, 74] 
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The macrocyclic Fc[Gly-CSA]2 17 can be thought of as having the two podant 
Gly substituents clipped together with a cystamine linker.[9] Its structure is shown in 
Figure 1.5. The molecule is also achiral and like Fc[Gly-OH]2 43, adopts a 1,2’-
configuration, having both Fc-C=O pointing outwards. Both carbonyl groups and are 
engaged in intermolecular H-bonding interactions to adjacent molecules. Strong 
intramolecular H-bonding was observed as result of both amide NH contribution 
opposite peptide C=O across the ring (d(N(11)···O(22) = 2.862(4) Å, d(N(21)···O(12)) = 
2.873(4) Å, d(N(31)···O(42) = 2.959(4)Å, d(N(41)···O(32)) = 2.815(4) Å).  
 
Figure 1.5. Molecular structure of the macrocyclic Fc[Gly-CSA]2 (17) showing the 
intra- and intermolecular H-bonding interactions. The molecule has two diastereomers 
in the asymmetric unit.[9] 
 
Interestingly, expansion of the ring by additional amino acids results in the 
formation of a fascinating macromolecular assembly, in which the peptide macrocycles 
associate into “pseudo-β-barrels”.[13] Fc[Gly-Val-CSA]2 21 has Gly as the first amino 
acid to be attached to the Fc group, giving maximum flexibility to the podant peptide 
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chains, followed by Val, an amino acids with very high propensity to form β-sheets.[50] 
The Fc-system itself adopts a “Herrick conformation” and the cystamine acts as a 
structural restraint enabling additional H-bonding and establishing the appropriate H-
bonding interface on the “exterior” of the macrocycle which allows β-sheet type 
interaction with adjacent molecules.[13] 
 
Figure 1.6. a) Structural drawing of dimethyl-1',1'-ureylenedi (1-ferrocenecarboxylate) 
24  ; b) the crystal packing showing the intermolecular hydrogen bonding pattern. 
Redrawn from the original crystal structure.[55]  
 
Figure 1.6 shows the single crystal structure of the urea compound 24. In 
comparison to other urea compounds, the urea oxygen is not involved in intermolecular 
H-bonding. Instead, intermolecular H-bonding involves the methylester C=O and the 
urea N-H of an adjacent molecule resulting in a slight asymmetry of the urea group, 
resulting in the formation of a one-dimensional chain. However, on the molecular level, 
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this introduces a degree of asymmetry in the molecule which manifests itself in two 
different C-N bond lengths (N(11)-C(15) = 1.367(3) Å, N(12)-C(15) = 1.378(3) Å).  
Interestingly, Rapić and Metzler-Nolte observed a turn-structure into their first 
Fca peptide conjugate 29 induced by this unnatural organometallic amino acid Fca with 
an anti-parallel motif. The solid state structure showed two intra-molecular H-bonds as 
shown in Figure 1.7. The N–H–O bond angle deviates only slightly from linearity, and 
N–O distances around 2.9 Å indicate strong hydrogen bonding. The angle ω between 
the substituents on the Cp rings is 60.7°, which confirm a typical 1,2'-conformation of 
the Fc system. The structure adopts a P-helical arrangement in the solid state and in 
solution which parallels work by Hirao and coworkers on peptide conjugates of 
Fc[COOH]2 conjugates.[72] Additional studies show that amino acid and peptide 
conjugates of Fca in general adopt a β-turn-like structure in which the peptide strands 
are forced to adopt an antiparallel orientation with respect to each other.  
 
Figure 1.7. X-ray structure of the first Fca peptide conjugate 29 showing two intra-
molecular hydrogen bonds. Selected hydrogen bond distances (Ǻ) and angles (°): N1–
O52 2.812(3), N51–O2 2.914(3), N1–H1N–O52 169(3), H51–H51N–O2 157(3). 
Redrawn from reference [35]. 
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adjacent carbonyl of the Boc causing M-helicity of the compound. 
 
 
Figure 1.9. Structure  of 1,1'-bis(tert-butoxycarbonylamino)ferrocene 40 showing three 
rotamers having the two substituents at different rotational angles with respect to the 
Cp-Fe-Cp vector with an approximate 1,2' (70º) and 1,3' (144º, 180º) conformation. All 
three rotamers are linked via intermolecular N(H)•••O=C bonding, redrawn from 
Reference [67]. 
 
Importantly, for amino acid conjugates the intramolecular NH···O=C H-bonding 
results in the formation of a previously unobserved 14-membered H-bonded ring, which 
is a new structural motif for Fc-peptide conjugates. [67] The resulting bioconjugates from 
the reaction of 1,1'-bis(tert-butoxycarbonylamino)ferrocene 40  with Me-protected D- 
and L-Ala showed a specific secondary structure through the involvement of strong 
intramolecular H-bonding in the solid state as well as in solution, forming a 14-
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membered ring as is seen in antiparallel β-sheet peptides. The chirality of the amino 
acid is found to change the chiral organization of the peptide strands with respect to Fc 
center. To the best of our knowledge, this is the only available example of 
diaminoferrocene-labeled bioconjugates. 
 
1.3. Oligomeric and Polymeric Ferrocene Amides   
Fc-based organometallic polymers have received  considerable attention since 
the first report of poly(vinylferrocene) by Arimoto and Haven in 1955.[28-30, 78-89]  A 
large number of attempts to produce Fc-containing polymers, including polyalkenes, 
polyketones, polyesters, polyamines, polyamides, polyurethanes, and polyureas were 
reported.[84, 90] Polyamidoamine-based conjugates represent a class of polymere which 
can be readily ferrocenylated through amide-linked Fc in which the metallocene is 
linked to the side chain.[91] Early synthetic efforts have focused on the modification of 
the polymer side chains with Fc groups. In particular, ferrocenylalkylcarboxylic acids, 
Fc-(CH2)n-COOH (n = 0-3) were useful by allowing a facile conjugation to the polymer 
by a variety of methods.[78, 82, 92-96]  
The preparation of polyamides having metallocenes incorporated into the 
backbone can be achieved by the use of bifunctional Fc derivatives, such as diacid 
chlorides or diamines. In the following, a few examples of such reactions are presented. 
In the early 1960’s Knobloch and Rauscher reported the preparation of polyamides and 
polyesters by the reaction of 1,1'-ferrocenyldicarbonyl chloride 30 with several 
diamines and diols by interfacial polycondensation.[97]  
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Related work by Cuadrado and coworkers focused on the interfacial 
polycondensation protocol to prepare organosilicon polymer 50 in which the amid-
linked ferrocenyl moieties are part of the main polymer chain as shown in Scheme 
12.[98] The material was prepared by polycondensation of 1,1'-ferrocenyldicarbonyl 
chloride 30 with the siloxane 49 in the presence of triethylamine as base. 
 
H2N (CH2)3 Si O Si (CH2)2 NH2
Me
MeMe
Me
+
N
H
(CH2)3 Si O
Me
Me
Fe
C
O
Si (CH2)2
H
N
Me
Me
C
O
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O
Fe
Cl
O
Cl
 
Scheme 1.13. Synthesis of the methylsiloxane polymer [-Si-(CH3)2-(CH2)3-NHC(O)-
Fc-C(O)NH(CH2)3Si(CH3)2O-]n 50 having Fc in the backbone of the polymer chain 
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Scheme 1.14. Synthesis of cyclopeptides 51 and 52 by condensation of 1,1'-
ferrocenyldicarbonyl chloride and bifunctional cystein derivatives.   
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Using Fc[COCl]2, it should also be possible to prepare polypeptide conjugates, 
in which the Fc group is part of the polymer backbone and linked to the polypeptide 
through amide linkages.  Han and coworkers were able to prepare 1,1'-ferrocenophane 
derivatives 51 as well as cyclodimers 52 and macrocyclic compounds from 30 and 
various cystein derivatives (Scheme 1.14).[99] Presumably, a non-defined polymer was 
also formed under the reaction conditions. This reaction is akin to the reaction leading 
to the formation of other Fc-peptide macrocycles discussed earlier (see Scheme 1.4).  
Several other reports have considered the synthesis, solubility, and thermal 
properties of the formed polymers. For example, Khan et al.[61, 100, 101] recently prepared 
Fc-containing aromatic polyamides, by solution phase polycondensation of Fc[COCl]2 
with various aromatic diamines in solution at low temperature. The resulting 
polyaramides possess glass transition temperature above 350 °C. However, the 
polymers were only soluble in concentrated H2SO4, which limited their characterization 
significantly. 
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Scheme 1.15. Synthesis of  some Fc-containing aromatic polyamides 53. 
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In a similar fashion, Mehdipour-Ataei and coworkers attempted to improve the 
solubility of Fc-polyamides by introducing a flexible linker into the polymeric 
backbone though the synthesis of Fc-containing diamine decorated by ether and amide 
units 54 (Scheme 1.16).[102] The polymers showed improved solubility and good 
thermal stability.  
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Scheme 1.16. Preparation of some Fc-based poly(amide ether amide)s 54.  
 
An interesting development is the use of Fca for the formation of a 
ferrocenylene polymer, in which the Fc groups are connected through amide 
linkages.[53]  In essence, Fca polymers could be built up in a stepwise fashion using 
orthogonalized building blocks. Nakamura and Heinze presented good examples for this 
approach. Starting from a protected Fca derivative, Nakamura was able to obtain its 
amide dimer.[58] The structure was related to the symmetrical ferrocenyl-substituted 
urea, dimethyl 1',1'-ureylenedi(1-ferrocenecarboxylate) 24 (see Scheme 1.6).[55] Based 
on the structure of this Fc-amide dimer, Nakamura proposed a strongly H-bonded 
structure for the polymeric material (Scheme 15).   
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Scheme 1.17. Structure of the organometallic Fc-polypeptide proposed by Nakamura.[58]   
 
Heinz prepared diferrocenyl diamide 68 from the reaction of ferrocenoyl 1-
hydroxybenzotriazole ester  66 with aminoferrocene  (Scheme 1.18).[56]  She was able  
to make use of this flexible building block, which can be incorporated into a peptide 
backbone by solid phase synthesis.[103]  
 
 
Fe FeFe
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O N
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+
55 24 56
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Scheme 1.18.  Coupling of ferrocenoyl benzotriazole ester 55 with aminoferrocene 24 
to give the diferrocenyl diamide 56; (i) THF, 12 h.  
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Figure 1.10.  a) Molecular structure of the diferrocenyl peptide 56 in the solid state, 
b) hydrogen bonding pattern in the solid state. Redrawn from Reference.[56] 
 
The crystal structure shows that the diferrocenyl dimer 56 possesses a 
conformation similar to Nakamura’s dimer. In addition, the individual molecules are 
connected through intermolecular H-bonding between the NH-acetyl group and the 
amide C=O (N1···O2 distance: 3.04 Å) and between the NH-amide group and the C=O 
oxygen atom of the acetyl group (N2···O1 distance: 3.03 Å) resulting in a sheet-like 
structure (Figure 1.10). 
Kraatz and coworkers have described the synthesis of a series of oligomeric and 
polymeric Fca-peptide conjugates based on D and L alanines.[104] They employed 
peptide-coupling strategies in solution to prepare the desired monomers Fca-L-alanine 
30 and Fca-D-alanine 31, their corresponding oligomers 32-37, and poly(Fca-L-alanine) 
38 (Scheme 1.19). A parallel β-sheet-like structure involving the amino acid residues 
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with 12-membered hydrogen-bonded rings was formed. By exploiting the turn-inducing 
ability of Fca they proposed a structure that shows some structural similarities to the β-
helical motif found in naturally occurring proteins which may be employed as 
electrochemical screens for “β-breakers”.   
 
 
Fe
O
O
Fe
NHBoc
23a
O
OH
N
H
BocHN
Me
O
n
n =1: 57 (S) ; 58 (R)
n =2: 59 (S) ; 60 (R)
n =3: 61 (S) ; 62 (R)
n =4: 63 (S) ; 64 (R)
polymer: 65 (S)  
Scheme 1.19. Synthesis of P- and M-helical foldamers from the conjugates of Fca with 
L- and D-alanine resulted in the formation of the oligomers 57-64 and the polymer 65. 
 
In addition to the poly-Fc amide derived from Fc[COCl]2 and Fca, very few 
reports described the synthesis of poly-Fc amides obtainable by the polycondensation 
ferrocenediamine derivatives. For example, the synthesis of elastomeric polyamides 68, 
Mn = 10 000-18 000) in high yields was reported by Rausch and coworkers from 1,1'-
bis(β-aminoethyl)ferrocene 67 and diacid chlorides (Scheme 1.20). The reaction with 
bis-isocyanates allows the formation of Fc-containing polyureas 69. 
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Scheme 1.20. Synthesis of elastomeric polyamides 67 and 68 from 1,1'-bis(β-
aminoethyl) Fc 66 and diacid chlorides. (i) Cl-CO-R-CO-Cl; (ii) OCN-R'-NCO. 
 
 
Frejd's 1,1'-ferrocenylbisalanine system[105-110] is another interesting bifunctional 
molecule for the synthesis of macrocyclic oligopeptides and potentially of Fc-
containing polypeptides. The fully protected 1,1'-ferrocenylbisalanine derivative 69 
contains orthogonal protecting groups, which allow their deprotection by 
hydrogenolysis, which is followed by cyclization in the presence of the peptide 
coupling reagent PyAOP.[105, 106, 110, 111]  The obtained product was a mixture of the 1,1'-
ferrocenophane 71 and two macrocyclic peptides, a  cyclic “dimer” 72 and a cyclic “trimer” 
73 (Scheme 1.21). Interestingly, poly-Fc amides obtained facial condensation of Fc[NH2]2 
and Fc[COCl]2 were completely missing from the literature.      
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Scheme 1.21. Cyclization of 70 forming macrocyclic oligopeptides 71-73: (i) H2, 
Pd/C(5%),MeOH (ii) 7-azabenzotriazol-1-yloxytris(pyrrolidino)phosphonium 
hexafluoro phosphate (PyAOP), Dipea, DMF. 
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1.4. Objectives and Motivation  
  The objectives of this thesis are to explore the preparative and structural aspects 
of Fc-peptide conjugates and their potential applications as new biosensors and 
polymeric materials. 
 
              
Scheme 1.22. Schematic representation summarizes the objectives of the study 
described in this thesis. 
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After surveying the literature we pointed out some challenges and scientific 
questions that were not answered or not properly addressed in the field of Fc-peptide 
conjugates and their applications in the fields of molecular recognition, biosensing and 
material science. First, the artificial amino acid 1'-amino-ferrocene-1-carboxylic acid 
(ferrocene amino acid, Fca) was recognized as a useful tool in bioorganometallic 
chemistry. Therefore, it was important to investigate the capability of this promising 
artificial amino acid to conjugate with amino acids and peptides, and study the 
structural properties of these conjugates. This will be addressed in Chapter 2.  
Second, it is important to explore the influence Fca on the self-assembly abilities 
of the conjugates and investigate the supramolecular structure of the Fca-peptides. This 
will be addressed in Chapter 3.  
Third, because of the interesting reversible redox properties and the suitable 
potential ranges of Fc, it was widely exploited as part of molecular recognition systems. 
Fc-peptide conjugates combine the ability of Fc to mediate electron transfer with the 
molecular recognition potentials of peptides. Is it possible to devise a strategy that uses 
Fc-peptide conjugates as biosensors? Labeling the peptide recognition site in a 
biosensor is potentially problematic. It is always interfering with the protein recognition 
process and may even prevent it. Thus, it was decided to explore this possibility and test 
the capability of Fca-peptide conjugates linked to surfaces to act as an effective 
electroactive probe for the detection of biological materials. This will be addressed in 
Chapter 4.  
Fourth, the synthesis of metallopolymers is one major application of ferrocenes. 
Significant efforts have focused on the synthesis of poly(ferrocenylenes) in which the 
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Fc groups form part of the backbone or located in the side chain. To the best of my 
knowledge there are no examples of oligomers and polymers that have peptide-like 
characteristics and possess a Fc in their backbone. This raises a fundamental question if  
the individual Fc units will be able to interact with each others electronically in such 
oligomers and polymers? This will be addressed in Chapter 5.  
Next I expand on these ideas and try to answer another question, what would be 
the effect of incorporating different linkers having different electronic environments, 
such as phenylene, cyclohexylene and lysyl groups on the electronic properties of Fc-
containing oligomers or polymers?  The phenylene group is expected to enhance the 
electronic communication between the Fc groups because of its strong conjugation 
effect however it should also give rise to a stiffer on the polymer. On the other hand, the 
cyclohexylene group is more flexible however it may not allow any communication 
because of the lack of conjugation system. The answers to this question will be 
addressed in Chapters 6. 
By pointing out these important scientific questions, three challenges will be 
addressed in this growing field.  The first is to investigate the biocompatibility of the 
organometallic moieties with the conjugated amino acids and peptides. New Fc building 
blocks such as Fca and 1,1'-bis(tert-butoxycarbonylamino)ferrocene are synthesized and 
employed for that purpose. In particular, the tendency of disubstituted Fc systems to 
impose secondary structural elements on the conjugated peptides was investigated in 
detail. The second is to design and synthesize specific Fca-peptide conjugates to 
develop a surface based electrochemical biosensor for proteins, in which the Fc label is 
part of the recognition site but will not interfere with the peptide-protein interactions. 
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 Such systems were not available prior to my studies and, if successful, represent 
a significant step forward. The third is to build new electroactive peptide-like Fc oligo- 
and polyamides and to investigate their electronic properties, which could then be 
engaged in the bioelectronics applications. 
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 CHAPTER 2 
REARRANGEMENT OF THE ACTIVE ESTER INTERMEDIATE 
DURING HOBT/EDC AMIDE COUPLING 
 
2.0. Connecting Text 
The carbodiimide coupling protocol is often used in the peptide coupling for the 
activation of the carboxylic termini, which is then couples to the N terminal of the 
second amino acid. In order to begin this investigation, it was necessary to evaluate if 
the standard coupling protocol is applicable to the synthesis of ferrocene-peptides 
conjugates. This chapter describes the synthesis and full characterization of the new 
active ester benzotriazol-1-yl 1-(tert-butyloxycarbonylamino) ferrocene-1-carboxylate, 
which is a key intermediate in the coupling of  Fca to the amino acids and peptides. This 
chapter also addresses the transformation of this active ester into inactive N-oxide 
derivative, 3-{[1-(tert-Butyloxycarbonylamino)ferrocen-1-yl]carbonyl}-benzotriazole 
1-oxide, which represents a “non-productive” side products resulting in the loss of the 
organometallic label. 
This paper was reproduced with the permission from Eur. J. Inorg. Chem., 2005, 173-180, Copyright © 
2005, Wiley VCH. This paper was co-authored by Y.-T Long, G. Schatte, H.-B. Kraatz. All work 
described in this paper in terms of the experimental study, hypothesis, and initial writing of the 
manuscript, except the crystal structures solutions, were carried out by me. The text below is a verbatim 
copy of the published paper. 
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 2.1. Introduction 
 
1-Hydroxybenzotriazole (HOBt) is widely used in peptide synthesis as an 
activating agent for the acid component and for its ability to suppress racemization. The 
intermediate benzotriazole active ester A then reacts with an amino group to form 
urethane bond.[1] The conversion of A into the N-oxide isomer B was reported.[2, 3]   
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The N-oxide is favored in polar solvents, while the desired active ester A 
predominates in less-polar solvents.[4] It appears that the active ester A is the kinetic 
product, which is reactive towards rearrangement to the corresponding urethane form 
B.[5] In addition, Davies et al proposed the intermediacy of isomer C to explain 
enhanced racemization rates for certain amino acid esters.[6] Formation of the N-oxide 
under mild conditions was reported by Lu and coworkers by reacting Os3 cluster with 
HOBt.[7] Carbon-13 NMR spectroscopy,  used to identify the different isomers, 
confirmed the predominance of the active ester form A in DMSO,[8] while acetone will 
stabilize the more polar zwitterionic N-oxide.[9] More recently, Carpino reported a 
detailed investigation into the reactivity of the guanidinium salts HBTU and HATU. It 
was shown that the O-substituted uronium salt is significantly more reactive in peptide 
coupling reactions than the N-substituted guanidinium salt.[10]  
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 In the context of organometallic peptide conjugates, OBt-active esters provide 
convenient route to label peptides under very mild conditions, which are also readily 
automated for solid-phase peptide synthesis (SPPS). That was shown by the use of 
ferrocenoyl hydroxybenzotriazole (Fc-CO-OBt) as a stoichiometric delivery reagent for 
the redox active ferrocene (Fc) group, or more recently by the use of one-pot reactions 
involving cobaltocenium carboxylic acid and TBTU and HATU.[11] Whether the active 
ester is used stoichiometrically or used as an intermediate in a one-pot reaction or 
during SPPS, there is the potential for lowered incorporation of the organometallic label 
due to different reaction kinetics. During the preparation and column separation of Fc-
peptide conjugates, we and other groups noticed the appearance of a red Fc-containing 
material, which appears to possess also an OBt substituent. However, it was not 
possible to properly identify this material. Given the central role of OBt active ester 
intermediates for the preparation of organometallic peptide conjugates, we decided to 
investigate this in more detail. Here we describe our results of the study into the 
preparation of the OBt active ester of 1'-tbutylcarbamato-1-ferrocenecarboxylic acid (2) 
and its isomer 1-(3-benzotriazole-1-N-oxide)-1'-tbutylcarbamato ferrocene (3). 
 
2.2. Results and Discussion 
2.2.1 Synthesis and Characterization 
During the synthesis of the active ester 1-(1-benzotriazolato)-1'-tbutylcarbamato 
ferrocene (2), from 1'-tbutylcarbamato-1-ferrocenecarboxylic acid (1) in the presence of 
HOBt, and EDC, we prepared and isolated in addition to the desired product 2, the 
zwitterionic N-oxide 1-(3-benzotriazole-1-N-oxide)-1'-tbutylcarbamato ferrocene (3) 
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 (Scheme 2.1). We have no indication for the formation of the 2-N-ferrocenylated 
product. The two forms are readily separated from each other by chromatography, 
giving 2 as an orange-red compound and compound 3 as a dark red crystalline 
compound. The experimental results show that the active ester 2 is kinetic product, 
which is reactive towards rearrangement to the corresponding urethane form.[5] The 
rearrangement process is a phase dependant; in dry dichloromethane give a product 4% 
of 3 while in aqueous acetone the rearrangement is faster producing 11% yield of 3. . 
Although, we expected a higher reactivity according to earlier reports[10], the electron 
withdrawing effect of N-Oxide group most likely deactivates 3 with respect to its 
reactivity with the amino acids. Thus, we do not observe any reactivity with glycine. 
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Scheme 2.1. Two isolated products 1-(1-benzotriazolato)-1'-tbutylcarbamato ferrocene 
2 and N-oxide 1-(3-benzotriazole-1-N-oxide)-1'-tbutylcarbamato ferrocene 3 resulted 
form the activation of 1'-tbutylcarbamato-1-ferrocenecarboxylic acid 1 
 
Compounds 2 and 3 were characterized by NMR spectroscopy 1H, 13C., DEPT-
135 NMR, HMQC (Heteronuclear Multiple Quantum Correlation), and  HMBC  
(Heteronuclear Multiple Bond Correlation). Table 2.1 summarizes the complete 
assignment of the NMR signals for compounds 2 and 3. It is interesting to note that the 
signals due to H2, H5 and H2', H5' are observed at significantly different chemical 
shifts, indicating changes in local environment due to the change in the substituent, 
which undoubtedly affects both C rings. Changes are also significant in the 13C 
 45
 chemical shifts of the ipso-Cs indicating that electronic differences due to the 
substitutents are “seen” by the Fc system. C1 is affected more by the change from ester 
to amide N-oxide than C1', the ipso-C to which the different substituent is attached. 
Comparing the chemical shifts for the proton H11 in 2 and 3, then this proton is 
particularly deshielded on due to the proximity to the N-oxide group in 3. The NH 
proton showed broad singlet at δ 6.42 and 5.75 for 2 and 3, respectively.  
 
Table 2.1. Spectroscopic characterization of compounds 2 and 3. 
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Site 1H 13C HMQC HMBC 1H 13C HMQC HMBC 
1'    100.2    98.9 
1    65.2    71.6 
2' , 5' 4.71  62.9  4.52  62.7  
2 , 5 5.00  72.3  5.36  74.1  
3' , 4' 4.08  55.9  3.94  67.0  
3 , 4 4.62  74.7  4.63  74.8  
6  167.5    168.0   
7    129.5    132.4 
8 8.02  120.8  7.97  115.7  
9 7.38  125.2  7.49  127.0  
10 7.49  129.1  7.72  133.2  
11 7.45  109.1  8.46  117.3  
12    143.9    133.82 
13  153.5    153.5   
14    80.6    80.5 
15-17 1.27  28.5    28.5  
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 Table 2.2. Relevant bond distances (Å) and angles (º) for 2 and 3 
 2 3 
av Fe(1)-C(Cp1) 2.038(14) 2.039(13) 
av Fe(1)-C(Cp2) 2.043(16) 2.047(12) 
C(10)-C(15A)/ C(10)-C(15A) 1.489(9) 1.459(2) 
C(15A)-O(11A)/ C(15)-O(11) 1.172(9) 1.210(2) 
C(15A)-O(12A)/C(15)-N(11) 1.429(8) 1.426(2) 
O(12A)-N(11) 1.358(3)  
N(11)-N(12) 1.342(2) 1.364(2) 
N(12)-N(13) 1.302(4) 1.308(2) 
N(13)-O(12)  1.2699(19) 
C(20)-N(21) 1.411(4) 1.401(2) 
N(21)-C(25) 1.349(4) 1.366(2) 
C(25)-O(22) 1.350(3) 1.348(2) 
C(25)-O(21) 1.207(3) 1.206(2) 
C(10)-C(15A)-O(12A)/C(10)-C(15)- 106.6(6) 119.2(1) 
C(10)-C(15)-O(11A)/C(10)-C(15)-O(11) 131.7(6) 125.4(2) 
C(20)-N(21)-C(25) 123.7(2) 124.9(1) 
N(11)-N(12)-N(13) 106.4(3) 105.5(1) 
N(21)-C(25)-O(22) 109.6(2) 107.3(1) 
N(21)-C(25)-O(21) 124.8(3) 126,0(1) 
 
 
Both compounds exhibit a single broad absorbance in the visible region. For 
compound 2, λmax = 453 nm, while for 3 the band is observed at λmax = 484 nm. This 
bathochromic shift clearly shows electronic coupling of the N-oxide OBt with the Fc 
group.  Shifts were also observed for pyridine N-oxides (305-333 nm) and quinoline N-
oxides (>320 nm) with substituents that are in direct conjugation with the N-oxide 
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 group, and rationalized in terms of tautomer and resonance contributions. In 
quinoxaline-N,N-dioxide shifts are due to intramolecular charge transfer.[12] The IR 
spectra of both compounds show two carbonyl bands. For compound 2 a band due to 
the active ester is observed at 1788 cm-1. This band is absent in compound 3 and is 
replaced by an amide band at 1688 cm-1. Both compounds exhibit a strong absorption 
around 1722 cm-1, due to the carbamate carbonyl group on the other Cp ring.  
 
2.2.2. Crystal Structures of Compounds 2 and 3 
Selected bond distances and angles for 2 and 3 are given in Table 2.2. ORTEP 
views are of these complexes are presented in Figures 2.1 and 2.2, respectively. 
Compound  2 crystallizes in the polar orthorhombic space group Pna21 as a twinned 
racemic crystal, whereas compound 3 crystallizes in the monoclinic space group P21/c. 
In both complexes, the Cp rings are virtually parallel to each other (Cp-Fe-Cp angles: 2: 
2.1(3)º; 3: 2.98(14)º). The distances of the Fe atoms to the carbon atoms of the Cp rings 
are in the expected range in comparison to other ferrocene structures.[13]  
  For compound 2, the bond distances and angles of the Cp-ester-benzotriazole 
moiety are almost identical to those reported for Fc-CO-OBt.[14, 15] The ester bond to the 
benzotriazole moiety in 2 is expectedly long (1.429(8) Å).  The benzotriazole (Bt) 
substituent is rotated out of the ester plane only by 80.8(2)º, compared to 96.56(6)º in 
Fc-CO-OBt.[15] In case of Fc-CO-OBt, this does not permit the efficient interaction 
between the two π-systems,[15] but increases reactivity of the carbonyl C towards 
external nucleophiles to the carbonyl C and therefore allows a faster reaction of the 
ester. A similar observation was made for (S)-3-(Oγ-methyl.Nα-
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 triphenylmethylglutamyl) benzotriazole 1-oxide[16], which bears the acyl and OBt 
groups on the same plane, resulting in a slower reactivity towards amines compared to 
the OBt active ester.[17] 3-(Nα-Tritylmethionyl)benzotriazole 1-oxide also exhibits the 
same structural features with co-planar OBt and acyl groups.[18] 
  
 
Figure 2.1. Ortep drawing of compound 2 (30% probability).  H atoms omitted for 
clarity. Side-on view and view down the Cp-Fe-Cp axis to visualize the 1,2’-
conformation of the Fc group. 
         
The geometry and conformation for a variety of esters and amides derivatives of 
HOBt, HOAt and HOOBt have been reported.[19, 20] A more recent investigation into the 
reactivity of HATU showed that the O-substituted uronium salt is significantly more 
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 reactive in peptide coupling reactions than the N-substituted guanidinium salt[10], in line 
with earlier investigations on OBt derivatives. In compound 3, the planar OBt-N-oxide, 
the urethane and the Cp ring to which it is attached are not coplanar (OBt-N-oxide/Cp, 
16.5(1)º; amide/Cp, 18.9(1)º). Just like the parent benzotriazole-1-oxide and 
hydroxybenzotriazole, the heterocycle in compound 3 is essentially flat. In the N-oxide, 
the N-N bond distances are shortened compared to hydroxybenzotriazole.  
 
Figure 2.2. Ortep drawing of compound 3 (30% probability). H atoms omitted for 
clarity. Side-view and view down the Cp-Fe-Cp axis to show the 1,1'-conformation of 
the Fc system. 
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 For compound 3, the N-N bond distances in the heterocycle are non-equidistant. 
The distance between the N(O)-N are shorter and the distance N(12)-N(13) of 
1.3084(19) Å indicates significant double bond character between the two nitrogen 
atoms. Similar observations were made before for (S)-3-(Oγ-methyl.Nα-
triphenylmethylglutamyl) benzotriazole 1-oxide and 3-(Nα-tritylmethionyl)- 
benzotriazole 1-oxide. As you see from Table 2.3, the urethane moieties in 2 and 3 are 
not coplanar with the Cp rings.  The observed ω angle for 2 is close to the ideal value 
for a 1,2' conformation (-72º), while 3 crystallizes in the 1,1'-conformation with ω = 
13.3(8)°. 
 
Table 2.3. Torsions angles (º) for 2 and 3 
M
M
O
θ
β
ω
 
Angle 2 3 
θ [a] 2.1(3) 2.98(14) 
β[b] 5.0(7) [C(ipso)-C=O] / 12.3(2) 
[N-C=O] 
18.8(2) [C(ipso)-C=O] / 18.9(1) 
[N-C=O] 
ω[c] -70.8(8) 13.3(8) 
[a] The dihedral angle between two Cp rings. [b] The dihedral angle between the 
plane of the Cp ring and the C(ipso)C=O bond or between the plane of the Cp ring 
and the N-C=O bond. [c]  The torsion angle is defined as C(ipso)-Cp(centroid)-
Cp(centroid)-C(ipso). of the Cp ring and the C(ipso)C=O bond or between the 
plane of the Cp ring and the N-C=O bond. [c]  The torsion angle is defined as 
C(ipso)-Cp(centroid)-Cp(centroid)-C(ipso). 
 
 
There is no H-bonding present between adjacent molecules of 2. The amide 
proton is does not point towards the Bt substituent. In contrast, H-bonding is observed 
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 in the structure of compound 3 between oxygen atom attached to one of the nitrogen 
atoms of the Bt substituent, carrying a partial negative charge, and the amide proton in 
an adjacent molecule. The O(12)…N(21)* bond distances of 2.859(2) Å  indicates the 
presence of strong H-bonding in the solid state. 
 
 
 
Figure 2.3. Packing diagrams for compounds 2 and 3. 
 
The packing arrangements in 2 and 3 are very different (Figure 2.3). In 
compound 3, the Fc groups are lined up with the NO groups of the Bt group in the 
adjacent the molecules forming strands along the c-axis. In 2, the molecules form a 
strand-like arrangement along the 21-axis with the Fc groups adjacent to each other. 
Heinze recently[14] reported the structural properties of the acetylamino-analogue 
of compound 2. In the solid state, the molecule displayed significant intramolecular H-
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 bonding. The Boc-derivative 2 on the other hand, does not display any intramolecular 
H-bonding involving the urethane NH. Compound 3 on the other hand displays 
intermolecular H-bonding in the solid state. This raises the question if the presence of 
the Boc-protecting group can account for the differences in H-bonding behavior in the 
solid-state structures. Is the lack of intramolecular H-bonding in compound 2 due to the 
spatial requirement of the bulky Boc carbamate group? In order to answer these 
questions, we decided to investigate the H-bonding behavior of compounds 2 and 3 in 
solution. Variable-temperature 1H-NMR studies of compounds 2 and 3, recorded at 1 
and 50 mM in CDCl3 in a temperature range between 215 and 308 K, showed a 
significant difference in the NH chemical shift between the two compounds with the 
temperature variation. A plot of the ∆δ versus T is shown in Figure 2.4. For compound 
2, the chemical shift of the amide NH was affected by temperature but the temperature 
dependence was independent of concentration (1 mM: -5.1 ppb K-1; 50 mM: -6.4 ppb K-
1). In contrast, compound 3 displayed a concentration dependent temperature behavior (1 
mM: -2.8 ppb K-1; 50 mM: -7.1 ppb K-1), indicating the presence of intermolecular H-
bonding in compound 3 in solution. The temperature behavior of the NH chemical shift 
indicates the presence of intramolecular H-bonding in compound 2 in solution.[11, 21] 
However, the crystal structure does not show any H-bonding, presumably as a result of crystal 
packing.   
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Figure 2.4. Temperature dependence of the chemical shifts for NH signals of 
compounds 2 (●,○) , 3. (■,□) in CDCl3. (○,□)-open shapes indicate 1 mM; ( ●,■)-solid 
shapes indicate 50 mM. 
 
Interestingly, the Cp protons in compound 2 undergo some temperature 
dependent changes, as is shown in Figure 2.5. The signals due to H2 and H5 in 
compound 2 are very broad at low temperatures (215 - 220K) temperatures but appear 
at 228 K, and gradually sharpen. Heinze’s Ac-derivative displays a similar temperature 
behavior and which was interpreted as a possible interconversion between two 
ferrocenyl rotamers of the molecule. Our results suggest that a similar equilibrium may 
exist also for compound 2. The Cp region of compound 3 does not change with 
temperature (Figure 2.6).  
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Figure 2.5. Variable temperature 1H-NMR spectra of 2 (50 mM, CHCl3) in a region of 
215 – 308 K. 
 
 
 
 
Figure 2.6. Variable temperature 1H-NMR spectra of  3 (50 mM, CDCl3). 
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 2.2.3. Electrochemistry 
Figure 2.7 shows the electrochemical behavior of compounds 2 and 3. Both 
compounds show a quasi-reversible single one-electron oxidation. The separation 
between oxidative and reductive peak potentials ∆Ep is about 96±5 mV for 2 (87±5 mV 
for 3). The ratio of peak currents is close to unity for both compounds (2: ic/ia = 1; 3: 
ic/ia = 1.05). As expected for N and O-ferrocenylated systems, the halfwave potentials 
E1/2 for 2 and 3 are significantly different. While E1/2 = 672 ± 5 mV for the active ester 
2, the E1/2 = 591 ± 5 mV for the N-oxide 3. 
 
Figure 2.7. Electrochemical study of compounds 2 and 3 in CH3CN/ 0.1 M TBAP: A 
shows the cyclic voltammetry at a scan rate of 100 mV/s (∆Ep for the Fc/Fc+ couple 
under identical conditions was 68 ±5 mV); B shows the differential pulse voltammetry 
at a scan rate 10 mV/s. for 2:  DPV, Ep = 643 ± 5 mV; for 3, Ep = 566 ± 5 mV. 
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 2.3. Conclusion 
In summary, we have prepared the two ferrocene-amino acid derivatives 
(benzotriazol-1-yl)-1'-tbutylcarbamato ferrocene-1-carboxylate (2) and (benzotriazole-1-N-
oxide-3-yl)-1'-tbutylcarbamato ferrocene-1- carboxylate (3) and report their full 
characterization. Initially, compound 3 was obtained as a by-product in the preparation of 
the desired active ester. Reports on HATU active esters show this to be a common reaction 
in peptide synthesis. Importantly, this by-product was not reported in ferrocene chemistry. 
Given the importance of Fc-OBt active ester intermediates in the preparation of Fc-
bioconjugates and as potential intermediate for the stepwise synthesis of ferrocenamide-
based polymers, our finding is significant. Importantly, the reactivity towards peptide 
coupling is different. Whereas, the active ester derivative 2 undergoes amide bond 
formation with glycine ethylester and other amino acids and peptides,[22] the N-oxide 3 does 
not react.  This is in contrast with earlier reports on the reactivity of HATU N-oxide-
derivatives, which were shown to undergo a slow conversion to the desired amide. 
 
2.4. Experimental Section 
2.4.1. General Procedure 
The syntheses of 1'-tbutylcarbamato-1-ferrocenecarboxylic acid (1) was carried 
out using the published procedure.[23] All syntheses were carried out in air unless 
otherwise indicated. CH2Cl2 (BDH; ACS grade) used for synthesis was dried (CaH2) 
and distilled prior to use. CDCl3 (Aldrich) was dried (CaH2) , and stored over molecular 
sieves (8-12 mesh; 4Å effective pore size; Fisher) before use. EDC·HCl, HOBt 
(Quantum), MgSO4, and NaHCO3 (VWR) were used as received. For column 
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 chromatography, a column with a width of 2.7 cm (ID) and a length of 45 cm was 
packed 18-22 cm high with 230-400 mesh silica gel (VWR). For TLC, aluminum plates 
coated with silica gel 60 F254 (EM Science) were used. NMR spectra were recorded on a 
Bruker Avance-500 spectrometer using a 5-mm broadband probe operating at 500.134 
MHz (1H) and 125.766 MHz (13C{1H}). Peak positions in both 1H and 13C spectra are 
reported in ppm relative to TMS. The 1H NMR spectra are referenced to the residual 
CHCl3 signal at δ 7.27. All 13C{1H} spectra are referenced to the CDCl3 signal at δ 
77.23. Mass spectrometry was carried out on a VG Analytical 70/20 VSE instrument. 
Infrared spectra were obtained with a Perkin-Elmer model 1605 FT-IR. 
 
2.4.2. Preparation of (Benzotriazol-1-yl)-1'-tButylcarbamato Ferrocene-1-
Carboxylate (2) and (Benzotriazole-1-N-oxide-3-yl)-1'-tButylcarbamato Ferrocene-
1-Carboxylate (3) 
 
Procedure A:  To a solution of 1'-tbutylcarbamato-1-ferrocenecarboxylic acid 
(1) (3.68 mmol, 1.27 g) in CH2Cl2 (40 mL), solid HOBt (4.05 mmol, 0.62 g) and 
EDC·HCl (4.05 mmol, 0.78 g) were added. The reaction mixture was stirred for 2 hrs at 
room temperature (20°C) and then treated with an aqueous solution of saturated 
NaHCO3, citric acid (10%), and water. The organic phase was separated and dried over 
Na2SO4, and the evaporated to dryness under reduced pressure. The crude product was 
purified by flash column chromatography (SiO2, EthOAc:hexanes 1:2) to give dark 
orange crystals of compound 2 (1.32 g, 78%) (Rf = 0.74), followed by red crystals of 
compound 3 (68 mg, 4%) (Rf = 0.42).  
Procedure B: The same mixture as described under A was stirred for two hours 
at room temperature in aqueous acetone (30 ml). The reaction mixture was dried under 
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 reduced pressure and re-dissolved in CH2Cl2. After the purification (vide supra), 
compounds 2 and 3 were obtained yields of (1.15 g, 64%) and (180 mg, 11%), 
respectively. 
 
2.4.2.1 Characterization of  Compound 2 
FAB-MS (m/z): calc for C22H22N4O4Fe [M+1]+: 463.2; found: 463.1. FT-IR 
(KBr, cm-1): 3322 (m, N-H), 1788, 1723 (s, C=O). UV-vis (MeCN; λ in nm (ε in Lmol-
1cm-1)): 453 (706). 1H-NMR CDCl3, δ/ppm): 8.02 (1H, d, JHH = 8.5 Hz, Bt-ArH), 7.49 
(1H, t, JHH = 15.0 Hz, Bt-ArH), 7.45 (1H, d, JHH = 8.2 Hz, Bt-ArH), 7.38 (1H, t,  JHH = 
15.2 Hz, Bt-ArH), 6.42 (1H, bs, NH), 5.00 (2H, s, H-2 and H-5, Fc), 4.71 (2H, s, H-2` 
and H-5`, Fc), 4.62 (2H, s, H-3 and H-4, Fc), 4.08 (2 H, s, H-3` and H-4`, Fc), 1.27 (9H, 
s, C(CH3)3). 13C{1H}-NMR (CDCl3, δ/ppm): 167.5 (s, COON-Bt), 153.5 (s, 
COOC(CH3)3), 143.9, 129.5 (quaternary C of Ar Bt), 129.1, 125.2, 120.8, 109.1 (s, Ar  
Bt),  100.2 (C-1`, Fc), 80.58 (C(CH3)3), 74.7 (C-3 and C-4, Fc), 72.3 (C-2 and C-5, Fc), 
66.9 (C-3` and C-4`, Fc), 65.2 (C-1, Fc), 62.3 (C-2` and C-5`, Fc), 28.5 (C(CH3)3). 
 
2.4.2.2. Characterization of  Compound 3 
  FAB-MS (m/z): calc for C22H22N4O4Fe [M+1]+: 463.2; found: 463.1. FT-IR 
(KBr, cm-1): 3310 (m, N-H), 1721, 1688 (s, C=O). UV-vis (MeCN; λ in nm (ε in Lmol-
1cm-1)): 484 (1200). 1H-NMR CDCl3, δ/ppm): 8.46 (1H, d, JHH = 8.5 Hz, Bt-ArH), 7.97 
(1H, d, JHH = 8.4 Hz, Bt-ArH), 7.72 (1H, t, JHH = 15.5 Hz, Bt-ArH), 7.49 (1H, t,  JHH = 
17.3 Hz, Bt-ArH), 5.75 (1H, bs, NH), 5.36 (2H, s, H-2 and H-5, Fc), 4.63 (2H, s, H-
3and H-4, Fc), 4.52 (2H, s, H-2` and H-5`, Fc), 3.94(2 H, s, H-3` and H-4`, Fc), 1.26 
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 (9H, s, C(CH3)3). 13C{1H}-NMR (CDCl3, δ/ppm): 168.0 (s, CON-Bt), 153.5 (s, 
COO(CH3)3), 133.8, 132.4 (quaternary C of Ar Bt), 133.2, 127.0, 117.3, 115.7 (Ar Bt),  
98.9 (C-1`, Fc), 80.5 (C(CH3)3), 74.8 (C-3 and C-4, Fc), 74.1 (C-2 and C-5,  Fc), 71.6 
(C-1, Fc), 67.0 (C-3` and C-4`, Fc), 62.7 (C-2` and C-5`, Fc), 28.5 (C(CH3)3). 
 
2.4.3. Attempted Coupling of (Benzotriazole-1-N-oxide-3-yl)-1'-tButylcarbamato 
Ferrocene-1-Carboxylate 
 
A solution of H-Gly-OEt·HCl (0.24 mmol, 0.03 g) and Et3N (0.4 ml) in dry 
CH2Cl2 (5 ml) was added to a stirring solution of 3 (0.22 mmol, 0.10 g) in dry CH2Cl2 
(10 ml). Progress of the reaction was followed by TLC (EtOAc:hexanes:MeOH  4:5:1). 
No product was observed after 24 hrs.  
 
2.4.4. Electrochemical Measurements 
The electrochemical experiments were carried out at room temperature using 
CV-50W voltammetric analyzer. A gold electrode (diameter 50 µm) was used as 
working electrode. 1 mM solutions of compounds 2 and 3 were prepared in 0.1 M 
tetrabutylammonium perchlorate (TBAP) solution in a CH3CN. The measurements 
carried out in a low scan rate of 100, 10 mV/s for cyclic voltammetry (CV) and 
Differential Pulse Voltammetry (DPV), respectively. A platinum wire (1 mm) was used 
as the counter electrode and a Ag/AgCl (BAS) was used a the reference electrode. The 
E1/2 of the Fc/Fc+ couple under the experimental conditions is 448(+/-5) mV (vs. 
Ag/AgCl). 
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 2.4.5. X-ray Crystallography 
Suitable crystals of compounds 2 (orange plate-like crystal; 0.15 × 0.15 × 0.10 
mm) was obtained from a ether-layered solution of the compounds in chloroform, while 
3 (dark red plate-like crystal; 0.25 × 0.20 × 0.13 mm) was obtained by a slow 
evaporation from Ethyl acetate- hexane (3:1) solvent mixture. 
All measurements were made on a Nonius KappaCCD 4-Circle Kappa FR540C 
diffractometer using monochromated Mo K radiation (λ = 0.71073 Å) at -100 °C. An 
initial orientation matrix and cell was determined from 10 frames using φ scans.[24] Data 
were measured using φ- and ω-scans.[24] The data were processed using the standard 
Nonius software.[25] The structures were solved using direct methods (2: SIR-97; 3: 
SHELXS-97)[26, 27] and refined by full-matrix least-squares method on F2 with 
SHELXL97-2.[28]  The non-hydrogen atoms were refined anisotropically. Hydrogen 
atoms were included at geometrically idealized positions (C-H bond distances 0.95/0.99 
Å; N-H bond distances 0.88 Å) and were not refined. The isotropic thermal parameters 
of the hydrogen atoms were fixed at 1.2 times that of the preceding carbon or nitrogen 
atom. The carbon and oxygen atoms of one –C(O)O unit (labeled as C(15A), O(11A), 
O(12A), C(15B), O(11B), O(12B)) in 2 were disordered over two positions with site 
occupancy factors of 0.825(5) and 0.175(5). The refined absolute structure parameter 
[0.552(18)] for 2 was neither unity nor nil and was used as the scale parameter in the 
racemic twin refinement. 
The hydrogen atom at nitrogen atom N(21) in 3 was located in Fourier 
difference map. Its coordinates were allowed to refine, whereas its isotropic thermal 
parameter was fixed at 1.2 times that of the preceding nitrogen atom. Data relating to 
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 the structure determination are presented in Table 4. contains the supplementary 
crystallographic data for this paper. These data can be obtained free of charge at 
www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge Crystallographic 
Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: (internat.) +44-1223/336-
033; E-mail: deposit@ccdc.cam.ac.uk]. 
 
Table 2.4. X-ray crystallographic data of complexes 2 and 3. 
 2 3 
Formula C22H22FeN4O4 C22H22FeN4O4
Molecular mass 462.29 462.29 
Crystal dimensions /mm 0.15 × 0.15 × 0.10 0.25 × 0.20 × 0.13 
Crystal system Orthorhombic monoclinic 
Space group (no.) Pna21 P21/c (14) 
a /Å 12.6580(2) 11.8140(2) 
b /Å 17.2760(3) 12.0982(2) 
c /Å 9.7170(5) 15.4850(3) 
β /Å 90 110.9844(8) 
Cell volume /Å3 2124.91(2) 2066.45(6) 
Molecular units per cell 4 4 
µ /mm-1 0.746 0.768 
Density (calcd.) /g cm-3 1.445 1.486 
T /K 173 173 
Scan range (2θ) 1.99 – 24.70 3.28 – 30.06 
Scan speed /sec frame-1 135 40 
Measured reflections 3462 11239 
Unique reflections 3462 6005 
Obs. Reflections (I ≥ 2) 3187 4632 
Parameters refined  312 286 
Max. residual electron Density /Å-3 0.297 / -0.211 0.357/-0.374 
Agreement factors (F2 refinement) R1 = 3.27% 
Rw = 6.87% 
R1 = 3.90% 
Rw = 9.05% 
a R1 = [Σ||Fo|-|Fc||]/[Σ|Fo|] for [I > 2σ(I)] 
b wR2 = {[Σw(Fo2-Fc2)2]/[Σw(Fo2)2]}1/2 [all data CCDC-241248 (2), 236850 (3) 
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 CHAPTER 3 
HELICALLY CHIRAL ALANINE PEPTIDES CONTAINING  
1'-AMINOFERROCENE-1-CARBOXYLIC ACID SUBUNIT AS 
TURN INDUCER  
 
3.0. Connecting Text 
 In Chapter 2 it was demonstrated that the synthesis of the Fca-active esters 
derivative of Fca allows effective coupling of Fca to the amino acids and peptides. This 
Chapter presents the next step in the investigation, which is a detailed structural study 
of Fca-peptide conjugates. Fca was attached to D- and L- amino acids and peptides from 
the carboxy and/or amino terminals. The structural properties of the conjugates in solid 
state as well as in solution were assessed by a variety of techniques including x-ray 
crystallography, IR, NMR, and circular dicroism. This study was aimed at investigating 
the ability of Fca to impose secondary structural elements on the peptide structure. By 
doing so, it was possible to develop a general strategy of using Fca to induce a turn-like 
structure in Fca-peptide conjugates, which are stable in solution and in the solid state.  
This Chapter was extracted from the original international collaboration paper (Reference: Barišić, L.; 
Čakić, M.; Mahmoud, K. A.; Liu, Y. N.; Kraatz, H.-B.; Pritzkow, H.; Kirin, S. I.; Metzler-Nolte, N.; 
Rapić, V., Chem. Eur. J. 2006, 12,  4965-4980 Copyright © 2006, Wiley VCH). Therefore, the Chapter is 
reformatted and only work carried out by me is described in terms of experimental and discussion.
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 3.1. Introduction  
Architectural control of the supramolecular structure of peptides is of 
importance for the development of functional materials with potential applications in 
bioelectronics or biophotonics.[1] In addition, the design of structurally well-defined 
peptides is essential for understanding biochemical process of naturally occurring 
proteins and enzymes.[2]  
Molecular scaffolds are commonly used to impart a specific secondary structure 
onto a peptide backbone. In addition to the known organic molecular scaffolds, 
ferrocenes (Fc) are widely recognized as organometallic redox active scaffold.[3] The 
structure of Fc has a central reverse-turn unit with inter-ring spacing of about 3.3 Å, 
which is suitable for intra-strand H-bonding interactions as was observed in β-sheets.[4] 
One advantage of utilizing Fc as scaffold is the ability to influence the formation H-
bonded assemblies. Figure 3.1 describes three different types of disubstituted Fc peptide 
systems: derived from Fc-dicarboxylic acid (Fc[COOH]2, I), Fc-amino acid (Fca, II), 
and Fc-diamine (Fc[NH2]2, III). Conjugates of type-I can give raise to H-bonded β-
sheet like structure or even engage in chiral helical arrangements (Figure 3.1).[5-10]
  
Only 
recently some peptide derivatives of Fca and Fc-diamine became available, from type-II 
and type-III, respectively.[11] It was proposed that more rigid macrocyclic peptides, 
based on Fc-diacid or Fc-diamine building blocks have allowed for systems able to 
engage in well defined inter-molecular H-bonding.[11]
 
Derivatives of Fc-diacid was used 
as a transition state analogue in an antibody-catalyzed Diels-Alder reaction.[12] The 
same group reported an early synthesis of 1'-aminoferrocene-1-carboxylic acid 
(“ferrocene amino acid”; Fca).[12a, 13]
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Figure 3.1. The ferrocene-derived peptide conjugates. Arrows point from the C to the N 
terminals.   
 
  Rapić and coworkers reported on the efficient synthesis of Fca and described the 
synthesis of some related Fca-conjugates.[14] Recently, Rapić and Metzler-Nolte 
described the first Fca-peptides conjugate, initial studies proposed Fca can induce the 
formation of a peptide turn.[15] Herein,  we wish to expand on the initial investigations 
and demonstrate the ability of Fca to impose specific secondary structural elements onto 
the peptide. Varity of systematic spectroscopic techniques such as CD NMR and IR as 
well as crystallographic conformational analysis will be utilized in the investigation. 
 
3.2. Results and Discussion  
3.2.1. Synthesis and Characterization   
The preparation of the Fca-peptide conjugates 2-9 starting from Boc-Fca-OH 1 
is summarized in Scheme 3. First, the acid terminus of Fca was activated by 1-
hydroxybenzotriazole (HOBt) and N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide 
hydrochloride (EDC) and coupled with L- and D-Ala of H-Ala-OMe resulting in the 
formation of the C-terminal peptide conjugates 2 (74%), 3 (75%), respectively.  
Peptides 2 can be N-modified after Boc-deprotection of the organometallic core, 
followed by coupling with Boc-D-Ala-OH giving the tripeptide 4 (72%). In a similar 
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manner, dipeptide 3 was coupled with Boc-Ala-OH to yield tripeptide 5 (78%), The 
peptide can be elongated from the C- or the N-terminal side, followed by coupling with 
the desired amino acid derivative. For example, tetrapeptide 7 was prepared from 4 also 
tetrapeptide 6 was prepared following the same procedure. N-deprotection of compound 
6, followed by coupling with Boc-D-Ala-OH using O-(1H-benzotriazole-1-yl)-
N,N,N',N'-tetramethyluronium hexafluorophosphate HBTU/HOBt results cleanly in 
formation of the pentapeptide 8. Analogously, N-terminal coupling of Boc-D-Ala-OH 
with compound 7 results in formation of the pentapeptide 9.  
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Scheme 3.1. Syntheses of Fca peptides. (a) 1 M NaOH; (b) 1. EDC/HOBt or 
HBTU/HOBt, CH2Cl2, 2. H-(Aaa)x-OMe·HCl/NEt3, CH2Cl2; (c) HCl (gas)/EtOAc or 
TFA; (d) 1. EDC/HOBt or HBTU/HOBt, CH2Cl2, 2. Boc-(Aaa)y-OH/NEt3, CH2Cl2.  
 
                                                                                                          
Compd.  Formula δ (CD3Cl)a δ (DMSO)a ∆δ 
2, 3  Boc-Fca-Ala-OMe 6.40 (s), 6.77(bs) 8.43(bs), 8.04(d) 2.03, 1.27 
4 Boc- D-Ala1'-Fca-Ala1-OMe 7.35(d), 5.40(bs), 4.88(s) 
 9.31(bs), 8.06(d), 
7.04(d)  1.96, 2.60, 2.16 
5 Boc- Ala1'-Fca-D-Ala1-OMe 7.18(d), 5.29(bs), 4.92(m) 
9.31(bs), 8.05(d), 
7.04(d)  2.13, 2.66, 2.12 
6 Boc-Ala-1'-Fca-Ala1-D-Ala2-OMe 9.41(bs), 7.84(d), 7.29(d), 5.10(d) 
 9.32(s), 8.28(d), 
7.77(d), 7.01(d) 
-0.09, 0.44, 
0.48, 1.91 
7 Boc-Ala-1'-Fca-D-Ala1-D-Ala2-OMe 8.61(bs), 7.41(d), 7.18(d), 5.14(d) 
9.30(bs), 8.27(d), 
7.74(d), 7.00(d) 
0.69, 0.86, 0.56, 
1.86 
8 Boc-D-Ala2'-Ala1'-Fca-Ala1-D-Ala2-OMe 
9.08(bs), 7.83(bs), 
7.28b(s), 7.20(s), 
5.20(d) 
9.19(bs), 8.30(d), 
8.02(d), 7.73(d), 
7.01(d) 
0.11, 0.47, 0.74, 
0.53, 1.81 
  Table 3.1. Chemical shifts of the amino-protons of Fca-peptides. and standard numbering scheme. 
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a5×10-3− 2×10-4 M; Fca ≡1'-aminoferrocene-1-carboxylic acid. 
 
 
                                                                                                  68 
 NMR measurements were carried out on all compounds in two solvents: 
DMSO-d6 and CDCl3. In general, it can be expected a presence of an equilibrium 
between intra-molecular H-bonded and non-H-bonded states in solution. In addition, it 
was expected that non-polar solvents, such as CDCl3, favor intra-molecular H-bonded 
structures, while polar solvents such as DMSO disrupt H-bonding by competing with 
the H-bonding sites. Ideally, higher chemical shift of the amide protons should be 
observed for H-bonded structures when compared with the non-H-bonded structures. 
However, NMR timescale is not fast enough to determine the equilibrium between these 
states, which is a reason for not observing resolved signals for these states. Rather, an 
average value for δ is observed at shifts higher than expected for the putative non-H-
bonded species. The position of this equilibrium is strongly solvent dependent. The resulting 
chemical shift differences (∆δ) from measurements in the two solvents will be used to 
determine the populations in the H-bonded and non-H-bonded states (see Table 3.1).[17]
  Dipeptide 3 was used as an example to demonstrate this study. In CDCl3 
solution, compound 3 exhibits two amide resonances: at δ 6.77 for the NHAla and at 6.40 
for the NHFca group. In DMSO-d6, the resonances at δ 8.04 (NHAla) and 8.43 (NHFca) are 
observed. The chemical shift differences for the two amide protons in the two solvents 
are ∆δ = 1.27 for the NHAla and ∆δ = 2.03 for the Fca-NH group. That may indicate the 
presence of medium-strength hydrogen bonds.  
Similarly, tetrapeptide 6 was used as another representative example. In CDCl3, 
6 displays four amide resonances at δ 5.10 (NHAla1'), 9.41 (NHFca), 7.87 (NHAla1), and 
7.29 (NHAla2). In DMSO-d6, the resonances shift to δ 7.01 for NHAla1', 9.32 for NHFca, 
7.77 for NHAla1, and 8.28 for NHAla2. The chemical shift of both proximal NH protons 
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 (NHFca and NHAla1) moves strongly downfield in CDCl3 solutions if both Cp rings a 
substituted by amino acids because of the formation of intra-molecular H-bonds which 
involve these two protons. This H-bonding is disrupted in DMSO and consequently the 
order of the Ala1 and Ala2 amide protons is reversed. The chemical shift differences ∆δ 
for the four amide resonances in 6 are 0.44, 0.48, -0.09, 1.91    
The length of the peptide chain dominates the ability to maintain a 
conformation. Thus, only a single H-bond was adopted by short Fca peptides such as 2 
and 3 in solution. As a result, they exist as a mixture of conformers in solution. The 
longer Fca-peptides 4 - 9 can form two intra-molecular H-bonds between the podant 
peptide chains, resulting in a single conformer in the solid state as well as in solution. 
Solution IR studies, recorded in dichloromethane (c = 10-2
 
M L-1), were used to 
discriminate between the specific hydrogen bonded and non-H-bonded isomers for the 
compounds under investigation. As examples for our discussion sample compounds will 
be discussed and compared with the results from NMR studies. IR spectra of the 
dipeptides 2 and 3 showed two Amide A bands of approximately equal intensities 
typical of non-H-bonded NH at the first one resonated at around 3433 cm-1 that is 
typical region for non-H-bonded NH and the second was around 3327 cm-1 representing 
the H-bonded NH. These results compared well with the NMR studies. Both NMR and 
IR analyses indicate that intra-molecular H-bonding in the tetrapeptide 6 is stronger 
compared to the related dipeptide 2, since the IR band is slightly shifted to lower 
wavenumbers and compared to that found in compound 2.  
From the NMR results, we observe higher peptides 4 and 5 belong to another 
structural type having very strong H-bonds forming 9- and 11-membered ring. 
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 Expectedly the IR spectra of these oligopeptides were very similar. They contained one 
relatively narrow band in the range 3426-3438 cm-1, assigned to non-H-bonded NH and 
three broad signals at 3355-3373, 3283-3322, and 3251 cm-1
 
corresponding to intra-
molecular H-bonding. The first absorption may be attributed to the weak or medium 
intra-molecular H-bonded NH subunits of Ala1', Ala2' and Ala2. We assign the other 
absorptions to the strongly H-bonded NHFca group.  
 
3.2.2. X-Ray Crystallography  
Single crystals suitable for an X-ray analysis were obtained for two compounds 
in this study. Peptides 2 and 3 were crystallized by slow diffusion of ether in a 
chloroform solution (γ = 10 mg ml-1). Crystal structures of these compounds are shown 
in Figures 2 - 4. Three potential intra-molecular H-bonded conformers and one open 
conformer can be described for compound 2 (Figure 3.2).  
For example, in conformer 2A CO and NH groups directly attached to the Fc 
moiety are engaged in H-bonding resulting in a 6-membered ring. Conformer 2B has an 
H-bond between the amide Fca-CO-NH and the CO-NH-Fca forming an 8-membered 
H-bonded ring. Conformer 2C has the distal C=O group engaging in H-bonding with 
the NH-Fc group giving a 9-membered ring. While intra-molecular hydrogen bonding 
pattern differs significantly, the structures show a similar inter-molecular hydrogen 
bonding pattern. The two compounds 2 and 3 crystallize in the P212121 space group and 
build chains along the crystallographic c axis, connected via one hydrogen bond, as 
exemplified for dipeptide 2 in Figure 3.3.  
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Figure 3.2. Possible H-bonding pattern in 2. The numbering scheme is presented for 
conformer A, for the specification of ring size in the H-boded species. The pattern D 
has no intra-molecular H-bonds and could exist in equilibrium with an “open isomer. 
 
 
 
Figure 3.3. Crystal structure of 2 showing a L,M-configuration with one hydrogen 
bond. 
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Figure 3.4. Crystal structure of 3 showing a D,P-configuration with one hydrogen bond. 
 
Figure 3.5. Crystal packing of 2, view down the b axis.  
 
  The enantiomeric dipeptides 2 and 3 were crystallized from the same solvent 
system, and the same conformation was obtained. They represent the first examples 
where the “β-sheet like” conformer B was found in the solid state (Figures 3.3, 3.4 and 
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 3.5). The stereochemistry is L,M for 2 and D,P for 3, with one 8-membered intra-
molecular hydrogen bond.  
Bond lengths and angles found in the X-ray structures of 2 and 3 are in the 
expected range. A number of more significant structural parameters is collected in 
Table 3.2 and explained in Figure 3.6. In all three compounds, the two Cp rings are 
almost parallel to each other and consequently, the tilt angles are very small, θ < 4°. The 
ω angles are close to the ideal value in a 1,2'-conformation (360° / 5 = 72°) in all cases. 
A more interesting example is provided by the dihedral angle β and the 
pyramidalization of the amide nitrogen atoms. Dipeptides 2 , 3 have some strain. In L-
Ala conjugate 2 and D-Ala compound 3 the βCO is about 10°, but the sum of angles 
around the amide nitrogen atom N51 is only about 353°. It can be concluded that 
dipeptides 2 and 3 have to accommodate some sterical hindrance in order to gain 
stabilization energy from the formation of one “β-sheet like” hydrogen bond.  
 
Fe
θ
 
ω
Fe
 Fe
R
O
βCO
or
Fe
N
H
R
βNH
 
Figure 3.6. Tilt angle θ is the dihedral angle between the two Cp rings; ω is the dihedral 
angle between the two ring-bound substituents: C(ipso) - Cp(centroid) - Cp(centroid) - 
C(ipso); β is the dihedral angle between the Cp ring and the –NHR (βNH) or –COR´ 
(βCO) substituent. 
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 Table 3.2. Selected parameters in the crystal structures of 2 and 3.  
 
Parameter  2  3  
N1 – O3 / Åa 2.90  2.90  
N2 – O1 / Åb
 
2.86  2.86  
θ / °  2.0  1.9  
βNH / °  29.6  29.7  
βCO / °  9.3  9.3  
ω / °  85.1  85.0  
Angle sum around N2 / [°]  359.7  359.8  
Angle sum around N1 / [°]  352.1  353.9  
 
a intra-molecular hydrogen bond,b inter-molecular hydrogen bond. 
 
3.2.3. CD-Spectroscopy  
As we have learned from the crystallographic analyses of dipeptides 2 and 3, 
intra-molecular H-bonds are present in the solid state. This raises the question if the H-
bonded structure persists in solution. CD spectroscopy was used for conformational 
analysis of the ferrocene peptides 2 - 9 in CH3CN solution. CD signals between 300 - 
600 nm are characteristic for metal-centered transitions. In particular, the band at 480 
nm was described as a strong indication for a helically chiral ferrocene moiety.[5b]
 
Molar 
ellipticities, Mθ, were used in order to facilitate a comparison between different 
compounds.  The CD spectra of ferrocene dipeptides 2 and 3, both substituted at the C-
terminus only, are displayed in Figure 3.7. As expected, the CD spectra of enantiomers 
2 and 3 are a mirror image of each other. The L,M-derivative 2 displays a negative CD 
signal for the lowest energy band at about 500 nm, while this signal is positive for D,P-3.  
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Figure 3.7. CD spectra (CH3CN) of the dipeptides 2 and 3 
 
The CD spectra of higher Fca peptides are shown in Figure 3.8 with the 
examples of compounds 4, 5 and 9. All spectra of the ferrocene peptides 4 - 9 are 
qualitatively alike in the region above 400 nm with one signal centered at 480 nm, and 
differ significantly from the dipeptide 2 in Figure 3.7. This indicates that the solution 
conformation of ferrocene peptides 4 - 9 is similar, but different from that of 2. 
However, an important finding is that the helical chirality of Fca peptides is dominated 
only by the chirality of the N-terminal amino acid on Fca: Boc-Ala-Fca-D-Ala-OMe 5 
displays a positive CD signal at about 480 nm that is changed to negative in Boc-DAla-
Fca-Ala-OMe 4, Fig. 3.8. On the other hand, the same change on the C-terminus of Fca 
has no effect on the helicity of the central ferrocene core (4 → 5). The chirality of the 
outer Ala has no influence on the helical chiraliy of the ferrocene. In addition, a non-
monotonous correlation between the magnitude of the CD signal and the number of Ala 
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 subunits was observed, but roughly the intensity of the CD signal rise form shorter to 
longer oligopeptides (4 → 9).  
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Figure 3.8. CD spectra (CH3CN) of the tripeptides 4 and 5 
 
It should be noted that CD spectra give rise to relatively broad signals. Thus 
signals arising from structurally related but slightly different compounds such as the 
ones studied herein will not be resolved. In addition, dynamic equilibrium is impossible 
to detect by CD spectroscopy alone.  
 
3.2.4. Electrochemistry  
The electrochemical behavior of compounds 2-9 was studied by cyclic 
voltammetry (CV). All ferrocene-containing amino acid and peptide conjugates 
discussed in this study exhibit a reversible electrochemical one-electron oxidation. For 
Fca peptide derivatives, the half-wave potentials E1/2 are observed in a range of 476 - 
533 mV vs. Ag/AgCl, with peak-to-peak separation ∆Ep of 63 to 98 mV and with a 
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 Faradic current ratio of close to unity. Importantly, we do not observe any amino acid or 
peptide specific trends. All experimental values are listed in Table 3.3.  
 
 
Table 3.3. Solution electrochemical results for compounds 2-9. Conditions: 1 mM in 
MeCN; glassy carbon working electrode (BAS), Pt counter, Ag/AgCl reference, 0.1 M 
TBAP; E in mV and Ip in µA; errors in the measured potentials are ± 5 mV from five 
independent measurements. 
 
Compound  E1/2 ∆Ep Ia/Ic 
2  481  73  1.1  
3 488  75  1.0  
4  502  78  1.1  
5  533  62  1.0  
6  471  81  1.0  
7  488  73  1.1  
8  476  98  1.1  
9  483  74  1.1  
 
  
3.3. Conclusions  
Fca is one of the simplest organometallic amino acids based on the ferrocene 
sceleton. We provide a synthetic approach to amino acid and peptide conjugates of Fca, 
giving the desired compounds in good to excellent yields. We used standard peptide 
coupling techniques and two different synthesis strategies: The first strategy uses 
attachment of amino acids or dipeptides directly to the C- or the N-terminus of Fca. The 
second strategy includes coupling of one amino acid to Fca, its deprotection and 
subsequent coupling of the second amino acid. This second strategy can also be applied 
to both Fca termini. 
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 Using this synthetic approach, di- to pentapeptides containing Fca as an 
organometallic amino acid was obtained by solution peptide chemistry. Depending on 
the substitution pattern, these compounds exhibit turn-like peptide structures, which are 
stable in solution and the solid state. Characterization of the H-bonding patterns in 
solution is particularly challenging and we have used a combination of various 
spectroscopic techniques to get detailed information about solution conformations. In 
order to distinguish between possible conformers we used a nomenclature that indicates 
the relative orientation of the amide groups directly bound to the ferrocene core, Fig. 
3.2.  More detailed description of a general nomenclature for metal-based peptides has 
been proposed recently.[5b]
 
From the X-ray structures of dipeptides 2 and 3 it was clear that the dipeptides 
show a conformer B in the solid state, with one intra-molecular inter-strand hydrogen 
bond. Helical chirality of the metallocene core, a very important property of the Fca 
peptides, was studied by X-ray crystallography and CD spectroscopy. The 
representative examples 2 and 3 differ not only in their H-bonding pattern, but also in 
helical chirality. Dipeptide 2 was found to be in the L, M stereochemistry in the solid 
state. The CD spectrum of 2 shows a negative band at about 500 nm. For 3 on the other 
hand, the crystal structure reveals and D, P stereochemistry and the CD spectrum shows 
a positive signal at about 480 nm. CD spectroscopy has been previously used to 
elucidate.
 
In an attempt to determine the metal-centred chirality in peptide derivatives of 
ferrocene-1,1'-dicarboxylic acid, Hirao and coworkers showed that peptides made from 
H-bonding L-amino acids on both Cp rings induce P-chirality of the metallocene 
core.[5b, 7b] Also, Metzler-Nolte reported that equilibrium mixtures of M and P helicity 
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 can coexist when amino acids of different chirality are attached to either ring in such 
systems.[9c]
 
 our result showed different behavior for Fca peptides as was observed from 
this study. Fc chirality is completely dependent on the chirality of the first amino acid 
attached to the Fca amino group.  
The energetic barrier for rotation of the two Cp rings is small. This provides a 
degree of flexibility to such systems that is not achievable with the more common 
organic peptide mimetics. Janda and co-workers made use of this low rotational barrier 
in disubstituted ferrocenes to generate catalytic antibodies for endo- and exo-
stereoselective Diels-Alder reactions from one single ferrocene hapten.[12] 
Oligopeptides derived from Fca therefore possess special properties and may form 
unique secondary and tertiary structures. The systematic work described herein lays a 
solid foundation for the rational design of such unique Fc peptides. Further studies are 
going to investigation the obtained results in more details.  
 
3.4. Experimental Section  
3.4.1. General Procedure 
Most of synthesis were carried out under argon. CH2Cl2 used for synthesis and 
FT-IR was dried (P2O5), distilled over CaH2 and stored over molecular sieves (4 Å). 
EDC, HOBt, HBTU (Aldrich), Ala (Merck), were used as received. Products were 
purified by preparative thin layer chromatography on silica gel (Merck, Kieselgel 60 
HF254) using the mixtures CH2Cl2/ EtOAc and CH2Cl2/ MeOH. Melting points were 
determined with a Buechi apparatus. The infrared spectra were recorded as CH2Cl2 
solutions between NaCl windows or as KBr disks with a Bomem MB 100 mid, a Bruker 
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 Equinox55 FT-IR or a Perkin-Elmer model 1605 FT-IR spectrometer. Wavenumbers, ν, 
are given in cm-1. The 1H- and 13C-NMR spectra were recorded on a Varian EM 360, 
Varian Gemini 300 spectrometer in CDCl3 and DMSO-d6 solutions with Me4Si as 
internal standard. NMR spectra were determined on a Bruker AM 360 spectrometer, 1H 
at 360.14 MHz and 13C at 90.56 MHz. High field 1D and 2D NMR spectra were 
recorded on Bruker DRX 500 or Bruker Avance-500 spectrometers, 1H at 500.13 MHz. 
Spectral assignment for peptide oligomers was carried out with the help of standard 2D 
NMR spectroscopy. Peak positions are reported in ppm relative to TMS and are 
referenced with the help of the residual undeuterated solvent signal. UV/VIS spectra 
were measured on a Varian CARY 100 instrument in 1 cm quarz Suprasil cells 
thermostated at 20 °C. Absorption maxima, λmax, and molar absorption coefficients, 
εmax, are given in nm and M-1 cm-1, respectively. Mass spectra (MS) were run on MAT 
8200 (EI, FAB) or Hewelett-Packard HP 5989 (ESI). Only characteristic fragments with 
possible composition are given in brackets. For fragments containing metals, only the 
isotopomer with highest intensity was described. Crystallographic analyses were 
performed using Bruker SMART-CCD difractometer. CD-spectra were recorded as 
CH3CN solutions (c = 1 M) with CD-spectropolarimeter Jasco-810 in 1 cm quarz 
Suprasil cells under inert atmosphere thermostated at 20 °C. Ellipticity maxima, θmax, 
are given in nm. Molar ellipticity coefficients, Mθ, were calculated as Mθ = 100 [θ]/ c × 
l, where ellipticity [θ] is in deg, concentration c in mol.1-1 and pathlength l in cm, thus 
giving deg mM-1 cm-1.[19] Elemental analyses were determined in-house. The numbering 
of Ala subunits is presented in Table 2. 
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 3.4.2. General Synthesis of the Ferrocene Dipeptides 2 and 3  
1′-(tert-Butoxycarbonyl-amino)ferrocene-1-carboxylate (1, Boc-Fca-OH) (200 
mg, 0.58 mmol) was activated using EDC (167 mg, 0.87 mmol) and HOBt (117 mg, 
0.87 mmol) and H-Aaa-OMe (1.16 mmol, obtained from H-Aaa-OMe·HCl by treatment 
with Et3N in CH2Cl2, pH ~ 8) was added. The mixture was stirred for 30 minutes. After 
the standard aqueous work-up, the crude products were purified by TLC 
(CH2Cl2/EtOAc (10:1) to give orange crystalline materials upon standing in the 
refrigerator. 
 
3.4.2.1. Boc-Fca-Ala-OMe (2) 
  Orange powder, m.p.: 61-64 ºC. Silica gel column (hexane:ethyl acetate=1:1 Rf 
= 0.37) got yellowish crystal 337mg (yield: 78%). Re-crystallization from ethyl acetate 
gave yellow X-ray quality crystals (vide infra). EI-MS for C20H26N2O5Fe: Calc. for 
[M]+:430.1191, found: 430.1204. FT-IR(KBr,cm-1): 3300(m, N-H), 1724, 1698 (m, 
C=O), 1638 (s, Amid I), 1546 (s, Amid II). UV-vis(λmax in nm, [ε in M-1,cm-1]): 
442[253]. 1H-NMR (δ, CDCl3): 6.70 (s, 1H, CpHCO), 6.88 (s, 1H, NH, LAla), 6.50 (s, 
1H, NH, LAla), 4.71 (s, 1H, H-2,Cp), 4.68 (2 overlapping, m, 2H, Hα +H-5,Cp), 4.57 (s, 
1H, H-2'), 4.51 ((s, 1H, H-5',Cp), 4.36 (s, 1H, H-3, Cp), 4.33 (s, 1H, H-4, Cp), 4.05 (s, 
1H, H-3',Cp ), 3.98 (s, 1H, H-4',Cp), 3.78 (s, 3H, COOCH3), 1.52 (s, 3H, CH3, Ala), 
1.51 (s, 9H, C(CH3)3, Boc). 13C{1H}-NMR (CDCl3, δ in ppm): 174.9 (COOCH3), 
170.5(CONH), 153.9 (CO, Boc), 97.2 (C-1', Cp), 80.7 (C(CH3)3), 77.7 (C-1,Cp), 72.1 
(C-2,Cp), 71.0 (C-5,Cp), 70.1 (C-2',Cp), 66.5 (C-5',Cp), 65.8 (C-3,Cp), 65.5 (C-4,Cp), 
63.4 (C-3',Cp), 62.3 (C-4',Cp), 53.0 (COOCH3), 28.7 (C(CH3)3), 18.2 (CH3, LAla).1H-
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 NMR (DMSO-d6, δ in ppm): 8.43 (bs, 1H, NHFca), 8.04 (d, 1H, NHAla, J = 5.6 Hz), 4.75 
(s, 1H, H-2, Fn), 4.70 (s, 1H, H-5, Fn), 4.49 (m, 1H, CHAla), 4.40 (m, 2H, H-2' H-5', 
Fn), 4.25 (s, 2H, H-3 H-4, Fn), 3.92 (m, 2H, H-3' H-4', Fn), 3.64 (s, 3H, OCH3), 1.45 (s, 
9H, C(CH3)3), 1.38 (d, 3H, CH3Ala, J = 7.2 Hz). 13C-NMR (DMSO-d6, δ in ppm): 173.4 
(COOCH3), 168.9 (COFca), 153.1 (COOtBu), 98.0 (C-1', Fn), 78.7 (C(CH3)3), 75.6 (C-1, 
Fn), 71.3 (C-2 C-5, Fn), 68.9 (C-3' C-4', Fn), 65.4 (C-3 C-4, Fn), 61.1 (C-2′ C-5′, Fn), 
51.7 (OCH3), 47.7 (CHAla), 28.04 (C(CH3)3), 16.8 (CH3Ala).  
 
3.4.2.2. Boc-Fca-D-Ala-OMe (3) 
Orange powder, Silica gel column (hexane: ethyl acetate=1:1 Rf=0.37) got 
yellowish power (326mg, 75.8%). Re-crystallization from ethyl acetate gave yellow X-
ray quality crystals (vide infra). EI-MS(+vs) for C20H26N2O5Fe: Calc. [M]+: 430.1191, 
found: 430.1190. FT-IR (KBr, cm-1): 3298 (m,N-H), 1724, 1698 (m, C=O), 1637 (s, 
Amid I), 1546(s, Amid II). UV-vis(λmax in nm,[ε in M-1,cm-1]): 441[248]. 1H NMR 
(CDCl3, δ in ppm): 6.78 (s, 1H, CpHCO), 6.42 (s, 1H, NH, DAla), 4.71 (s, 1H, H-2,Cp), 
4.68 (s, 1H, H-5,Cp), 4.50 (s, 1H, H-2',Cp), 4.48 (m, 1H, H-5',Cp), 4.38 (s,1H,H-3,Cp), 
4.34 (s,1H, H-4,Cp), 4.07 (s,1H, H-3',Cp ), 4.00 (s, 1H, H-4,Cp), 3.80 (s, 3H, 
COOCH3), 1.52 (s, 3H,CH3, DAla), 1.50 (s, 9H, C(CH3)3, Boc). 13C NMR (CDCl3, δ in 
ppm): 174.9 (COOCH3), 170.5 (CONH), 153.9 CO, Boc), 97.2 (C-1',Cp), 80.7 
(C(CH3)3), 77.7 (C-1,Cp), 72.1 (C-2,Cp), 71.4 (C-5,Cp), 70.0 (C-2',Cp), 66.5 (C-5',Cp), 
65.8 (C-3,Cp), 65.6 (C-4,Cp), 63.4 (C-3',Cp), 62.8 (C-4',Cp), 53.0 (COOCH3), 29.0 
(C(CH3)3), 18.3 (CH3, DAla). 
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3.4.3. Synthesis of Boc-D-Ala-Fca-Ala-OMe (4) 
This compound was prepared as described above using HBTU as a coupling 
reagent. Boc-Fca-Ala-OMe (430 mg, 1 mmol), Boc-Ala-OH (190 mg, 1 mmol), HBTU 
(418 mg, 1.1 mmol). Silica gel column (hexane:EtOAc, 2:3, Rf = 0.33) to give yellow 
crystal (360 mg, 72 %). EI-MS(+vs) for C23H31N3O6Fe: Calc. for [M]+: 501.1562, 
found: 501.1565. FT-IR (KBr, cm-1): 3301(m, N-H), 1745, 1683 (m, C=O), 1637 (s, 
Amid I), 1531 (s, Amid II). IR (CH2Cl2, νmax/cm-1): 3429 m (N−H free), 3307 b, m 
(N−H, H-bonded), 1734 s (C=O), 1697 s, 1653 s, 1540 s, 1521, 1507 s. UV-vis (λmax in 
nm, [ε in M-1 cm-1]): 440 [247]. 1H-NMR (CDCl3, δ in ppm): 9.10 (s, 1H, CpNH), 7.35 
(d, J = 7.8 Hz, 1H, NHDAla), 5.40(s, 1H, NHLAla), 4.88 (m, 1H, NHLAla), 4.63 (s,1H, H-
2,Cp), 4.57 (s, 1H, H-5Cp4.52 m, 1H, HαDAla), 4.47 (s,1H, H-2',Cp), 4.40 (s,1H,H-5', 
Cp), 4.34 (s,1H, H-3,Cp), 4.29 (s, 1H, H-4,Cp), 4.02 (s, 1H, H-3',Cp ), 4.00 (s,1H, H-
4',Cp), 3.78 (s,3H,COOCH3), 1.47 (s, 3H,CH3LAla), 1.45 (s, 9H, C(CH3)3, Boc), 1.39 
(s,3H,CH3DAla). 1H-NMR (DMSO, assignments based on COSY spectra, δ in ppm): 
9.31 (s, 1H, FcNHCO), 8.06 (d, J = 6.5 Hz, 1H, NHDAla), 7.04(d, J = 5.6 Hz, 1H, 
NHLAla), 4.77 (s, 1H, HCp), 4.74 (s, 1H, HCp), 4.69 ( s, 1H, HCp), 4.53 ( s, 1H, HCp), 4.40 
(m, 1H, CHLAla), 4.28 (s, 2H, HCp), 3.98 (s, 2H, HCp), 3.93 (m, 1H, CHDAla2), 3.65 (s, 
3H, COOCH3), 1.40 (s, 9H, C(CH3)3), 1.38 ( s, 3H, CH3LAla1), 1.20 (d, J = 7.7 Hz, 3H, 
CH3DAla2). 13C{1H}-NMR (CDCl3, δ in ppm): 174.6 (COOCH3), 171.4 (CONHDAla), 
170.1 (CpCONHLAla), 155.9 (CO, Boc), 95.0 (C-1',Cp), 80.4 (C(CH3)3), 78.5 (C-1,Cp), 
76.8 (C-2,Cp), 76.2 (C-5,Cp), 71.7 (C-2',Cp), 71.2 (C-5',Cp), 69.6 (C-3,Cp), 66.0 (C-
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 4,Cp), 64.0 (C-3',Cp), 63.5 (C-4',Cp), 52.6 (COOCH3), 51.2 (CαDAla), 50.9 (CαLAla), 28.3 
(C(CH3)3), 18.2 (CH3DAla), 16.9 (CH3LAla). 
 
3.4.4. Synthesis of Boc-Ala-Fca-D-Ala-OMe (5) 
The synthesis procedure is similar to that of compound 4. Silica gel column 
(hexane:ethyl acetate = 2:3 Rf = 0.32) to give yellow crystals (390 mg, 78%). EI-
MS(+vs) for C23H31N3O6Fe Calc. [M]+: 501.1562, found: 501.1579. FT-IR (KBr, cm-1): 
3299 (m, N-H), 1741, 1684 (s, C=O), 1637 (s, Amid I), 1532 (s, Amid II). IR (CH2Cl2) 
νmax/cm-1: 3430 m (N−H free), 3359, 3317 (N−H, H-bonded), 1741 s (C=O), 1696 s, 
1636 s, 1650 s, 1563, 1503 s. UV-vis (λmax in nm, [ε in M-1 cm-1]): 438 [241]. 1H-NMR 
(CDCl3, δ in ppm): 8.55 (s, 1H, CpNH), 7.18 (d, J = 7.6 Hz, 1H, NHDAla), 5.29 (s, 1H, 
NHLAla), 4.92 (m, 1H, NHDAla), 4.63 (s, 1H, H-2,Cp), 4.59 (s, 1H, H-'Cp4.52 
overlapping, m, 2H, HαDAla +H-2', Cp), 4.43 (s, 1H, H-5', Cp), 4.39 (s, 1H, H-3, Cp), 
4.34 (s, 1H, H-4, Cp), 4.07 (s, 1H, H-3',Cp ), 4.04 (s, 1H, H-4', Cp), 3.82 (s, 3H, 
COOCH3), 1.56 (s, 3H, CH3DAla), 1.47 (s, 9H, C(CH3)3, Boc), 1.41 (s, 3H, CH3LAla). 1H-
NMR (DMSO, assignments based on COSY spectra, δ in ppm): 9.31 (s, 1H, FcNHCO), 
8.05 (d, J = 6.5 Hz, 1H, NHLAla), 7.04(d, J = 5.6 Hz, 1H, NHDAla), 4.77 (s, 1H, HCp), 
4.73 (s, 1H, HCp), 4.69 ( s, 1H, HCp), 4.53 ( s, 1H, HCp), 4.40 (m, 1H, CHDAla), 4.30 (s, 
2H, HCp), 4.00 (s, 2H, HCp), 3.95 (m, 1H, CHLAla), 3.56 (s, 3H, COOCH3), 1.38 (s, 9H, 
C(CH3)3), 1.37 (s, 3H, CH3DAla), 1.20 (s, 3H, CH3Ala). 13C{1H}-NMR (CDCl3, δ in 
ppm): 174.6 (COOCH3), 171.6 (CONHLAla), 170.4 (CpCONHDAla), 160.1 (CO, Boc), 
94.3 (C-1', Cp), 79.6 (C(CH3)3), 78.5 (C-1, Cp), 76.8 (C-2, Cp), 75.4 (C-5, Cp), 72.0 
(C-2', Cp), 71.2 (C-5', Cp), 70.5 (C-3, Cp), 65.4 (C-4, Cp), 64.0 (C-3', Cp), 63.4 (C-4', 
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 Cp), 52.6 (COOCH3), 51.4 (CαLAla), 50.9 (CαDAla), 28.3 (C(CH3)3), 18.1 (CH3LAla), 16.8 
(CH3DAla). 
 
3.4.5. Synthesis of Boc-Ala-Fca-Ala-D-Ala-OMe (6) 
To the solution of Boc-Ala-Fca-Ala-OMe (4) (500 mg, 1 mmol) in THF (12 ml), 
NaOH aqueous solution (0.1 M, 12 ml) was added dropwise at 0◦C for 30 mins, then 
reacted at room temperature overnight. THF was evaporated and 50ml water was added 
to the aqueous solution. Then the solution was washed with EtOAc (3 × 20 ml). The 
aqueous solution and 100 ml EtOAC were put in a flask and cooled to 0◦C, 0.1 M HCl 
was added slowly to the solution to pH 1-2. The aqueous phase was washed with EtOAc 
(3 × 100 ml) and dried over NaSO4, then filtered and evaporated under reduced pressure 
in a rotorvap to give the free acid as an orange solid 448 mg (92%). Boc-Ala-Fca-Ala-
OH (245 mg, 0.5 mmol) was dissolved in dry DCM (100ml), and reacted with H-D-
Ala-OMe. The procedure is similar to that of compound 4. Silica gel column 
(hexane:EtOAc = 1:3, Rf = 0.21) giving yellow crystals of compound 6 (214 mg, yield 
= 75 %). EI-MS(+vs) for C26H36N4O7Fe Calc. [M]+: 572.1933, found: 572.1938. FT-IR 
(KBr, cm-1): 3277 (m, N-H), 1724, 1683 (m, C=O), 1637 (s, Amid I), 1531 (s, Amid II). 
IR (CH2Cl2) νmax/cm-1: 3433 m (N−H free), 3328 b, m (N−H, H-bonded), 1716 s (C=O), 
1654 s, 1538 s, 1509 s. UV-vis (λmax in nm, [ε in M-1 cm-1]): 445[384]. 1H-NMR 
(CDCl3, δ in ppm): 9.41 (s, 1H, CpNH), 7.84 (d, J = 7.0 Hz, 1H, NHDAla), 7.29 (d, J = 
7.2 Hz, 1H, NHLAla1), 5.31 (s, 1H, H-2, Cp), 5.10 (d, J = 7.0 Hz, 1H, NHLAla), 4.80 (s, 
1H, H-5, Cp), 4.70 (m, 1H, HαDAla), 4.58 (s, 1H, H-2', Cp), 4.56 (overlapping, m, 2H, 
HαDAla+H'Cp), 4.27 (s, 1H, H-3, Cp 4.11 s, 1H, H-4, Cp), 4.06 (s, 1H, H-3', Cp), 4.00 (s, 
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 1H, H-4', Cp), 3.75 (s, 3H, COOCH3LAla2), 1.52 (s, 3H, CH3DAla), 1.45 (s, 9H, C(CH3)3, 
Boc), 1.42 (s, 3H, CH3LAla1), 1.36 (s, 3H, CH3DAla). 1H-NMR (DMSO, assignments 
based on COSY spectra, δ in ppm): 9.32 (s, 1H, FcNHCO), 8.28 (d, J = 6.7 Hz, 1H, 
NHDAla2), 7.77 (d, J = 7.1 Hz, 1H, NHLAla1), 7.01 (d, J = 6.1 Hz, 1H, NHLAla3), 4.77 (s, 
1H, HCp), 4.68 (s, 1H, HCp), 4.67 (s, 1H, HCp), 4.56 (s, 1H, HCp), 4.45 (m, 1H, 
CHLAla1), 4.31 (m, 1H, CHDAla2), 4.28 (s, 2H, HCp), 3.98 (s, 2H, HCp), 3.91 (m, 1H, 
CHLAla3), 3.65 (s, 3H, COOCH3), 1.39 (s, 9H, C(CH3)3), 1.34 ( m, 6H, CH3LAla1 + 
CH3DAla2), 1.21 (d, J = 6.6 Hz, 3H, CH3LAla3). 13C{1H}-NMR (CDCl3, δ in ppm): 173.4 
(COOCH3), 171.5 (CONHDAla), 170.5 (CpCONHLAla1), 156.4 (CONHLAla2), 95.3 (C-1', 
Cp), 78.0 (C(CH3)3, Boc), 77.4 (C-1, Cp), 71.7 (C-2, Cp), 70.2 (C-5, Cp), 69.3 (C-2', 
Cp), 69.0 (C-5', Cp), 66.3 (C-3, Cp), 66.1 (C-4, Cp), 64.0 (C-3', Cp), 62.9 (C-4', Cp), 
52.8 (COOCH3), 50.2 (CαLAla1), 48.8 (CαLAla1), 47.2 (CαDAla1), 28.2 (C(CH3)3), 17.8 
(CH3LAla1), 17.5 (CH3LAla2), 16.5 (CH3DAla). 
 
3.4.6. Synthesis of Boc-Ala-Fca-D-Ala-D-Ala-OMe (7) 
 The synthetic procedure is identical to that described for 6. Silica gel column 
(hexane:EtOAc = 1:3 Rf = 0.20) to get yellow crystals (205 mg yield = 73 %). EI-
MS(+vs) for C26H36N4O7Fe Calc. [M]+: 572.1933, found: 501.1579. FT-IR (KBr, cm-1): 
3289 (m, N-H), 1745, 1666 (m, C=O), 1635 (s, Amid I), 1531 (s, Amid II). IR (CH2Cl2, 
νmax/cm-1): 3426 m (N−H free), 3307 b, m (N−H, H-bonded), 1741 s (C=O), 1685 s, 
1654 s, 1558 s, 1507 s. UV/vis (in MeCN, UV-vis (λmax in nm,[ε in M-1,cm-1]): 
445[384]. 1H-NMR (CDCl3, δ in ppm): 8.61 (s, 1H, CpNH), 7.41 (d, J = 7.0 Hz, 1H, 
NHDAla2), 7.18 (d, J = 7.2 Hz, 1H, NHLAla), 5.38 (s, 1H, H-2, Cp), 5.14 (d, J = 7.0 Hz, 
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 1H, NHLAla), 4.80 (s, 1H, H-5, Cp), 4.73 (m, 1H, HαDAla), 4.65 (s, 1H, H-2', Cp), 4.60 
(overlapping, m, 2H, HαDAla1 + LAla), 4.47 (s, 2H, H-2'+H-5', Cp 4.39 s, 1H, H-3, Cp), 
4.36 (s, 1H, H-4, Cp), 4.20 (m, 1H, CαDAla2), 4.05 (s, 2H, H-3'+H-4', Cp), 3.77 (s, 3H, 
COOCH3), 1.54 (s, 3H, CH3LAla), 1.50 (s, 3H, CH3DAla1), 1.48 (s, 9H, C(CH3)3, Boc), 
1.42 (s, 3H, CH3DAla2). 1H-NMR (DMSO, assignments based on COSY spectra, δ in 
ppm): 9.30 (s, 1H, FcNHCO), 8.27 (d, J = 6.6 Hz, 1H, NHDAla2), 7.74 (d, J = 7.6 Hz, 
1H, NHDAla1), 7.00 (d, J = 5.4 Hz, 1H, NHLAla3), 4.77 (s, 1H, HCp), 4.69 (s, 1H, HCp), 
4.66 (s, 1H, HCp), 4.56 (s, 1H, HCp), 4.43 (m, 1H, CHαDAla1), 4.30 (m, 1H, CHDAla2), 4.26 
(s, 2H, HCp), 3.97 (s, 2H, HCp), 3.94 (m, 1H, CHαLAla3), 3.62 (s, 3H, COOCH3), 1.39 (s, 
9H, C(CH3)3), 1.33 ( m, 6H, CH3DAla1 + CH3DAla2), 1.21 (d, J = 6.6 Hz, 3H, CH3LAla3). 
13C{1H}-NMR (CDCl3, δ in ppm): 173.3 (COOCH3), 171.6 (CONHDAla1), 170.5 
(CpCONHLAla), 155.9 (CONHDAla2), 94.9 (C-1', Cp), 80.4 (C(CH3)3, Boc), 77.0 (C-1, 
Cp), 76.8 (C-2, Cp), 76.4 (C-5, Cp), 71.6 (C-2', Cp), 70.0 (C-5', Cp), 66.9 (C-3, Cp), 
65.4 (C-4, Cp), 64.0 (C-3', Cp), 63.3 (C-4', Cp), 52.3 (COOCH3), 50.8 (CαDAla2), 50.0 
(CαLAla), 48.0 (CαDAla1), 28.4 (C(CH3)3), 18.4 (CH3LAla), 17.9 (CH3DAla2), 17.7 
(CH3DAla1). 
 
3.4.7. Synthesis of Boc-D-Ala-Ala-Fca-Ala-D-Ala-OMe (8) 
Boc-Ala-Fca-Ala-D-Ala-OMe (285 mg, 0.5 mmol) Boc-D-Ala-OH (85 mg, 0.5 
mmol), HBTU (210 mg, 0.55 mmol). Silica gel column (hexane:EtOAc:MeOH = 
10:85:5, Rf = 0.12) to give a yellow solid 103 mg (yield = 31%). EI-MS (+vs) for 
C29H41N5O8Fe: Calc. for [M+1]+: 643.2304, found: 644.2370. FT-IR (KBr, cm-1): 3287 
(m, N-H), 1740, 1659 (m, C=O), 1634 (s, Amid I), 1530 (s, Amid II). IR (CH2Cl2, 
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 νmax/cm-1): 3424 m (N−H free), 3325 b, m (N−H, H-bonded), 1742 s (C=O), 1684 s, 
1670 s, 1517 b, s. UV-vis (λmax in nm,[ε in M-1,cm-1]): 439[416]. 1H-NMR (CDCl3, δ in 
ppm): 9.08 (s, 1H, CpNH), 7.83 (s, 1H, NH,), 7.28 (s, 1H, NH), 7.20 (s, 1H, NH), 5.37 
(s, 1H, H-2, Cp), 5.20 (d, J = 7.0 Hz, 1H, NH), 4.86 (overlapping, 2H), 4.46 (s, 1H, Cp), 
4.47 (s, 1H, Cp), 4.26 (overlapping, 2H), 4.17 (m, 1H) 4.11 s, 2H), 3.91 (s, 1H), 3.82 (s, 
3H, COOCH3), 1.46 (overlapping, 12H, CH3Ala+C(CH3)3, Boc), 1.43-1.42 (overlapping, 
9H, CH3Ala). 1H-NMR (DMSO, assignments based on COSY spectra, δ in ppm): 9.19 
(s, 1H, FcNHCO), 8.30 (d, J = 5.8 Hz, 1H, NHDAla2), 8.02 (d, J = 6.2 Hz, 1H, NHLAla4), 
7.73 (d, J = 6.8 Hz, 1H, NHLAla1), 7.01 (d, J = 5.5 Hz, 1H, NHLAla3), 4.78 (s, 1H, HCp), 
4.71 (s, 1H, HCp), 4.66 (s, 1H, HCp), 4.57 (s, 1H, HCp), 4.43 (m, 1H, CHLAla1), 4.30 (m, 
2H, CHDAla2 & CHDAla3), 4.25 (s, 2H, HCp), 3.99 (s, 2H, HCp), 3.98 (m, 1H, CHLAla4), 
3.62 (s, 3H, COOCH3), 1.37 (s, 9H, C(CH3)3), 1.32 ( m, 6H, CH3LAla1 + CH3DAla2), 1.27 
(d, J = 7.0 Hz, 3H, CH3LAla4), 1.18 (d, J = 7.0 Hz, 3H, CH3LAla3). 13C{1H}-NMR (CDCl3, 
δ in ppm): 176.8 (COOCH3), 173.4, 170.9, 165.7, 155.6 (CONH), 95.3 (Cp), 80.3 
(C(CH3)3, Boc), 72.4, 71.5, 70.7, 70.5, 70.0, 66.0, 65.8, 65.3, 64.4, 62.8 (Cp), 
52.7(COOCH3), 50.4, 50.0, 48.5, 48.0 (CαAla), 28.3 (C (CH3)3), 19.6, 18.2, 17.5, 17.3 
(CH3Ala). 
 
3.4.8. Synthesis of Boc-Ala-Ala-Fca-D-Ala-D-Ala-OMe (9) 
Identical procedure to 6. Silica gel column (hexane:EtOAc:MeOH = 10:85:5, Rf 
= 0.12) to give a yellow solid (137 mg, 43%). EI-MS (+vs) for C29H41N5O8Fe: Calc. for 
[M+1]+: 644.2304, found: 644.2379. FT-IR (KBr, cm-1): 3293 (m, N-H), 1742, 1668 (s, 
C=O), 1629 (s, Amid I), 1527 (s, Amid II). UV/vis (in MeCN, (λmax in nm,[ε in M-1,cm-
                                                                                                          
89
 1]): 448[323]. 1H-NMR (CDCl3, δ in ppm): 9.27 (s, 1H, CpNH), 7.88 (s, 1H, NH), 7.28 
(s, 1H, NH), 6.68 (s, 1H, NH), 5.18 (s, 1H, H-2, Cp), 4.95 (d, J = 7.0 Hz, 1H, NH), 4.87 
(s, 1H), 4.68 (s, 1H), 4.53-4.50 (overlapping, 3H), 4.27 (overlapping, 3H), 4.10 (s, 2H)  
3.90 (s, 1H), 3.76 (s, 3H, COOCH3), 1.47 (overlapping, 12H, CH3Ala + C(CH3)3, Boc), 
1.43-1.38 (overlapping, 9H, CH3Ala). 13C{1H}-NMR (CDCl3, δ in ppm): 174.6 
(COOCH3), 173.5, 170.9, 166.1, 156.4 (CONH), 95.3 (Cp), 80.3 (C(CH3)3, Boc), 72.0, 
71.5, 71.6, 70.4, 70.1, 66.5, 66.4, 66.1, 64.4, 63.8 (Cp), 52.9 (COOCH3), 51.3, 50.3, 
48.9, 48.6 (CαAla), 28.7 (C(CH3)3), 18.3, 18.2, 17.9, 17.8 (CH3Ala). 
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 CHAPTER 4 
 
A BIOORGANOMETALLIC APPROACH FOR THE 
ELECTROCHEMICAL DETECTION OF PROTEINS: A STUDY ON 
THE INTERACTION OF FERROCENE-PEPTIDE CONJUGATES 
WITH PAPAIN IN SOLUTION AND ON AU SURFACES 
 
4.0. Connecting Text 
This chapter describes the first application of ferrocene-peptide bioconjugates. It was 
demonstrated in Chapters 2 and 3 that 1'-amino-ferrocene-1-carboxylic acid (ferrocene 
amino acid, Fca) effectively conjugates to amino acids and peptides. In addition, it was 
shown that this artificial amino acid has the ability to impose secondary structural 
elements on the supramolecular structure of Fca-peptide conjugates; therefore, it may be 
possible to exploit the redox properties of the Fc group for the recognition of 
bimolecular interactions. This has led to a successful study on the interaction between 
selected series of surface modified Fca-peptide conjugates and papain. This novel 
approach may overcome some of the drawbacks of known electrochemical biosensors 
where the presence of a terminal redox probes significantly interferes with the 
molecular recognition processes. 
This paper was reproduced with the permission from Chem. Eur. J. 2007, 13, 5885-5895, Copyright © 
2007, Wiley VCH. This paper was co-authored by H.-B. Kraatz. All work described in this paper, in 
terms of the experimental study, hypothesis, and initial writing of the manuscript were carried out by me. 
The text below is a verbatim copy of the published paper.    
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 4.1. Introduction 
 
Enzymatic transformations of substrates are often exploited for the development 
of amperometric sensors. The electrochemical sensors have received a major attention 
in the biosensing technology, in particular the use of glucose oxidase for the 
development of an electrochemical glucose sensitive detector.[1-7] The resulting devices 
exploiting this technology are simple to use, inexpensive and accurate. More 
importantly, they are amenable to miniaturization and hence the design of high-density 
arrays.[8]                                                                                                                                                       
The detection of biomolecular interactions by electrochemical methods requires 
in general the presence of a redox-active probe as part of the detection system (Scheme 
4.1). The redox probe can be in solution or can be covalently attached to the molecule 
capturing the biomolecule from solution. In both cases, the interaction of the surface 
with the biomolecule will alter the electron transfer properties of the systems. For 
solution-based redox probes, significant differences exist in the electron transfer 
properties or ability of the redox probe and/or counter ions to diffuse into the film 
(Scheme 4.1.A). These differences can be exploited for the detection of protein binding 
to a range of capture probes. In essence, this approach is “label-free”, since no chemical 
modifications of the capture probe or of the target protein are necessary.[9, 10] An 
interesting variation on the theme of a solution-based electroactive probe is the use of a 
redox-active polymer. Using a ferrocene (Fc)-labeled polythiophene which 
electrostatically binds to duplex DNA or duplex DNA-PNA), it was possible to detect 
thrombin.[10-13]  More recently, electrochemical immunoassays (EIA) were developed in 
which an analyte binds to an immobilized antibody, followed by binding of a redox 
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 mediator bound to an antibody which binds to the electrode-bound analyte (Scheme 
4.1.B).[14, 15] In cases where the redox-probe is covalently attached to a terminal position 
of a molecule such as single stranded DNA, the interaction with the appropriate target 
will result in large structural changes of the capture probe causing changes in the 
electron transfer kinetics of the system. Heeger’s DNA-hairpin loop is an example for 
this approach (Scheme 4.1.C).[16] In the absence of a suitable target, a Fc probe attached 
to the 5’-position in a single stranded DNA is in close proximity to the electrode surface 
and gives rise to a significant redox response. Upon hybridization of a target strand to 
the Fc-labeled capture strand, significant structural changes occur which change the 
distance between the Fc group and the surface, resulting in a decrease of the 
electrochemical response. Although this approach is useful in cases of DNA-DNA or 
DNA-protein detection where the interaction does not involve the site of the redox 
probe,[17] it will have limited utility for monitoring peptide-protein interactions. In this 
case, the presence of a terminal redox probe may significantly interfere with the 
interaction and may even prevent it.  
We are proposing a new approach making use of our expertise in bioorganometallic 
chemistry to join a peptide recognition sequence to a redox probe. The idea is that a 
surface-bound redox probe is in close proximity to the electrode surface and thus 
unaffected by diffusive processes. Interaction between the recognition sequence and 
electrode surface will not be hindered by the interaction with the target analyte. This in 
turn may enhance the sensitivity and may render a potential device less susceptible to 
environmental influences.    
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Scheme 4.1. Schematic representation of some of the common electrochemical 
biosensor systems (A-C) and the new proposed system making use of an ferrocene-
peptide conjugate (D): (A) The redox active probe in solution and the target protein 
blocks its interaction with the surface. (B) In the electrochemical immunoassay (EIA) a 
protein binds to a surface-bound capture probe followed by binding labeled antibody. 
(C) Conformational changes take place upon binding of a target DNA to a single 
stranded capture DNA. Changes in the distance between the redox label and the surface 
alter the electrochemical behavior of the system. (D) Bioorganometallic capture probe: 
protein binding is detected by monitoring the electrochemical properties before and 
after protein binding. 
 
Fc-peptide conjugates are an attractive class of organometallic peptide conjugates 
that are conveniently obtained by solution or solid-phase synthetic strategies,[18] that 
have the potential to be tailored to target DNA and specific proteins.[19-22] In a recent 
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 study, it was demonstrated that 1'-aminoferrocene-1-carboxylic acid (ferrocene amino 
acid, Fca) induces a turn into a peptide sequence and thereby allows control over the 
peptide secondary structure.[23] Recently, Rapić et al and Heinze et al independently 
used solid phase peptide synthesis (SPPS) to produce Fca-oligopeptides by combining 
Fmoc- and Boc- procedures.[24, 25]  
In this contribution, we outline how Fca-peptide conjugates can be used in protein 
detection and demonstrate our approach for the detection of papain a cysteine-protease 
commonly found in the papaya fruit and used commercially as a meat tenderizer. In our 
approach (see Scheme 4.1.D), a thin film on gold prepared from a conjugate of Fca with 
an inhibitory peptide sequence to papain is used for the detection of papain. We are 
reporting the results of a combined synthetic, spectroscopic and electrochemical study 
into the properties of these films and their behavior in the presence of papain. 
 
4.2. Results and Discussion 
 
  4.2.1. Synthesis 
In an early report, it was shown that the organometallic peptide conjugate Fc-
Gly-Gly-Tyr-Arg interacts with papain and acts as a competitive inhibitor.[22] Based on 
this result, it was decided to work with two peptide systems, making use of conjugation 
Fca, exploiting the papain-binding sequence Gly-Gly-Tyr-Arg and Gly-Gly-Arg-Tyr. 
Conjugation of the tetrapeptide to the C-terminal side of Fca will allow the interaction 
with the protein, while the N-terminal side will be exploited to surface binding of the 
Fca-conjugate. The synthesis of Fca-peptide conjugate 4 was achieved by carbodiimide 
coupling in solution and is summarized in Scheme 4.2. Compound 4 displayed a broad 
band in the IR assigned to the OH stretch and the expected carbonyl stretch for the acid 
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 group at 1741 cm-1. Unfortunately, it was not possible to deprotect the guanidine group 
of peptide conjugate 4 by hydrogenation, presumably due to Pd catalyst poisoning due 
to the thiostic acid (Thc) disulfide group. In order to overcome this problem, we decided 
to implement a small positional change in the sequence involving the Tyr and Arg, 
which facilitated the synthesis and did not require protection of the Tyr. The Arg 
guanidine group was protected by Mtr, which could be deprotected in the presence of 
TFA and thioanisol. The synthesis of Fca-peptide conjugates 9 and 10 is summarized in 
Scheme 4.3. 
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Scheme 4.2 Synthesis of Fca-peptide conjugate 4. (i) TFA/CH2Cl2; Boc-Fca-OBt; Et3N, 
CH2Cl2 (ii) TFA/CH2Cl2; ThcOH, EDC/HOBt; Et3N, CH2Cl2  (iii) NaOH/CH3OH/H2O. 
 
 
The peptide building block 6 was synthesized from Boc-Gly2-OH and the 
corresponding dipeptide H-Arg(Mtr)-Tyr-OMe 5. Boc-deprotection and conjugation to 
the carboxylic acid group of Fca resulted in the desired conjugate 7. After Boc-
deprotection of the amino group of Fca under anaerobic conditions, the thiostic acid 
(Thc) conjugate 8 was formed. Stepwise deprotection of the methyl ester by hydrolysis 
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 and of the Mtr group by TFA/anisol resulted in the formation of compound 9 and 10, 
respectively. Final purification of compound 10 was carried out by HPLC. The identity 
of compounds 9 and 10 was confirmed by full spectroscopic analysis including ToF-
MS, IR and 1H-NMR spectroscopy. In the IR, compounds 9 and 10 showed Amide-A 
bands at 3306 and 3447 cm-1 respectively and carbonyl stretch at 1748 and 1725 cm-1 
respectively. Figure 4.1 shows the 1H-NMR spectra in DMSO-d6 for the main three 
peptides 4, 9, and 10 under investigation. In all three peptides, the amide as well as 
guanidine protons were observed in the region δ 8.6-7.3. The peaks assigned for Mtr 
protecting group in peptide 9 disappeared in peptide 10 indicating the successful 
deprotection. 
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Scheme 4.3. Synthesis of Fca-peptide conjugates 7-10. (i) TFA/CH2Cl2; EDC/HOBt; 
Et3N,/CH2Cl2 (ii) TFA/CH2Cl2; Boc-Fca-OBt; Et3N,/CH2Cl2 (iii)TFA/CH2Cl2; 
ThcOH/EDC/HOBt; Et3N,/CH2Cl2  (iv) NaOH/CH3OH, (v) TFA/ thioanisol/CH2Cl2. 
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Figure 4.1. 1H-NMR of peptides 4, 9, and 10. * (D5)DMSO trace at δ2.50, water trace 
at δ3.33. 
 
 
4.2.2. Inhibition Studies 
Before linking the Fca-peptide conjugates to a gold surface, it was important to 
evaluate the Fca-conjugates for their ability to inhibit papain in solution.  For this 
purpose, papain was assayed with the chromogenic substrate Z-Phe-Arg-NHNp in the 
absence and presence of the Fca-peptide conjugates 4, 9 and 10. The Michaelis-Menten 
constant (Km) for papain as well as the inhibition constant Ki for the peptides were 
determined. A Km value of 980 ± 26 µM was determined at pH 6.2 by non-linear 
regression fit of the concentration velocity curve using Michaelis-Menten equation (υ = 
υ max [S]/(Km+[S]), where υ is the velocity and υmax is the maximum velocity, and [S] is 
the substrate concentration (Figure 4.S2). The value compared well with the previously 
reported one, 965±244 µM.[26] Figure 4.S3 shows a representative kinetic analysis of 
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 papain inhibition by the two Fca-peptide conjugates 9 and 10. The Dixon-Webb plots 
indicate a time-independent inhibition. The slopes of the progress curves were directly 
used to determine Ki' value, from which Ki value was calculated to be 210 ± 1.4 µM for 
compound 9 and 6.9 ± 0.2 µM for compound 10. Our results suggest that these Fca-
peptide conjugates exhibit competitive inhibition behavior.[26] The inhibition constants 
for 10 indicates very good competitive inhibition of papain, comparable to that of the 
Fc-conjugate Fc-Gly-Gly-Try-Arg-OH, which has a Ki = 9 µM at pH 6.2 (Table 4.1).[22]  
 
Table 4.1. Inhibition constant Ki of the Fc-peptide conjugates 4, 9, and 10 and some 
literature compounds. 
 
Compound pH Ki’  (µM) Ki (µM) Ref 
4 6.2 2510.6± 8.8 820.9 ± 2.5 This work 
9 6.2 639.1±1.1 210 ± 1.4 This work 
10 6.2 21.1±0.3 6.9 ± 0.2 This work 
Gly2TyrArg 6.0  150 [27]  
Gly2Tyr(Bz)Arg  6.0  123 [28]  
Fc- Gly2TyrArg 6.2  9 [22]  
 
On the other hand, lower affinities were observed for the Fca-peptide conjugates 
4 (Ki = 820.9 ± 2.5 µM) and 9 (Ki = 210 ± 1.4 µM), which is rationalized by the 
presence of protecting groups which may not allow a proper interaction with Cys-25 
and His-159 in the active site of papain.[29-31] It is interesting to note that switching the 
peptide sequence from the original sequence employed by Kaiser for purification of 
papain by affinity chromatography Gly-Gly-Tyr-Arg[28] to Gly-Gly-Arg-Tyr, the 
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 peptide became a more potent inhibitor. Blumberg[27] and Kaiser[28] used Gly-Gly-
Tyr(Bzl)-Arg for the purification of papain by affinity chromatography. It was shown 
that papain inhibition can be achieved by peptides that have Arg and an aromatic amino 
acid in the P1 and P2 subsites (nomenclature according to Schechter and Berger,[32] see 
supplemental material Figure 4.S4). It was found that the peptide sequence Z-Arg-Leu-
Val-Gly-DAM gave the most potent inhibitor of papain with apparent second order rate 
constants of the same order of magnitude as those determined for {1-[N-[(L-3-trans-
carboxyoxirane-2-carbonyl)-L-leucyl]amino]-4-guanidinobutane} E-64, the most 
common inhibitor of cysteine proteases.[33] Moreover, a strong electron-withdrawing 
phenyl groups at the C-terminus constructs a good irreversible inhibitor for papain.[34]  
Crystal structures of related papain-inhibitor complexes showed that the inhibitor 
extends along the Sn (n= 1~2) subsites of the enzyme and is stabilized in the active-site 
groove by a series of hydrogen bonds and hydrophopic interactions which may have 
higher priority than the P–S interactions.[34-36]  Based on X-ray structures showing the 
interaction of inhibitor molecules with papain, it is proposed that our inhibitor interacts 
with His 158, Gly-66, Asp-158 and Gln-19(Figure 4.2).[34, 36, 37] Despite the recent 
results obtained by Gütschow[26] that papain prefers aromatic residues over aliphatic 
ones in the P2 position, the structural basis of this argument was not clearly addressed. It 
appears that the binding pocket is more flexible with regards to molecular recognition. 
Peptide 10 possesses Arg in P2 and Tyr in P1 and exhibits good molecular recognition 
properties. The new sequence Thc-Fca-Gly-Gly-Arg-Tyr exhibits the strongest 
inhibition of papain, Ki = 6.9 ± 0.2 µM. Presumably, N-conjugation of the inhibitory 
sequence with Thc-Fca residues enhances the affinity for papain binding site.[22] As was 
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 demonstrated earlier in solution studies on the Fc derivative,[22] the organometallic Fca 
group is most likely encapsulated, which appears to enhance the interaction with the 
protein. 
 
Figure 4.2. Proposed structure of peptide 10 interacting with the binding site of papain. 
The initial enzyme-inhibitor structure was modeled in the VEGA ZZ 2.0.5 program[38] 
based on the papain structure 1PE6 studied by Yamamoto et al.[36] The papain-peptide 
complex model was constructed by replacing the inhibitor in structure 1PE6 with 
peptide 10 as the chosen inhibitor in our case. The initial geometry of peptide 10 and 
papain-peptide complex were modeled by energy minimization using molecular 
mechanics calculation method (MM) in Spartan. The enzyme-inhibitor complex 
distances were in good agreement with x-ray crystallographic studies.[36]  
 
4.2.3. SPR Imaging 
The next step in this investigation was to determine the potential of the Fca-
peptide conjugates to be active towards papain binding when linked on a surface. This 
will allow us to evaluate the formation of the peptide-protein complex on the surface 
and is a useful step towards the evaluation of the interaction by electrochemical 
methods. The idea was to exploit the Thc disulfide of conjugates 4, 9, and 10 for 
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 binding to a gold surface. The resulting Fca-peptide film will have the Fca groups 
firmly embedded in the film and the inhibitory peptide exposed allowing papain to bind. 
SPR imaging was selected as a method of choice because of its powerful ability to study 
the bio-affinity interactions of thin films on gold.[39-42] The quantitative measurements 
of papain interactions with the Fca-peptide modified surface by SPR imaging allowed to 
measure the change in the percentage reflectivity (∆%R) which was directly 
proportional to the fractional surface coverage θ of the peptide-modified surface by 
papain, providing ∆%R is below 10%.[43]  Using this method, the adsorption and 
desorption kinetics of papain were determined. Peptides 4, 9 and 10 were immobilized 
on spot ready SPR microchips by spotting ethanolic solutions of the conjugates onto the 
four gold pads each per chip and then monitored the selective binding to papain by real-
time SPR imaging, as described in the Experimental Section (Figure 4.3). This was 
achieved by monitoring changes in percentage reflectivity (∆%R) as a function of 
papain concentration (up to 200 nM) under continuous flow. Conjugate 10 exhibited a 
significantly higher change in ∆%R compared to the other two conjugates 4 and 9. This 
was in agreement with the solution studies (vide supra). Figure 4.4 shows the increase 
in ∆%R due to papain-surface interaction.  
The binding curve reaches a steady state when papain adsorption and desorption 
rates were equal. At this point, papain-free buffer was injected and flowed over the 
peptide array. In order to extract values for the association (ka) and dissociation (kd) rate 
constants, sequential fitting of the response curves over a series of different protein 
concentrations was required. Assuming a 1:1 interaction model between papain and the 
surface-bound Fca-peptide, Equation 4.1 was used to determine the rate of desorption. 
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Figure 4.3. SPR imaging measurements showing the interaction of papain (150 nM) 
with surface-bound Fca-peptide conjugates 4, 9, and 10 and a decanethiol control. 
Papain was dissolved in a buffer solution (0.1 M sodium phosphate pH 6.2, 2.5 mM 
EDTA, 300 µM DTT, and 30% DMSO, 23 °C. (A) SPR difference image resulting from 
subtraction of the buffer image from the ones obtained after interaction with papain; (B) 
The line profile, taken across the difference images, shows significant differences in the 
∆%R for measurements taken in the absence and presence of papain. 
 
 
∆ %R(t) = ∆R exp (-kdt)      (4.1) 
The adsorption curves are determined using a simplified Langmuir isotherm by: 
∆ %R(t) = ∆R (1- eγt)      (4.2) 
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Figure 4.4. Plot of ∆%R versus time for the interaction of papain with thin films of 
Fca-peptide conjugate 10 on gold. The concentration of papain was increased from 25 – 
200 nM. 
 
Where γ = kaC + kd with C being the protein concentration. ∆R can also be defined as 
equal to the product ∆Rmaxθ, where ∆Rmax is the maximum SPR signal obtained when all 
surface binding sites are occupied and θ is the fraction of the total surface coverage. 
Figure 4.5 shows a plot of γ versus papain concentration by fitting the adsorption curves 
shown in Fig (4.S5) to Equation 4.2.  ka = 1.75 ± 0.05 x 105 M-1 s1 and kd = 2.90 ± 0.05 x 
10-2 s-1 were obtained from the slope and intercept, respectively. Moreover, the 
equilibrium adsorption constant Kads = 6.03 x 106 M-1 was obtained from the ratio of ka 
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 and kd. The Kads value was falling within the reported range of binding constants for the 
interaction between proteins with immobilized peptides from 1.7 x 106 M-1 to 1.5 x 108 .[42, 44-47]  
 
Figure 4.5. Plot of γ versus papain concentration for conjugate 10 obtained from fitting 
the adsorption curves to Eq 4.2. The linear slope corresponds to the adsorption rate 
constant ka = 1.75 ± 0.05 x 105 M-1 s1 and the y-intercept corresponds to the desorption 
rate constant  kd = 2.90 ± 0.05 x 10-2 s-1 
 
4.2.4. Electrochemistry 
Fca-peptide conjugates 10 displayed the lowest inhibition constant in solution and 
also performed well when present as a thin film. Next, we decided to test our major 
hypothesis of the new label-based electrochemical detection and exploit the redox 
activity of the Fca group to detect the binding of papain to the inhibitory peptide 
sequence in conjugate 10. The electrochemical studies were carried out using Fca-
peptide films prepared on 25-µm gold microelectrodes. The peptide films were prepared 
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 by immersing the microelectrodes in Thc-terminated peptides prepared in 5% (by 
volume) acetic acid in ethanol at concentration of approximately 1 mM for 36 hours. As 
described in Scheme 4.1.D Fca label is located at the base of the peptide capturing-layer 
allowing direct connection and close proximity to the gold surface. Under these 
conditions, the disulfide-containing Thc group adsorbed to the gold surface involving a 
stable Au-S linkage.[48, 49]  
The next step involved the dilution of the Fca-peptide in order to close available 
pinholes present in the film and cover any solution accessible gold. The dilution was 
carried out by immersing the Fca-peptide-modified gold microelectrodes in an ethanolic 
solution of decanethiol (0.5 mM) for about two minutes. The electrochemical response 
of the films was evaluated by cyclic voltammetry (CV) measurements in papain 
activation buffer at pH 6.2 containing NaClO4 (2 M) as supporting electrolyte. 
Measurements were repeated for ten separate microelectrodes in order to obtain 
statistically meaningful results. The films exhibited a single fully reversible one-
electron redox peak with a formal potential E° of 0.459± 0.005 V at a scan rate of 10 
V/s versus Ag/AgCl. Figure 4.6 shows the change of the CVs as a function of 
increasing papain concentration.   
As the enzyme concentration increased, the formal potential of the Fca probe was 
shifting to higher potentials, indicating that oxidation of the Fca group became 
increasingly more difficult as papain was binding to the inhibitory peptide. In case of 
the Fc derivative Fc-Gly-Gly-Tyr-Arg, these changes were caused by slight changes in 
the chemical environment around the Fc group.[22] This change is illustrated in Figure 
4.6, which shows a plot of Eo as a function of papain concentration. 
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Figure 4.6. Cyclic voltammogram of 25 µm diameter gold microelectrodes modified with a 
mixed film of Fca-peptide 10 and decanethiol in the presence of increasing concentrations of 
papain (The arrow direction indicates a signal decrease and shift to higher potential with 
increasing the concentration from 0 to 200 nM). Enzyme activation buffer (0.1 M sodium 
phosphate pH 6.2, 2.5 mM EDTA, 300 µM DTT, and 30% DMSO, 23◦C) with 2M NaClO4. 
Scan rate of 10 Vs-1, Pt counter, Ag/AgCl reference. 
 
A linear relationship was observed for papain concentration of up to 80 nM, 
after this concentration the potential reaches a steady state indicating potentially the 
saturation of the surface with papain. The detection limit was 4 x 10-9 M, estimated 
from 3(Sb/m), where Sb is the standard deviation of the measurement signal for the 
blank and m the slope of the analytical curve in the linear region.[50]  
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Figure 4.7. A plot of the formal potential (E°) vs papain concentration. 
 
In addition, a small decrease in the overall signal intensity was observed, most 
likely as a result of less efficient penetration of the film by the supporting electrolyte, 
thereby decreasing the ability of the Fca to be oxidized. However, we do not lose the 
ability to detect the interaction between the peptide and the protein. In contrast to our 
observations, in some cases severe problems can occur that will result in the loss of 
signal. In Katayama’s sensor system,[9] a significant reduction in current was observed 
as a function of c-AMP addition to the system, ultimately leading to loss of signal at 
high c-AMP concentrations. It is likely that these changes are caused by decreased 
access of the [Fe(CN)6]3-/4- redox probe to the surface. In aptamer-based systems, the 
aptamer is highly dynamic in the absence of the target analyte allowing efficient 
electron transfer between the redox tag and the surface. The electron transfer is affected 
by analyte binding and in some cases even inhibited.[51-54]          
In order to gain further support for the interaction of papain with films of 
conjugate 10, measurements were carried out involving a quartz crystal microbalance. 
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 For this purpose, peptide films were immobilized on the gold pad on the quartz crystals 
following the identical procedure used for gold microelectrodes. In the QCM 
measurements, changes in the frequency are monitored as a function of time, Figure 
4.3.8. In the presence of the blank activation buffer solution, only continuous decay of 
∆f was observed, most likely caused by buffer migration. In the presence of papain, the 
protein adsorbes to the film of conjugates 10 and after some time reaches steady state. 
The change in frequency ∆f before and after papain addition is 34.1± 3 Hz, which is 
converted into a mass change using the Sauerbrey equation (Eq. 4.3.5). The average 
mass of papain adsorbed to the surface was 245± 3 ng cm-2 or 1.62 x 10-12 mol cm-2, 
which compared very well with the theoretical value (1.35 x 10-12 mol cm-2) assuming 
100% surface coverage.  
 
Figure 4.8. QCM measurement of papain adsorption on films of Fca-peptide conjugate 
10 on gold covered AT-cut type crystals. Papain activation buffer: 0.1 M sodium 
phosphate pH 6.2, 2.5 mM EDTA, 300 µM DTT, and 30% DMSO, 23°C with 2.0 M 
NaClO4. 
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 4.3. Conclusion 
In summary, we have synthesized a bioorganometallic conjugate of Fca 
equipped with an inhibitory peptide sequence that targets papain. Competitive 
inhibitions from solution assays and adsorption-desorption kinetics from real-time SPR 
imaging studies allowed the selection of peptide 10 as the most efficient capture probe 
for papain detection. The electrochemical measurements of surface-bound Fca-peptide 
10 showed a significant electrochemical response of the sensor upon binding to papain. 
The signal is shifting anodically as well as decreasing in intensity, presumably due to 
the partial shielding of the Fca group by the papain. This represents proof of concept 
that our approach using bioorganometallic sensor systems provides an attractive 
alternative for the electrochemical detection of non-labeled non-redox active proteins, 
which under current detection schemes remains a significant challenge. Thus, the next 
step in our investigation is to optimize the sensor platform and expand our studies to 
include multiplexed measurements of several analytes by varying the recognition 
sequence on the Fca redox probe.  
 
4.4. Experimental Section 
 
Materials and General Procedure: All syntheses were carried out under dry nitrogen 
gas unless otherwise indicated. CH2Cl2 (ACS grade) used for synthesis was dried 
(CaH2) and distilled prior to use. CDCl3 (Aldrich) was dried (CaH2), and stored over 
molecular sieves (8-12 mesh; 4Å effective pore size; Fisher) before use. THF was dried 
by benzophenone/sodium still, and stored over molecular sieves (8-12 mesh; 4Å 
effective pore size; Fisher) before use. 2-(1-H-Benzotriazol-1-yl-)-1,1,3,3-
tetramethyluronium (HBTU), hydroxybenzotrizole (HOBt) (Nova), MgSO4, and 
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 NaHCO3 (VWR) were used as received. For column chromatography, a column with a 
width of 2.7 cm (ID) and a length of 45 cm was packed 18-22 cm high with 230-400 
mesh silica gel (VWR). For TLC, aluminum plates coated with silica gel 60 F254 (EM 
Science) were used. NMR spectra were recorded on a Bruker Avance-500 spectrometer 
using a 5-mm broadband probe operating at 500.134 MHz (1H) or 125.766 MHz (13Cc). 
Peak positions in the 1H-NMR spectra are reported in ppm relative to TMS. All 
otherwise it is described 13C{1H} spectra are referenced to the DMSO-d6 signal at δ 
39.85. Mass spectrometry was carried out on a VG Analytical 70/20 VSE instrument. 
Infrared spectra were recorded on a Perkin-Elmer model 1605 FT-IR spectrometer. 
Analytical RP-HPLC for peptide 10 was performed on a Dionex HPLC system 
equipped with a Dionex Acclaim 3 lm C-18 (150 · 4.6 mm) column with a flow rate of 1 
mL/min. Semi-preparative RP-HPLC was performed on a Dionex HPLC system 
equipped with a Phenomenex Gemini 5 lm C-18 (250 · 10 mm) column with a flow rate 
of 2.0 mL/ min. Mobile phase A was 0.1% TFA in water, mobile phase B was 0.1% 
TFA in acetonitrile. The gradiant was T= 0 min, B = 5%; T= 20 min, B = 65%; T= 25 
min, B = 90%; T= 27 min, B = 95%; T= 27.1 min, B = 8%; T= 35 min, B = 5%. 
Papain, lyophilized powder, ≥10 units/mg protein (E1%/280) and thiostic acid 
(Thc-OH) were purchased from Sigma. DTT (±-threo-2,3-dihydroxy-1,4-butanedithiol) 
was obtained from Fluka. Z-Phe-Arg-NHNP was purchased from Bachem, Bubendorf, 
Switzerland. The amino acid derivatives were purchased from Advanced ChemTech.  
Spot-ready SPR chips having sixteen 1 mm gold spots and plane gold SPR chips were 
purchased from GWC technologies. The syntheses of Boc-Gly-Gly-Tyr(Bzl)-Arg(NO2)-
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 OMe,[22] benzotriazol-1-yl-1´-(tert-butyloxycarbonylamino)ferrocene-1-carboxylate 
(Boc-Fca-OBt)[55] were described elsewhere.  
 
4.4.1. Synthesis of Boc-Fca-Gly-Gly-Tyr(Bz)-Arg(NO2)-OMe (2)  
Boc-Gly-Gly-Tyr(Bz)-Arg(NO2)-OMe 1 (2.2 mmol, 1.54 g) was dissolved in 
CH2Cl2 and treated with TFA (3 mL) in CH2Cl2 (3 mL) for 30 min. The TFA and 
CH2Cl2 were subsequently removed in vacuo. The resulting residue was redissolved in 
CH2Cl2 and cooled in ice bath prior to the dropwise addition of Et3N (0.45 mL). To this 
was added a solution of Boc-Fca-OBt (2 mmol, 0.92 g). The reaction mixture was then 
warmed to room temperature and left to stir overnight. Purification of the crude product 
was carried out by column chromatography on silica (CDCl3, MeOH 90:10) to give 
yellow crystals of compound 2 (1.41 g, 76%). 1H-NMR [D6]DMSO, (δ in ppm): 7.43 
(2H, d, J = 8 Hz, Bz), 7.38 (2H, t,  J = 9 Hz, Bz), 7.32 (1H, t, J = 9 Hz, Bzl), 7.15 (2H, 
d, J = 8 Hz, Tyr-Bz),  6.89 (2H, d, J = 9 Hz, Tyr-Bz),  5.05 (2H, s, Tyr(O-CH2)), 4.78 
(s, 2 H, H-2 and H-5, Fc), 4.59 (s, 2 H, H-2´ and H-5´, Fc), 4.47 (1H, m, Tyr(αCH)), 
4.42 (s, 2 H, H-3 and H-4, Fc), 4.28 (1H, m, Arg(αCH)), 4.06 (s, 2 H, H-3´ and H-4´, 
Fc), 3.71(2H, s, Gly1(αCH)), 3.67 (2H, s, Gly2(αCH)), 3.61 (3H, s, COOCH3), 3.03 
(2H, m, CH2 of CH2CH2CH2NH), 2.89 (1H, m, one H of the two diastereotopic CH2 of 
Tyr), 2.70 (1H, m, one H of the two diastereotopic CH2 of Tyr), 1.69 (1H, m, one H of 
the two diastereotopic CH2 of CH2CH2CH2NH), 1.54 (1H, m, one H of the two 
diastereotopic CH2 of CH2CH2CH2NH), 1.45 (2H, m, 2H of CH2 of CH2CH2CH2NH), 
1.43 (9H, s, Boc C(CH3)3). 13C{1H}-NMR [D6]DMSO, (δ in ppm):  172.6 ,171.8, 170.4, 
169.9, 168.9, 157.4, 153.5, 137.7, 130.7, 130.3, 128.9, 128.2, 128.1, 114.8, 89.6, 76.9, 
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 70.7 ,69.5, 69.4, 65.9, 61.4, 45.3, 52.4, 52.2, 42.3, 37.2, 31.4, 28.6, 28.5, 22.5, 14.4. FT-
IR (KBr, υmax/cm-1): 3301 (m, N-H), 1741 (s, C=O). TOF-MS (m/z): calc for 
C43H53N9O11Fe [M]+: 927.3214; found: 927.3217. 
 
4.4.2. Synthesis of Thc-Fca-Gly-Gly-Tyr(Bz)-Arg(NO2)-OMe (3) 
 After the removal of the Boc group from 2 (1.1 mmol, 1.01 g) using TFA (1.5 
mL), the excess acid was removed in vacuo and Et3N (1.0 mL) in CH2Cl2 (10 mL) was 
added. To this was added a solution of Thc-OBt, prepared in situ from thiostic acid (1.0 
mmol, 0.206 g), HOBt (1.1 mmol, 0.153 g), and EDAC•HCl (1.1 mmol, 0.191 g) in dry 
CH2Cl2 (15 mL, 0 °C). The reaction mixture was then warmed to room temperature and 
left to stir overnight. The reaction mixture was then treated consecutively with aqueous 
solutions of NaHCO3 (sat.), citric acid (10%), and water, dried over Na2SO4, and 
evaporated to dryness under reduced pressure. The crude product was purified by flash 
column chromatography (SiO2, 95:5 EtOAc:MeOH) to give pale yellow crystals of 
compound 3 (0.69 g, 68%). 1H-NMR [D6]DMSO, (δ in ppm): 8.38 (1H, s, NH), 8.36 
(1H, s, NH), 8.10 (2H, b s, NH), 8.04 (2H, b s, NH), 7.43 (2H, d, J = 7 Hz, Bz), 7.38 
(2H, t,  J = 9 Hz, Bz), 7.32 (1H, t, J = 9 Hz, Bz), 7.15 (2H, d, J = 8 Hz, Tyr-Bz),  6.90 
(2H, d, J = 8  Hz, Tyr-Bz),  5.06 (2H, s, Tyr(O-CH2)), 4.78 (s, 2 H, H-2 and H-5, Fc), 
4.58 (s, 2 H, H-2´ and H-5´, Fc), 4.44 (1H, m, Tyr αH), 4.42 (s, 2 H, H-3 and H-4, Fc), 
4.26 (1H, m, Arg αH), 4.05 (s, 2 H, H-3´ and H-4´, Fc), 3.96 (2H, s, Gly1αH), 3.66 (2H, 
s, Gly2 αH), 3.64 (3H, s, COOCH3), 3.61 (1H, m, one H of the two diastereotopic CH2 
of Thc), 3.20 (1H, m, one H of the two diastereotopic CH2 of Thc), 3.14 (1H, m, one H 
of the two diastereotopic CH2 of Thc)  3.03 (2H, m, CH2 of CH2CH2CH2NH), 2.89 (1H, 
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 m, one H of the two diastereotopic CH2 of Tyr), 2.70 (1H, m, one H of the two 
diastereotopic CH2 of Tyr), 2.49 (1H, m, 1H of the two diastereotopic CH2 of Thc), 2.30 
(2H, m, Thc (CH2)), 1.90 (1H, m, Thc (CH)), 1.75 (4H, m, two CH2 of Thc),  1.69 (1H, 
m, one H of the two diastereotopic CH2 of CH2CH2CH2NH), 1.54 (1H, m, one H of the 
two diastereotopic CH2 of CH2CH2CH2NH), 1.53 (2H, m, Thc (CH2)), 1.45 (2H, m, 2H 
of CH2 of CH2CH2CH2NH). 13C{1H}-NMR [D6]DMSO, (δ in ppm): 172.6, 171.8, 
171.4, 170.6, 169.7, 168.9, 157.4, 137.7, 130.6, 130.2, 128.8, 128.2, 128.1, 114.8, 97.1, 
77.0, 71.7, 69.6, 69.6, 69.4, 66.0, 62.2, 65.6, 54.4, 52.4, 52.2, 42.7, 42.3, 38.6, 37.2, 
36.2, 34.7, 34.6, 28.8, 28.7, 28.4, 25.3, 24.7. FT-IR (KBr, υmax/cm-1): 3297 (b m, N-H), 
1741, 1653, 1538 (s, C=O). TOF-MS (m/z): calc for C46H57O10N9S2Fe [M]+: 
1015.3019; found: 1015.3025. 
 
4.4.3. Synthesis of Thc-Fca-Gly-Gly-Tyr(Bz)-Arg(NO2)-OH (4) 
To a solution of compound 3 (0.50 g, 0.49 mmol) in MeOH (2.0 mL) a solution 
of 1 N NaOH in water (2.6 mL) was added while stirring. The reaction was stored at 
room temperature for 6 h after which 1 N HCl (1.5 mL) was added. The MeOH was 
then removed in vacuo followed by cooling of the solution in a ice bath prior to the 
dropwise addition of 1 N HCl (3.0 mL). The solution was then stored in the fridge for 3 
h after which the precipitate was filtered off and washed three times with cold, distilled 
water (50 mL) and dried under reduced pressure overnight to give compound 4 as a 
yellow solid (0.69 g, 68%). m. p. 152-159 °C. 1H-NMR [D6]DMSO, (δ in ppm): 9.44 
(1H, s, COOH), 8.63 (1H, s, NH), 8.29 (1H, s, NH), 8.22 (1H, s, NH), 8.12 (2H, b s, 
NH), 7.36 (1H, b s, NH), 7.42 (2H, d, J = 8 Hz, Bz), 7.38 (2H, t,  J = 9 Hz, Bz), 7.32 
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 (1H, t, J = 8 Hz, Bz), 7.15 (2H, d, J = 9 Hz, Tyr-Bz),  6.90 (2H, d, J = 9 Hz, Tyr-Bz),  
5.06 (2H, s, Tyr(O-CH2)), 4.78 (s, 2 H, H-2 and H-5, Fc), 4.58 (s, 2 H, H-2´ and H-5´, 
Fc), 4.44 (1H, m, Tyr αH), 4.42 (s, 2 H, H-3 and H-4, Fc), 4.26 (1H, m, Arg αH), 4.05 
(s, 2 H, H-3´ and H-4´, Fc), 3.96(2H, s, Gly1αH), 3.66 (2H, s, Gly2 αH), 3.61 (1H, m, 
one H of the two diastereotopic CH2 of Thc), 3.20 (1H, m, one H of the two 
diastereotopic CH2 of Thc), 3.14 (1H, m, one H of the two diastereotopic CH2 of Thc)  
3.03 (2H, m, CH2 of CH2CH2CH2NH), 2.89 (1H, m, one H of the two diastereotopic 
CH2 of Tyr), 2.70 (1H, m, one H of the two diastereotopic CH2 of Tyr), 2.49 (1H, m, 
one H of the two diastereotopic CH2 of Thc), 2.30 (2H, m, Thc CH2), 1.90 (1H, m, Thc 
CH), 1.75 (4H, m, two CH2 of Thc),  1.69 (1H, m, one H of the two diastereotopic CH2 
of CH2CH2CH2NH), 1.54 (1H, m, one H of the two diastereotopic CH2 of 
CH2CH2CH2NH), 1.53 (2H, m, Thc CH2), 1.45 (2H, m, two H of CH2 of 
CH2CH2CH2NH). 13C{1H}-NMR [D6]DMSO, (δ in ppm): 188.5, 171.4, 169.6, 159.8, 
157.4, 137.7, 130.7, 128.9, 128.2, 114.8, 97.2, 77.1, 71.6, 69.6, 69.5, 65.9, 62.3, 56.6, 
42.6, 38.6, 36.2, 43.7, 28.8, 25.4. FT-IR (KBr, υmax/cm-1): 3297 (b m, N-H), 1741, 1654, 
1546 (s, C=O). TOF-MS (m/z): calc for C45H55O10N9S2Fe [M]+: 1001.2863; found: 
1001.2865. 
 
4.4.4. Synthesis of Boc-Arg(Mtr)-Tyr-OMe (5)  
Boc-Arg(Mtr)-OH (4.11 mmol, 2.00 g), HOBt (4.52 mmol, 0.75 g), and 
EDAC·HCl (4.52 mmol, 0.95 g) were mixed in dry CH2Cl2 (30 mL, 0 °C) and allowed 
to stirred for 30 minutes. To this, a solution of H-Tyr-OMe, obtained by treatment of H-
Tyr OMe·HCl (4.52 mmol, 1.14 g) with Et3N (1.5 mL) in dry CH2Cl2 (20 mL) was 
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 added and the stirring continued at room temperature. The reaction mixture was then 
treated consecutively with aqueous solutions of saturated NaHCO3, citric acid (10%), 
again saturated NaHCO3 and water, dried over Na2SO4, filtered and evaporated to 
dryness under reduced pressure. The crude product was purified by flash column 
chromatography (SiO2, 1:2 EtOAc-hexane) to give compound 5 as a white crystalline 
solid (yield: 2.32 g, 85%). 1H-NMR CDCl3, (δ in ppm): 7.48 (1H, s, Bz-OH), 6.97 (2H, 
d, J = 8 Hz, Tyr-Bz),  6.91 (1H, b s, α NH Arg), 6.78 (2H, d, J = 8 Hz, Tyr-Bz),  6.55 
(1H, s, Ar-H (Mtr)), 6.20 ((2H, b, NH of guanidine group) 5.98 (1H, b, NH of guanidine 
group), 5.41 (1H, b, NH of guanidine group), 4.79 (1H, m, Arg αH), 4.00 (1H, m, Tyr 
αH), 3.89 (3H, s, COOCH3), 3.75 (3H, s, OCH3 of Mtr), 3.15 (2H, m, CH2 of 
CH2CH2CH2NH), 3.09 (1H, m, one H of the two diastereotopic CH2 of Tyr), 2.88 (1H, 
m, one H of the two diastereotopic CH2 of Tyr), 2.70 (3H, s, Ar-CH3 of Mtr), 2.62 (3H, 
s, Ar-CH3 of Mtr), 2.14 (3H, s, Ar-CH3 of Mtr), 1.54 (2H, m, CH2 of CH2CH2CH2NH), 
1.42 (9H, s, Boc C(CH3)3), 1.23 (1H, m, one H of the two diastereotopic CH2 of 
CH2CH2CH2NH). TOF-MS (m/z): calc for C31H45O9N5S [M]+: 663.2938; found: 
663.2940. 
 
4.4.5. Synthesis of Boc-Gly-Gly-Arg(Mtr)-Tyr-OMe (6)  
Boc-Arg(Mtr)-Tyr-OMe (3.01 mmol, 2.00 g) was dissolved in CH2Cl2, (3 mL) 
and treated with TFA (3 mL) for 30 min. The CH2Cl2 and TFA were subsequently 
removed in vacuo. The resulting residue was redissolved in CH2Cl2 (10 mL) and cooled 
in an ice bath prior to the dropwise addition of Et3N (1.2 mL). To this was added a 
solution of Boc-Gly-Gly-OBt, prepared in situ from Boc-Gly-Gly-OH (2.74 mmol, 0.64 
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 g), HOBt (3.0 mmol, 0.46 g), and EDAC·HCl (3.0 mmol, 0.58 g) in dry CH2Cl2 (20 
mL, 0 °C). The reaction mixture was then warmed to room temperature and left to stir 
overnight. The resulting solution was then treated as per 5. The product was purified by 
flash column chromatography (SiO2, 1:2 EtOAc-hexane) and recrystallized from CHCl3 
to yield white crystalline compound 6 (yield: 1.73 g, 74%): 1H-NMR [D6]DMSO, (δ in 
ppm): 9.22 (1H, s, Bz-OH), 8.42 (1H, s, NH-C(NH)-NH(Mtr), 8.30 (1H, d, J = 6 Hz, 
αNH(Arg), 8.09 (1H, s, NH of guanidine group), 8.05 (1H, s, NH of guanidine group), 
7.96 (1H, d, J = 6 Hz, αNH(Tyr), 6.97 (2H, d,  J = 8 Hz, Tyr-Bz),  6.68 (1H, s, Ar-H of 
Mtr), 6.64 (2H, d, J = 8 Hz, Tyr-Bz), 6.38 ((2H, b, NH of guanidine group) 4.60 (1H, 
m, Tyr αH), 4.30 (1H, m, Arg αH), 3.82 (2H, d, Gly αH), 3.78 (3H, s, COOCH3), 3.70 
(2H, d, Gly αH), 3.53 (3H, s, OCH3 of Mtr), 3.01 (2H, m, CH2 of CH2CH2CH2NH), 
2.88 (1H, m, one H of the two diastereotopic CH2 of Tyr), 2.82 (1H, m, one H of the 
two diastereotopic CH2 of Tyr), 2.59 (3H, s, Ar-CH3 of Mtr), 2.49 (3H, s, Ar-CH3 of 
Mtr), 2.04 (3H, s, Ar-CH3 of Mtr), 1.62 (1H, m, one H of the two diastereotopic CH2 of 
CH2CH2CH2NH), 1.43 (9H, s, Boc C(CH3)3), 1.36 (2H, m, CH2 of CH2CH2CH2NH), 
1.23 (1H, m, one H of the two diastereotopic CH2 of CH2CH2CH2NH). 13C{1H}-NMR 
[D6]DMSO, (δ in ppm): 172.3, 171.9, 170.2, 168.9, 1579, 156.6, 156.5, 156.3, 138.1, 
136.1, 130.6, 130.5, 127.5, 115.5, 112.2, 78.6, 56.0, 54.5, 52.3, 52.2, 52.1, 43.7, 42.3, 
63.4, 28.7, 24.1, 22.5, 18.5, 12.2. TOF-MS (m/z): calc for C35H51O11N7S [M]+: 
777.3367; found: 777.3370. 
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 4.4.6. Synthesis of Boc-Fca-Gly-Gly-Arg(Mtr)-Tyr-OMe (7) 
Boc-Gly-Gly-Arg(Mtr)-Tyr-OMe (1.9 mmol, 1.50 g) was dissolved in CH2Cl2 
and treated with TFA (2 mL) in CH2Cl2 (2 mL) for 30 min. The TFA and CH2Cl2 were 
subsequently removed in vacuo. The resulting residue was re-dissolved in CH2Cl2 and 
cooled in ice bath prior to the dropwise addition of Et3N (0.50 mL). To this was added a 
solution of Boc-Fca-OBt (1.73 mmol, 0.80 g). The reaction mixture was then warmed to 
room temperature and left to stir overnight. The residue was chromatographed (CDCl3, 
MeOH 90:10) to give compound 7 as a yellow solid (1.47 g, 85%): 1H-NMR 
[D6]DMSO, (δ in ppm): 9.22 (1H, s, Bz-OH), 8.42 (1H, s, NH of guanidine group), 8.30 
(1H, d, J = 6.3 Hz, αNH Arg), 8.09 (1H, s, NH of guanidine group), 8.05 (1H, s, NH of 
guanidine group), 7.96 (1H, d, J = 6 Hz, αNH Tyr), 6.97 (2H, d,  J = 8 Hz, Tyr-Bz),  
6.68 (1H, s, Ar-H of Mtr) 6.64 (2H, d, J = 8 Hz, Tyr-Bz), 6.38 ((2H, b, NH of guanidine 
group) 4.72 (s, 2 H, H-2 and H-5, Fc), 4.60 (1H, m, Tyr αCH), 4.47 (s, 2 H, H-2´ and H-
5´, Fc), 4.30 (1H, m, Arg αCH), 4.24 (s, 2 H, H-3 and H-4, Fc), 3.95 (s, 2 H, H-3´ and 
H-4´, Fc), 3.82 (2H, d, αCH2 Gly αCH2), 3.78 (3H, s, COOCH3), 3.70 (2H, d, Gly 
αCH2), 3.53 (3H, s, OCH3(Mtr)), 3.01 (2H, m, CH2 of CH2CH2CH2NH), 2.88 (1H, m, 
one H of the two diastereotopic CH2 of Tyr), 2.82 (1H, m, one H of the two 
diastereotopic CH2 of Tyr), 2.59 (3H, s, Ar-CH3 of Mtr), 2.49 (3H, s, Ar-CH3 of Mtr), 
2.04 (3H, s, Ar-CH3 of Mtr), 1.62 (1H, m, one H of the two diastereotopic CH2 of 
CH2CH2CH2NH), 1.43 (9H, s, Boc C(CH3)3), 1.36 (2H, m, CH2 of CH2CH2CH2NH), 
1.23 (1H, m, one H of the two diastereotopic CH2 of CH2CH2CH2NH). 13C{1H}-NMR 
[D6]DMSO, (δ in ppm): 172.7, 172.4, 170.3, 170.0, 169.4, 157.9, 156.6, 153.5, 138.1, 
138.1, 136.1, 130.5, 127.3, 124.0, 115.6, 112.2, 100.0, 79.7, 76.8, 71.7, 69.3, 65.8, 56.0, 
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 5.3, 52.2, 42.9, 42.1, 36.5, 28.6, 24.1, 18.5, 12.2. TOF-MS (m/z): calc for 
C46H60O12N8SFe [M]+: 1004.3401; found: 1004.3402.  
 
4.4.7. Synthesis of Thc-Fca-Gly-Gly-Arg(Mtr)-Tyr-OMe (8) 
The Boc group was removed from compound 7 (1.2 mmol, 1.20 g) by addition 
of TFA (1.5 mL). After 30 minutes, the excess acid was removed in vacuo and Et3N 
(0.7 mL) in CH2Cl2 (10 mL) was added. To this was added a solution of Thc-OH (1.1 
mmol, 0.224 g), HOBt (1.2 mmol, 0.184 g), and EDAC·HCl (1.2 mmol, 0.230 g) in dry 
CH2Cl2 (15 mL, 0 °C). The reaction mixture was left to stir overnight at room 
temperature and then treated to an aqueous work up as described above. The crude 
product was purified by flash column chromatography (SiO2, 90:10 EtOAc:MeOH) to 
give a pale yellow solid of compound 8 (0.89 g, 68%). 1H-NMR [D6]DMSO, (δ in 
ppm): 9.22 (1H, s, Bz-OH), 8.42 (1H, s, NH of guanidine group), 8.30 (1H, d, J = 6 Hz, 
αNH Arg), 8.09 (1H, s, NH of guanidine group), 8.0 (1H, s, NH of guanidine group), 
7.96 (1H, d, J = 6 Hz, αNH Tyr), 6.97 (2H, d,  J = 8 Hz, Tyr-Bz),  6.68 (1H, s, Ar-H of 
Mtr) 6.64 (2H, d, J = 8 Hz, Tyr-Bz), 6.38 ((2H, b, NH of guanidine group) 4.72 (s, 2 H, 
H-2 and H-5, Fc), 4.60 (1H, m, Tyr αH), 4.47 (s, 2 H, H-2´ and H-5´, Fc), 4.30 (1H, m, 
Arg αH), 4.24 (s, 2 H, H-3 and H-4, Fc), 3.95 (s, 2 H, H-3´ and H-4´, Fc), 3.82 (2H, d, 
Gly αH2), 3.78 (3H, s, COOCH3), 3.70 (2H, d, Gly αH2), 3.61 (1H, m, one H of the two 
diastereotopic CH2 of Thc), 3.53 (3H, s, OCH3 of Mtr), 3.20 (1H, m, one H of the two 
diastereotopic CH2 of Thc), 3.14 (1H, m, one H of the two diastereotopic CH2 of Thc), 
3.01 (2H, m, CH2 of CH2CH2CH2NH), 2.88 (1H, m, one H of the two diastereotopic 
CH2 of Tyr), 2.82 (1H, m, one H of the two diastereotopic CH2 of Tyr), 2.59 (3H, s, Ar-
 121
 CH3of Mtr),  2.49 (1H, m, one H of the two diastereotopic CH2 of Thc), 2.49 (3H, s, Ar-
CH3 of Mtr), 2.30 (2H, m, Thc CH2), 1.90 (1H, m, Thc (CH)), 2.04 (3H, s, Ar-CH3 of 
Mtr), 1.75 (4H, m, two CH2 of Thc), 1.62 (1H, m, one H of the two diastereotopic CH2 
of CH2CH2CH2NH), 1.53 (2H, m, Thc (CH2)), 1.36 (2H, m, CH2 of CH2CH2CH2NH), 
1.23 (1H, m, one H of the two diastereotopic CH2 of CH2CH2CH2NH). 13C{1H}-NMR 
[D6]DMSO, (δ in ppm): 188.5, 172.2, 172.1, 171.9, 171.4, 170.6, 169.8, 169.0, 157.9, 
156.6, 149.6, 138.1, 136.1, 135.0, 124.0, 122.0, 112.2, 97.1, 79.7, 77.0, 71.7, 69.4, 66.0, 
62.2, 56.5, 56.5,. 56.0, 52.3, 38.6, 34.7, 34.5, 25.3, 24.6, 24.1, 12.2. FT-IR (KBr, 
υmax/cm-1): 3315, 3090 (b m, N-H), 1722, 1655, 1548 (s, C=O). TOF-MS (m/z): calc for 
C49H64O11N8S3Fe [M]+: 1092.3206; found: 1092.3208. 
 
4.4.8. Synthesis of Thc-Fca-Gly-Gly-Arg(Mtr)-Tyr-OH (9) 
The methylester 8 (0.20 g, 0.18 mmol) was deprotected as described for 
compound 4 to give the free acid 9 as a yellow solid (0.16 g, 82%). m. p. 125-133 °C. 
1H-NMR [D6]DMSO, (δ in ppm): 9.58 (1H, s, COOH), 9.05 (1H, s, Tyr-OH), 8.49 (1H, 
s, NH of guanidine group), 8.35 (1H, d, J = 6 Hz, αNH Arg), 8.18 (1H, s, NH of 
guanidine group), 8.05 (1H, s, NH of guanidine group), 7.95 (1H, d, J = 6 Hz, 
αNH(Tyr)),  7.59 (1H, m, αNH(Gly)),  7.25 (1H, m, αNH(Gly)), 6.94 (2H, d,  J = 8 Hz, 
Tyr-Bz),  6.67 (1H, s, Ar-H of Mtr),  6.57 (2H, d, J = 8 Hz, Tyr-Bz), 4.75 (d, 2 H, J = 9 
Hz, H-2 and H-5, Fc), 4.60 (1H, m, Arg αH), 4.59 (d, 2 H, J = 9 Hz, H-2´ and H-5´, 
Fc), 4.24 (s, 2 H, H-3 and H-4, Fc), 4.17 (1H, m, Tyr αH), 3.97 (s, 2 H, H-3´ and H-4´, 
Fc), 3.84 (2H, d, Gly αCH2), 3.84 (3H, s, Ar-O-CH3 of Mtr), 3.75 (2H, d, Gly αCH2), 
3.61 (1H, m, 1H of the two diastereotopic CH2 of Thc), 3.53 (3H, s, OCH3 of Mtr), 3.17 
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 (1H, m, 1H of the two diastereotopic CH2 of Thc), 3.11 (1H, m, 1H of the two 
diastereotopic CH2 of Thc), 2.97 (2H, m, CH2 of CH2CH2CH2NH), 2.88 (1H, m, one H 
of the two diastereotopic CH2 of Tyr), 2.82 (1H, m, one H of the two diastereotopic CH2 
of Tyr), 2.60 (3H, s, Ar-CH3 of Mtr),  2.49 (1H, m, one H of the two diastereotopic CH2 
of Thc), 2.49 (3H, s, Ar-CH3 of Mtr), 2.30 (2H, m, Thc CH2), 1.91 (1H, m, Thc CH), 
2.04 (3H, s, Ar-CH3 of Mtr), 1.74 (4H, m, two CH2 of Thc), 1.60 (1H, m, one H of the 
two diastereotopic CH2 of CH2CH2CH2NH), 1.53 (2H, m, Thc CH2), 1.36 (2H, m, CH2 
of CH2CH2CH2NH), 1.22 (1H, m, one H of the two diastereotopic CH2 of 
CH2CH2CH2NH), 0.85 (1H, m, one H of the two diastereotopic CH2 of 
CH2CH2CH2NH). 13C{1H}-NMR [D6]DMSO, (δ in ppm): 188.5, 172.2, 172.1, 171.9, 
171.4, 170.6, 169.8, 169.0, 157.9, 156.6, 149.6, 138.1, 136.1, 135.0, 124.0, 122.0, 
112.2, 97.1, 79.7, 77.0, 71.7, 69.4, 66.0, 62.2, 56.5, 56.5,. 56.0, 52.3, 38.6, 34.7, 34.5, 
25.3, 24.6, 24.1, 12.2. FT-IR (KBr, υmax/cm-1): 3306, 3086 (m, N-H), 1748 (s, C=O), 
1656 Amide I, 1550 Amide II. TOF-MS (m/z): calc for C48H62O11N8S3Fe [M]+: 
1078.3049; found: 1078.3049. 
 
4.4.9. Synthesis of Thc-Fca-Gly-Gly-Arg-Tyr-OH (10) 
  Thc-Fca-Gly-Gly-Arg(Mtr)-Tyr-OH (9) (60 mg, 0.07 mmol) was suspended in 
CH2Cl2 (2 mL) and a mixture (TFA/thioanisol/H2O 96:3:1, 3 mL) was added and the 
mixture left to stir for 4 hours at  room temperature. The reaction mixture was 
concentrated in vacuo, the resulting residue was dissolved in TFA and precipitated by a 
dropwise addition to ice-cold Et2O. The precipitate was collected by centrifugation, and 
purified by semi-preparative HPLC (tR = 22.4 min, λ = 220 nm) to yield a faint yellow 
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 solid of compound 10 (22 mg, 0.03 mmol, 37%). RP-HPLC (analytical, tR = 9.8 min). 
m. p. 118-122 °C. 1H-NMR [D6]DMSO, (δ in ppm): 9.48 (1H, s, COOH), 9.23 (1H, s, 
Tyr-OH), 8.30 (1H, m, αNH Arg), 8.22 (1H, s, NH of guanidine group), 8.02 (1H, s, 
NH of guanidine group), 7.66 (1H, m, αNH(Tyr), 7.56 (2H, m, αNH(Gly)), 6.93 (2H, d,  
J =8 Hz, Tyr-Bz),  6.57 (2H, d, J = 8 Hz, Tyr-Bz), 4.75 (s, 2 H, H-2 and H-5, Fc), 4.60 
(s, 2 H, H-2’ and H-5’, Fc), 4.26 (1H, m, Arg αH), 4.25 (s, 2 H, H-3 and H-4, Fc), 4.01 
(1H, m, Tyr αH),3.98 (s, 2 H, H-3’ and H-4’, Fc), 3.80 (2H, d, Gly αH2), 3.77 (2H, d, 
Gly αH2), 3.61 (1H, m, 1H of the two diastereotopic CH2 of Thc), 3.20 (1H, m, 1H of 
the two diastereotopic CH2 of Thc), 3.18 (1H, m, one H of the two diastereotopic CH2 
of Thc), ), 3.11 (1H, m, one H of the two diastereotopic CH2 of Tyr), 2.98 (2H, m, CH2 
of CH2CH2CH2NH), 2.83 (1H, m, 1H of the two diastereotopic CH2 of Tyr), 2.71 (2H, 
s, NH2 of guanidine group), 2.41 (2H, m, Thc CH2), 2.36 (1H, m, 1H of the two 
diastereotopic CH2 of Thc), 2.15 (1H, m, 1H of the two diastereotopic CH2 of Thc), 
1.66 (2H, m, CH2 of CH2CH2CH2NH), 1.55 (2H, m, Thc CH2), 1.35 (2H, m, CH2 of 
CH2CH2CH2NH), 1.23 (1H, m, 1H of the two diastereotopic CH2 of CH2CH2CH2NH), 
0.85 (1H, m, 1H of the two diastereotopic CH2 of CH2CH2CH2NH). 13C{1H}-NMR 
[D6]DMSO, (δ in ppm): 172.1, 172.0, 171.8, 171.4, 170.5, 169.8, 157.8, 156.6, 138.1, 
136.1, 135.0, 123.9, 121.9, 112.2, 97.1, 79.7, 76.9, 71.7, 69.4, 65.9, 62.2, 56.5, 56.4, 
52.3, 38.5, 34.7, 34.5, 25.3, 24.6, 24.2. FT-IR (KBr, υmax/cm-1): 3447 (m, N-H), 1725 (s, 
C=O), 1658 Amide I, 1547 Amide II. TOF-MS (m/z): calc for C38H50O8N8S2Fe [M]+: 
866.2542; found: 866.2541. 
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 4.4.10. Papain Inhibition Studies 
For the inhibition studies, the following stock solutions were prepared: 
A 5 mM stock solution of the chromogenic substrate Z-Phe-Arg-NHNp was 
prepared in DMSO. Stock solutions of the Fca-peptide inhibitors were prepared in 
DMSO.  
A papain stock solution was prepared in 1 mM HCl. For daily activation, the 
papain stock solution was diluted 1:100 in 0.1 M sodium phosphate pH 6.5, containing 
2.5 mM EDTA and 15 mM DTT and was incubated at 23 °C for 1 h. The activated 
enzyme was kept on ice.  
Inhibition of papain enzyme was assayed at 23 °C with the chromogenic substrate 
Z-Phe-Arg-NHNp (200 µM) in the presence of increasing concentrations of the 
inhibitory peptides 4, 9 and 10. The buffer solution used for the assay was 0.1 M 
sodium phosphate pH 6.2, 2.5 mM EDTA, 300 µM DTT, and 30% DMSO. Rates were 
determined by duplicate measurements of seven different concentrations of each single 
inhibitor. The concentration of the liberated p-nitroaniline (pNA) was monitored 
spectrophotometrically by measuring the absorbance at λ = 405 nm against a blank 
sample containing no enzyme and an extinction coefficient of ε = 9.96 cm2/µmol. The 
final volume made up to 1 mL. The reaction was initiated by addition of the enzyme (20 
µL); its final concentration catalyze the conversation of the substrate with a rate of 1-2 
µM/min. Progress curves were monitored over 10 min. A control assay to determine the 
total hydrolysis of Z-Phe-Arg-NHNp (480 µM) was carried out in the absence of the 
inhibitors (70 µL DMSO was added to the cuvette). The papain concentration was 20 
fold higher than the inhibition assays. The resulting activity was considered as 100%. A 
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 Lineweaver-Burk plot was constructed and the value of the Michaelis-Menten constant 
(Km) was determined. The apparent inhibition constants Ki' were determined by fitting 
equation 3[26] to the experimental data.  
υ  =  υo / (1 + [I] / Ki' )      (4.3) 
Where υ is the rate, υo is the rate in the absence of the inhibitor, [I] is the inhibitor 
concentration and Ki' is the apparent inhibition constant. The true inhibition constants Ki 
were calculated by correction of Ki' according to equation 4.4[26]  
Ki = Ki' / (1 + [S] / Km)      (4.4) 
Where [S] is the substrate concentration and Km is the Michaelis-Menten constant. 
 
4.4.11. Preparation of Peptide Arrays 
Peptide arrays on spot ready SPR chips were prepared by spotting three different 
peptides 4, 9 and 10 on three arrays. The gold chip was placed on a piece of clean 
parafilm in a humidity chamber and the freshly prepared peptide solutions were spotted 
immediately 5 mM in DMSO (100 mM TEA pH 8)  for 20 hours. As a control 
experiment, a 5 mM solution of decanethiol was used to immobilize the decanethiol 
onto the control array. The excess probe solutions were then removed with a pipet prior 
to rinsing with the few mL of buffer solution (0.1 M sodium phosphate, pH 6.2, 2.5 mM 
EDTA, 300 µM DTT, and 30% DMSO, T = 23±3°C).  
Preparation of films on flat substrates: Each peptide was immobilized on the gold 
surface of a plane SPR chip by soaking the chips overnight in a 1 mM solution of 
disulfide-terminated peptides 4, 9 and 10 in absolute ethanol. 
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 4.4.12. Real-Time SPR Imaging Studies 
An SPR imaging system (GWC Technologies) was used for the real-time 
monitoring of the interaction between immobilized peptides and papain enzyme. 
Briefly, a collimated p-polarized light at a fixed angle reflected from the 
sample/gold/prism assembly was sent through a narrow band-pass filter and then 
detected with a CCD camera. The data were collected using the software package V++ 
(Digital Optics, NZ). Custom macros were used so that data could be collected with 
simultaneous processing of several specific user designated regions of interest (ROIs) 
on the array surface.[42] Kinetic data for each ROI were obtained by collecting one data 
point approximately every 1 second, which was the average of five camera frames. The 
difference in percent reflectivity for each probe area was normalized with respect to the 
average change in percent reflectivity measured for the buffer background. Kinetic data 
from multiple identical array elements were averaged to obtain the final SPR response 
curves. Microsoft Excel and Origin 7.5 were used for all data processing and kinetic 
model fitting in these experiments.   
 
4.4.13. Surface Electrochemistry 
Peptide films were immobilized on home made 25 µm diameter microelectrodes by 
soaking the gold electrodes in 1 mM solution of disulfide terminated peptides for 36 h. 
Then, the concentrated film was diluted by immersing the modified electrodes in 1 mM 
ethanolic solution of decanethiol for 2 min. The CVs were recorded in aqueous 
solutions of NaClO4 (2.0 M). Ag/AgCl was used as a pseudo-reference electrode, and Pt 
wire as a counter electrode. Ten gold microelectrodes with peptide films were measured 
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 for each compound and all experiments were carried out at room temperature (23±3°C). 
Blocking studies were carried out in a solution containing 0.1 mM Ru(NH3)6Cl3 and 0.1 
N HClO4, See Figure 4.S6.    
Studies using the electrochemical quartz crystal microbalance: An EQCM system 
interfaced to a PC (CH instruments 440) was used for recording the frequency change 
during the process of protein adsorption onto the peptide film. The EQCM electrodes 
with a fundamental resonant frequency of 8 MHz and 13.7 mm diameter were of the 
AT-cut type, with optically polished surfaces coated on both sides with 200 nm thick 
gold layer, 5 mm diameter, over a thin chromium adhesion mediator film. Since the 
EQCM operated in time-resolved mode, the frequency difference of the working crystal 
and the reference crystal was measured. The relationship between the changes in mass 
per unit area (m) and frequency (f) are given by Sauerbrey equation (Eq. 4.5)[56]  
                               
qq
o
A
mnff ρµ
22∆−=∆
                                                    (4.5)  
Where A is the surface area of the electrode, µq is shear modulus of quartz and ρq is 
the density of quartz. 
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 4.6. Supplemental Material 
 
 
 
Figure 4.S1. HPLC trace of peptide 10. 
 
 
 
 
Figure 4.S2. Michaelis-Menten plot, with an inset Lineweaver-Burk plot. Michaelis-
Menten constant (Km) was determined by non linier regression fit of the concentration 
velocity curve using Michaelis-Menten equation {V= Vmax [S]/(Km+[S]). The Km value 
was determined by monitoring the total papain-catalyzed hydrolysis of Z-Phe-Arg-
NHNp in the absence of the inhibitors and at high initial concentration of the substrate. 
The fitting was performed using GraphPad Prism version 4.03 for Windows, GraphPad 
Software, San Diego California USA. 
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Figure 4.S3. Plot of the rates of hydrolysis of Z-Phe-Arg-NHNp versus concentrations of 
Fca-peptide 9 (upper) and Fca-peptide 10 (lower) monitoring of the papain-catalyzed 
hydrolysis of Z-Phe-Arg-NHNp (90 µM) in the presence of increasing concentrations of the 
Fca-peptide conjugate (0.1 M sodium phosphate pH 6.2, 2.5 mM EDTA, 300 µM DTT, and 
30% DMSO, 23◦C). The reaction was initiated by addition of the enzyme. Data were obtained 
by measuring the absorption at λ = 405 nm. The linear dependence shown in the Dixon plot 
(inset) indicates competitive inhibition. Nonlinear regression gave an apparent inhibition 
constant Ki' = (1 + [S]/Km)Ki = 639.1±1.1µM for conjugate 9 and 21.1 ± 0.3 µM for conjugate 
10. A Michaelis constant Km = 980 ± 26 µM was determined separately according to the 
Michaelis-Menten equation. 
 
 
Papain enzyme is considered as the archetype of cysteine proteases. It consist of 
212 amino acid residues folded to form two domains with a deep cleft between them, 
Cys-25, His-159, and Asn-175 residues represent the catalytic site of the enzyme.[1, 2]  
While the first two of which are responsible for a permanent thiolate-imadozelium Ione 
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 pair, the last residue acts as hydrogen bond acceptor during the catalytic process of the 
enzyme. According to Schechter and Berger[3] nomenclature, S2, S1 binding sites are 
mainly responsible for the recognition of substrate residues (P2, P1) N- to C- terminus. 
S2 and S3 pockets consist of Val-133, Val-157 and Asp 158 and of Tyr61, Gly-66 and 
Tyr-67 residues of papain, respectively.  
 
 
Figure 4.S4. Substrate-papain subsites according to Schechter and Berger,[3]  S2 and S3 
pockets consist of Val-133, Val-157 and Asp 158 and of Tyr61, Gly-66 and Tyr-67 
residues of papain, respectively. 
 
 
Figure 4.S5: Curve fitting for the adsorption curves obtained for various concentrations 
of peptide 10, fitted using Equation (4.2). 
 133
  
Figure 4.S6. Representative figure describing the dilution studies of the peptide 10 films. The 
diluted films were characterized by observing their blocking effect on the electrochemical 
response of the Ru(NH3)63+/2+ redox probe. The reversible redox behavior was observed on bare 
gold electrode with E1/2 = -0.16 V vs Ag/AgCl has almost disappeared that may implies a fully 
covered surface. 
 
 
Figure 4.S7. Control QCM measurement demonstrating a comparison between the binding 
efficiency of peptides 10 and 4 to papain. The inset shows only peptide 4, which was used as a 
control. The peptide films were formed on gold covered AT-cut type crystals. Papain activation 
buffer: 0.1 M sodium phosphate pH 6.2, 2.5 mM EDTA, 300 µM DTT, and 30% DMSO, 23°C 
with 2.0 M NaClO4. 
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 CHAPTER 5 
 
SYNTHESIS AND ELECTROCHEMICAL INVESTIGATION OF 
OLIGOMERIC FERROCENE AMIDES: TOWARDS 
FERROCENE POLYAMIDES 
 
 
5.0. Connecting Text 
One major potential application of ferrocene compounds in material science is 
as standing motive for the synthesis of metallopolymers. These polymers may have 
novel and interesting properties. This chapter builds on the application of our novel 
achievement described in Chapter 1 where we were able to demonstrate a very convenient 
synthon for a protected 1,1'-diaminoferrocene. By utilizing this very stable diamine, it 
was possible to describe the synthesis and investigation of oligomeric and polymeric 
ferrocene peptides as a novel class of ferrocene-containing metallopolymers. To the best 
of our knowledge, there were no examples of peptide-like Fc-containing long chains 
oligomers or polymers. This chapter describes the condensation reaction of 1,1'-
diaminoferrocene and 1,1'-ferrocene dicarboxylic acid to give rise to a series of novel 
oligo- and poly-ferrocene peptides. These materials are fully soluble in a variety of 
solvents and are fully characterized spectroscopically. Finally, electrochemical investigation of 
the electronic interaction between the individual ferrocene units is described.  
This paper was reproduced with the permission from J Inorg. Organomet. Polym.  2006, 16, 
201- 210, Copyright © 2006, Springer Science + Business Media. This paper is co-authored by 
H.-B. Kraatz. All work described in this paper, in terms of the experimental study, hypothesis, 
and initial writing of the manuscript were carried out by me. The text below is a verbatim copy 
of the published paper.   
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 5.1. Introduction 
Metallopolymers have received considerable attention in recent years.[1, 2] 
Significant efforts focused on the synthesis of poly(ferrocenylenes), in which the 
ferrocene (Fc) groups form part of the backbone and are either linked directly to each 
other[3] or are linked by π-conjugated organic bridges (1) and on polymers in which the 
Fc is located in the side chain (2).[4-9] However, in many cases, these polymers are 
sparingly soluble which limits their characterization.[10] Significant progress has been 
made by Manners whose research group was able to exploit the ring strain in 
silaferrocenophanes to develop high molecular weight Fc-backbone polymers (3) by 
ring-opening metathesis.[10-12]
 
In some cases, electronic interactions between neighboring Fc centers were 
observed.[7-13] Intermolecular electronic interactions in conjugated Fc oligomers and 
polymers have been subjected to considerable studies due to their potential applications 
in the construction of electronic devices and electron storage media.[14-17] In some cases, 
the extent of communication between the redox centers was controlled and modulated 
in several ways; including protonation or alkylation of the compounds and changing the 
solvent polarities.[18]
Polyferroceneamides (4) based on 1'-aminoferrocene-1-carboxylic acid, linking 
the Fc subunits via an amide linkage, were proposed in the literature and there have 
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 been several reports of Fc- amide dimers, obtained via stepwise amide coupling.[19-22]  
Work by Nakamura shows the presence of intra- as well as intermolecular H-bonding 
between Fc-amide dimers in solution as well as in the solid state. Moreover, he 
proposes that H-bonding would play an important role in determining the secondary 
structure of the polymeric Fc-pseudopeptide.[21] 
In contrast, the alternative poly- and oligoamides (5) derived from 1,1'-
ferrocenedicarboxylic acid and 1,1'-ferrocenediamine subunits are not known to date. 
The lack of a facile method to generate a suitable Fc-diamine precursor is most likely 
responsible for this. We recently reported the synthesis of the stable precursor 1,1'-
bis(Boc-amino)ferrocene (6),[23] which serves as a convenient precursor for 1,1'-
diaminoferrocene. 
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Here we report the reaction of 1,1'-bisaminoferrocene with ferrocenecarboxylic 
acid chlorides, with the aim to study the use of the diamine for the synthesis of 
ferrocene amide polymers. We report the synthesis and spectroscopic characterization 
of a series of well-defined Fc-amide oligomers, having the repeat unit as shown in 5, as 
well as of a high molecular weight Fc-amide polymer. Their electrochemical and optical 
properties are reported and compared to other oligoferrocenes in order to assess the 
magnitude of the electronic interaction between the Fc centres. 
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 5.2. Results and Discussion 
 5.2.1. Synthesis  
In order to assess the use of 1,1'-bis(Boc-amino)ferrocene 6 as a useful precursor 
the synthesis of Fc-amide polymers, we initially studied the reaction of 6 with the Fc-
acid chloride 7 or the active ester 10. An overview of these reactions is shown in 
Scheme 5.1. In both cases, deprotection of the bis-Boc-Fc derivative 6 followed by 
coupling with the acid chloride 7 or the active ester 10 resulted in the formation of 
triferrocenes 8 and 10, in which the Fc-diamine was flanked on either side by the Fc-
acid component. Triferrocene 8 is a diester, while the triferrocene 10 is a Boc-protected 
diamine. Both compounds were characterized spectroscopically.  
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Scheme 5.1. Synthesis of compounds 8 and 10 (i) a) TFA, CH2Cl2; b) Et3N/THF. 
 
The Amide A absorption bands of the triferrocene amides 8 and 10 indicate at 
least in the case of 11 the presence of H-bonding in the solid state. While for 10, the 
Amide A band was observed at 3340 cm-1, in a region typically associated with H-
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 bonding, this band was shifted to higher energies for 8, indicating a lack of strong H-
bonding. However, we cannot conclude the complete absence of H-bonding. 
Differences in behavior were observed also in the 1H-NMR spectra of the two 
triferrocenes in CDCl3. The two equivalent Fc-amide NH groups in 8 gave rise to a 
single resonance at δ 8.19. In compound 10, two sets of NH signals are observed, one 
due to the Fc-amide NH at δ 9.07, indicating potentially less involvement of H-bonding, 
and a second signal downfield at δ 6.49 due to the Boc-carbamide (Figure 5.1). 
 
Figure 5.1. The 1H-NMR patterns of compounds 8 and 10 in CDCl3: * residual peak of 
CHCl3   
 
 Next, we attempted the polymerization of the Fc-diamine with Fc-bis-acid 
chloride 8. Polymer 15 was obtained from the Boc-protected Fc-diamine 6 after Boc-
deprotection followed by coupling to ferrocene-1,1'-dicarbonyl chloride 8 in THF. The 
yellow polymer 15 was filtered off and washed with methanol. The remaining solution 
was dried in vacuo and subjected to chromatography, allowing us to isolate the four bis-
ester oligomers 8, 12-14 (Scheme 5.2). These ranged from the dimer 12, to the trimer 8, 
which was also prepared independently (vide supra), to the pentaferroceneamide 13 and 
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 the heptaferroceneamide 14. The isolation of the dimer 12 was surprising since it 
suggested partially incomplete Boc-deprotection of 6. All compounds were obtained as 
methyl esters. Esterification most likely was the result of the presence of methanol 
during the work up. In nonpolar solvents, such as chloroform, the Fc-oligomers engage 
in H-bonding as detected in the analyses of the IR and 1H NMR spectra and comparison 
to related oligoferrocenes. 
n
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15:  poly Fc-peptide  
Scheme 5.2. Synthesis of compounds 8, 12-14 and of polymer 15. (i) a) TFA, CH2Cl2; 
b) Et3N/THF. 
 
Figure 5.2 shows the IR absorption patterns of compounds 8 and 10 in chloroform 
solution and allows a comparison of their H-bonding interactions. The positions of the 
Amide A band in both compounds indicate the presence of H-bonding in both 
compounds.  Both systems display a strongly H-bonded Amide A band at 3305 cm-1 for 
10 and at 3264 cm-1 for 8. In addition, the weak band at 3519 and 3505 cm-1 indicates 
the presence of amides that are not involved in H-bonding. This may be rationalized by 
invoking an equilibrium between H-bonding and non-H-bonding states in solution. The 
position of the Amide A band shifts to approximately lower wavenumbers with 
increasing number of Fc units and oligomer length. This is intuitive since elongation of 
the Fc-oligomer generates more H-bonding sites. 
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Figure 5.2. IR spectra  of (a) BocNH-Fc-NHCO-Fc-COOMe (12) and (b) MeOOC-Fc-
CONH-Fc-NHCO-Fc-COOMe (8) in CHCl3 solution. 
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 In this regard, the position of the Amide A band in compound 12, Boc-NH-Fc-
NHCO-Fc-COMe, was very low. However, this dimer is closely related to Nakamura’s 
Ac-NH-Fc-CONH-Fc-CONHMe, which was proposed to engage in strong 
intramolecular H-bonding in solution and the solid state, enabled by its structure which 
aligns the amide NH and amide CO resulting in effective interactions.[14]
Interestingly, 1H-NMR spectrum of compounds 8, 12, 13, and 14 showed a 
downfield shift of the amide signal as the number of Fc units increased (Figure 5.3). 
The amide signal shifts downfield from δ 8.19 for 8, to δ 8.33 for 13, and to δ 8.41 for 
compound 14. This spectroscopic evidence lends additional support to the presence of 
NH….OC hydrogen bonds, which shift to lower field with increasing the number of Fc 
units. 
  
Figure 5.3. 1H-NMR spectra in CDCl3 of ferroceneamide oligomers, 12-14 in CDCl3. * 
residual peak of CHCl3. 
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 MALDI-TOF analysis of polymer 15 showed a broad envelope centred around 
2.8x104 Da. Interestingly, the poly-Fc “peptide” 15 is soluble in water. This maybe 
rationalized by the “protein-like” nature of this polymer. Its average molecular weight, 
as determined by dynamic light scattering experiments of the polymer in water, was 
2.7x104 Da with an average molecular diameter of 4.2 nm, which in line with the MS 
results. 
 
5.2.2. Electrochemistry 
The electrochemical properties of the oligo-Fc compounds 8, 10 and 12-14 were 
investigated by cyclic voltammetry (CV) and differential pulse voltammetry (DPV) in 
dichloromethane containing 0.1 M tetrabutylammonium perchlorate (TBAP) as a 
supporting electrolyte. The CVs of compounds 8 and 10 are shown in Figure 5.4. Both 
compounds displayed two well-separated redox waves. While the more cathodic 
oxidation was a one-electron oxidation, and was ascribed to oxidation of the central 
diamino-Fc unit, the more anodic wave was a two-electron wave and was ascribed to 
the simultaneous oxidation of the two terminal Fc groups. The experimental results are 
summarized in Table 5.1.  
Since the terminal Fc groups for compounds 8 and 10 have different 
substituents, the redox potential was expected to vary. Compound 8 possesses electron 
withdrawing ester groups and thus the second more anodic redox wave for 8 was 
observed at  E1/2  = 973 mV (vs Ag/AgCl). The terminal Fc group in compound 10 
possesses more electron-rich Boc-NH substituents making the terminal Fc group easier 
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 to oxidize compared to compound 8. Thus, for compound 10, the oxidation of the 
terminal Fc groups was cathodically shifted to E1/2 = 584 mV (vs Ag/AgCl).  
Our results are in sharp contrast to results obtained in other triferrocenyl systems 
in which three separate oxidation waves were observed, indicating significant electronic 
communication in the triferrocenes. Oxidation of the two outer Fc groups to the dication 
proceeded stepwise giving rise to two poorly resolved one-electron waves, which were 
separated from the oxidation of the central Fc unit by 0.31 V.[24-26] In the system under 
study here, electronic communication was significantly diminished. The 
electrochemical oxidation of compounds 8 and 10 can be described as two separated 
electron transfer processes as shown in Scheme 5.3.  
 
Figure 5.4: Cyclic voltammetry of compounds 8 and 10 in CH2Cl2. All solutions 
contain 0.1 mM of the compounds and 0.1 M TBAP. GCE vs. Ag/AgCl. Scan rate = 
100 mV/s. The E1/2 of the Fc/Fc+ couple under the experimental conditions was 448(±5) 
mV (vs. Ag/AgCl). 
 
 
Scheme 5.3.  Representation of the two oxidation steps of compounds 8 and 10.  
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 The CVs and DPVs of compounds 12-14 are shown in Figure 5.5. Interestingly, 
all compounds displayed only two redox waves and not multiple redox waves as maybe 
expected for systems in which a strong electronic interaction between the redox centers 
is present.   
 
 
Figure 5.5. Cyclic voltammetry (CV) (left) and differential pulse voltammetry 
(DPV) (right) of compounds 12-14 in CH2CL2. All solutions contain 0.1 mM of the 
compounds and 0.1 M TBAP. GCE vs. Ag/AgCl. Scan rate = 0.1 v/s. 
 
The first more cathodic wave was due to oxidation of the Fc groups that are 
derived from Fc-diamine, while the more anodic oxidation was ascribed to the Fc-
dicarbonyl groups. Our studies indicated that either no or very small amount of 
electronic interaction existed between the Fc centers in our systems. This may be 
attributed to ineffective redox-matching between the Fc units, as suggested by Swager 
and coworkers.[27] A similar lack of electronic communication between redox centers 
was observed in other Fc-containing oligomers.[28-31]  The approximate ratio of the 
signals due to the Fc-diamine and Fc-dicarboxyl groups was 2:3 for 13 and 3:4 for 14 
(within experimental error). The appearance of a stripping cathodic peak in compounds 
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 13 and 14 compared to the redox behavior was most likely due to solubility changes of 
the compounds after oxidation.[31]
 
Table 5.1. Half-wave potential of tri-ferrocene analogues 8 and 10 and oligo-ferrocene 
peptides 12-14 in CH2Cl2 (0.1 M TBAP. GCE vs. Ag/AgCl. Scan rate = 0.1 V/s).  
 
 1E1/2(mV) 2E1/2(mV) 1∆Ep 2∆Ep 1(ia/ic) 2(ia/ic) 
8 292 ± 5 973 ± 5 131 137 0.99 1.04 
10 277 ± 5 584 ± 5 73 103 1.04 1.01 
12 241 ± 5 1032 ± 5 106 156 1.01 1.03 
13 268 ± 5 943 ± 5 127 121 1.02 0.97 
14 274 ± 5 936 ± 5 94 125 0.99 0.94 
 
5.2.3. Ultraviolet/Visible Spectroscopy 
UV-Vis spectra of compounds 8, 10, 12-14 were recorded in dichloromethane 
over the range of 190-600 nm to examine the degree of electronic delocalization and are 
shown in Figure 5.6. Analysis of the UV-vis spectra for the oligomers 12-14 revealed a 
slight blue shift of the Fc-based transition upon elongation of the oligomer. For 
example, while the Fc-based transition for 8 was observed at λmax = 454 nm, the 
transition shifts to λmax = 446 nm for 13 (see Table 5.2). A comparison of compounds 8 
and 10, which differ only in the substituent on the terminal Fc groups (COOMe for 8 
and NH-Boc for 10) showed a significant increase in the signal intensity and thus an 
increase in the extinction coefficient ε, indicating an effect of the substituent on orbital 
overlap.  
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Figure 5.6. Electronic spectra of the triferrocenes 8 and 10 (left) and the ferrocene 
amide oligomers 12-14. All concentrations were 0.1 mM in CH2Cl2. 
 
 
Table 5.2: UV-vis data for compounds 8, 10 and 12-14 in CH2Cl2. 
 
Compound Wave length (nm) (ε in Lmol-1cm-1) 
8 202(9910) 215(9140) 259(3520) 296(2019) 454(280) 
10 205(15019)   296(36874) 449(401) 
12 203(7588) 213(7020) 260(2720) 296(1642) 446(252) 
13 203(8762) 214(7663) 259(3102) 296(2021) 447(504) 
14 204(14140)  259(5305) 296(3960) 447(644) 
 
 
5.3. Conclusion 
We successfully achieved the synthesis of a series of novel Fc-amide oligomers 
based on ferrocenediamine. We were able to isolate and characterize oligomers ranging 
from two to seven Fc units in their backbone. Spectroscopic evidence suggests the 
presence of H-bonding in these oligomers, which is in line with oligo-Fc-amides 
derived from 1'-aminoferrocene-1-carboxylic acid. Interestingly, no evidence for 
electronic interaction was observed for our systems, which is somewhat surprising and 
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 requires further investigation. As part of this study, we also succeeded in the 
preparation of the first Fc-amide polymer by polycondensation of Fc-diamine with Fc-
dicarboxylic acid derivatives. The polymer was water soluble, which maybe 
rationalized by assuming a globular “protein-like” nature of this polymer. Hydrophilic 
groups may be exposed to the exterior of the polymer. At the present time, we are 
continuing to explore condensation reactions involving Fc-diamine and are exploring 
the electronic properties of this polymer in more detail.         
 
5.4. Experimental 
5.4.1. General Procedure 
All syntheses were carried out under dry nitrogen gas  unless otherwise 
indicated. CH2Cl2 (BDH; ACS grade) used for synthesis was dried (CaH2) and distilled 
prior to use. CDCl3 (Aldrich) was dried (CaH2), and stored over molecular sieves (8-12 
mesh; 4Å effective pore size; Fisher) before use. THF was dried over 
benzophenone/sodium, and stored over molecular sieves (8-12 mesh; 4Å effective pore 
size; Fisher) before use. 1'-methoxycarbonyl ferrocene-1-carboxylic acid and 1'-Boc-
aminoferrocene-1-OBt were prepared according to literature procedures, 
hydroxybenzotriazole (HOBt) (Nova), NaSO4, and NaHCO3 (VWR) were used as 
received. For column chromatography, a column with a width of 2.7 cm (ID) and a 
length of 45 cm was packed 18-22 cm high with 230-400 mesh silica gel (VWR). For 
TLC, aluminum plates coated with silica gel 60 F254 (EM Science) were used. NMR 
spectra were recorded on a Bruker Avance-500 spectrometer using a 5-mm broadband 
probe operating at 500.134 MHz (1H) and 125.766 MHz (13C{1H}). Peak positions in  
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 1H spectra are reported in ppm relative to TMS. All, unless otherwise described 13C{1H} 
spectra are referenced to the CDCl3 signal at δ 77.23. Mass spectrometry was carried 
out on a VG Analytical 70/20 VSE instrument. Infrared spectra were obtained with a 
Perkin-Elmer model 1605 FT-IR. Dynamic light scattering experiments were carried 
out on a Dynampro-MS800 instrument using a 20 µL sample in a quartz cuvette. 
 
5.4.2. Preparation of 1'-methoxycarbonyl ferrocene-1-carbonyl chloride (7) 
A mixture of 1'-methoxycarbonyl ferrocene-1-carboxylic acid (0.86 g 3.0 
mmol), freshly distilled 2 M oxalyl chloride in dichloromethane (3.5 mL), 0.5 mL 
pyridine and dry dichloromethane (20 mL) was stirred in dark at r. t. for 20 hours and 
then at reflux for 4 hours. The mixture was evaporated to dryness. The crude product 
was extracted by hot dry ether several times. Purification was accomplished by flash 
column chromatography (SiO2, EtOAc: hexane 1:3) to give pale red crystals of 
compound 7 ( 0.85 g, 92%).  TOF-MS (m/z): calc for C13H11Cl FeO3 [M]+: 306.5270; 
found: 306.1746. IR (CH2Cl2, υmax/cm-1): 1760 (s, C=O, COCl), 1710 (s, C=O, 
COOMe). UV-vis (CH2Cl2; λ in nm (ε in Lmol-1cm-1)): 453 (706). 1H-NMR (CDCl3, δ 
in ppm): 5.00 (2H, t, J = 4 Hz, H-2' and H-5', Fc), 4.95 (2H, t, J = 4 Hz, H-2 and H-5, 
Fc), 4.64 (2H, t, J = 4 Hz, H-3' and H-4', Fc), 4.61 (2 H, m, J = 3 Hz, H-3 and H-4, Fc), 
3.84 (3H, s, COOCH3).  
 
5.4.3. Preparation of MeOOC-[Fc-NHCO]2-Fc-COOMe (8) 
1,1'-bis(Boc-amino)ferrocene[23] 1 (0.42 g, 1.0 mmol) was dissolved with 
stirring in CH2Cl2 (2.0 mL) and after cooling to 0 ºC with an ice bath, TFA (2.0 mL) 
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 was added dropwise under a nitrogen atmosphere. Then the ice bath was removed and 
stirring was continued. After 30 min, CH2Cl2 (10 mL) was added and the solution was 
cooled to 0 ºC before an excess Et3N was added dropwise. To this, a solution of 1'-
methoxycarbonyl ferrocene-1-carbonyl chloride 7 (0.67 g, 2.2 mmol) in dry CH2Cl2 was 
added. The reaction mixture was stirred for 2 h at room temperature and then washed 
consecutively with saturated aqueous sodium bicarbonate, 10% aqueous citric acid, 
saturated sodium bicarbonate, and water. The organic phase was separated and dried 
over Na2SO4, filtered and then evaporated to dryness. After purification by flash column 
chromatography (EtOAc: hexane 2:1), orange crystals of compound 8 were obtained 
(0.66 g, 88%). TOF-MS (m/z): calc for C36H32N2O6Fe3 [M]+: 756.0308; found: 
756.0305. Anal. Calc. C 57.18, H 4.27, N 3.70%; Found C 57.39, H 4.11, N 3.62%. FT-
IR (KBr, υmax/cm-1): 3406 (m, N-H), 1709 (s, C=O). UV-vis (MeCN; λ in nm (ε in 
Lmol-1cm-1)): 454 (800). m. p 172-178 ºC. 1H-NMR CDCl3, (δ in ppm): 8.19 (2H, s, 
NH), 4.87 (4H, t, J = 4 Hz, Fc), 4.82 (4H, s, Fc), 4.59 (4H, b s, Fc), 4.51 (4 H, t, J = 4 
Hz, Fc), 4.42 (4H, m, Fc), 4.15 (4 H, m, Fc), 3.84 (6H, s, COOCH3).  13C{1H} NMR 
(CDCl3, δ in ppm) 172.3 CONH, 162.7  COOCH3, 96.3, 78.8, 73.2, 72.6, 72.3, 72.2, 
70.2, 65.7, 63.1 Fc, 52.4 OCH3
 
5.4.4. Preparation of BocNH-[Fc-NHCO]2-Fc-NHBoc (10) 
1,1'-bis(Boc-amino)ferrocene[23] 6 (0.42 g, 1.0 mmol) was treated as described 
above for compound 8 prior the reaction with 1'-Boc-aminoferrocene-1-OBt[8] 9 (1.01 g, 
2.2 mmol) in 5.0 mL dry CH2Cl2. The resulting solution was stirred at r. t. overnight, 
worked up as described above, and the solvent was removed under reduced pressure.  
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 The residue was chromatographed (SiO2, hexane: EeOAc 60:40) to give a dark yellow 
powder of compound 10 (0.49 g, 56%). TOF-MS (m/z): calc for C42H46N4O6Fe3 [M]+: 
870.3900; found: 870.1450. Anal. Calc. C 57.96, H 5.33, N 6.44%; Found C 58.13, H 
5.16, N 6.33%. FT-IR (KBr, υmax/cm-1): 3340, 3286 (m, N-H), 1697 (s, C=O). UV-vis 
(CH2Cl2; λ in nm (ε in Lmol-1cm-1)): 449 (600). m. p 173-177 ºC. 1H-NMR CDCl3, (δ in 
ppm): 9.07 (2H, s, NH, NHCO), 6.49 (2H, s, NH, NHBoc), 4.82 (4H, s, Fc), 4.58 (4H, 
s, Fc), 4.44 (4H, s, Fc), 4.42 (4 H, t, J = 4 Hz, Fc), 4.13 (8H, m, Fc), 1.52 (18H, s, 
C(CH3)3). 13C{1H} NMR (CDCl3, δ in ppm) 172.8 CONH, 153.5 COOC(CH3)3, 80.4 
C(CH3)3, 99.8, 78.9, 74.7, 73.3, 72.5, 70.9, 66.9, 66.0, 65.2, 62.3 Fc , 28.7 C(CH3)3 . 
 
5.4.5. Preparation of Ferrocene-1,1'-dicarbonylchloride (11) 
A mixture of 1,1'- ferrocenedicarboxylic acid (2.00 g 7.3 mmol), freshly distilled 
2 M oxalyl chloride in dichloromethane (7.5 mL), 1.0 mL pyridine and dry 
dichloromethane (30 mL) was allowed to stirred in dark at  r. t. for 20 hours and then at 
reflux for 4 hours. The mixture was evaporated to dryness. The crude product was 
purified by flash column chromatography (SiO2, EtOAc:hexane 1:3) to give red crystals 
of compound 8 (1.32 g, 97%). TOF-MS (m/z): calc for C12H8Cl2FeO2 [M]+: 310.9454; 
found: 310.7321. IR (CH2Cl2, υmax/cm-1): 1761 (s, C=O, COCl). UV-vis (CH2Cl2; λ in 
nm (ε in Lmol-1cm-1)): 453 (706). 1H-NMR CDCl3, (δ in ppm): 4.85 (2H, t, J = 4 Hz, H-
2 and H-5, Fc), 4.43 (2 H, t, J = 4 Hz, H-3 and H-4, Fc). 
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 5.4.6. Synthesis and Characterization of Oligo- and Poly-Ferrocene Peptides 
1,1'-bis(Boc-amino)ferrocene[23] 6 (1.00 g, 2.4 mmol) was dissolved in CH2Cl2 
(2.0 mL) and after cooling to 0ºC, 30:70 (v/v) CH2Cl2: TFA (3.0 mL) was added 
dropwise, then the solvent was evaporated under dry nitrogen stream. To the residue, 20 
mL of dry THF was added followed by dropwise addition of Et3N (3.0 mmol) at 0° C.  
To this, ferrocene-1,1'-dicarbonyl chloride 11 (1.49 g, 2.8 mmol) in THF (10 ml) was 
added, the solution was allowed to stir for 1 hour at 0° C, then 2 hours at room 
temperature. The reaction product was filtered; the solid residue was washed 
successively with chloroform, Methanol, and then recrystallized from methanol/water to 
produces faint yellow powder of polymer 15 (0.36 g, 34.2%).  The remaining solutions 
from filtration and successive washings of polymer 15 were combined and evaporated 
to dryness, and then the crude residue was purified by flash column chromatography 
(SiO2, EtOAc:hexane 1:1) to give compounds 12 (0.04 g, 2.6%, Rf = 0.78), 9 (0.08 g, 
6.2%,  Rf = 0.54), 13 (0.05 g, 7.3%, Rf = 0.31) and 14 (0.10 g, 12.2%, Rf = 0.24).  
 
5.4.6.1. Characterization of Compound 12 
TOF-MS (m/z): calc for C28H30N2O5Fe2 [M]+: 586.2485; found: 586.0862. FT-IR 
(KBr, υmax/cm-1): 3302 (m, N-H), 1720, 1697 (s, C=O). UV-vis (CH2Cl2; λ in nm (ε in Lmol-
1cm-1)): 445 (766). m. p 158-163 ºC. 1H-NMR CDCl3, (δ in ppm): 7.06 (1H, s, NH, 
NHCO), 6.57 (1H, s, NH, NHBoc), 4.86 (2H, s, Fc), 4.81 (2H, s, Fc), 4.51 (4H, s, Fc), 
4.41 (4 H, s, Fc), 4.14 (4 H, m, Fc), 3.37 (3H, s, COOCH3), 1.39 (9H, s, C(CH3)3). 
13C{1H} NMR (CDCl3, δ in ppm) 172.4 CONH, 153.7 COOC(CH3)3, , 81.0 C(CH3)3, 
98.7, 73.3, 72.2, 71.4, 70.2, 65.7, 63.2 Fc, 52.0 OCH3, 28.6 C(CH3)3 . 
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 5.4.6.2. Characterization of Compound 13 
TOF-MS (m/z): calc for C58H50N4O8Fe5 [M]+: 1210.2860; found: 1210.0376. 
FT-IR (KBr, υmax/cm-1): 3278 (m, N-H), 1771, 1717 (s, C=O). UV-vis (CH2Cl2; λ in nm 
(ε in Lmol-1cm-1)): 446 (784). m. p 168-174 ºC.  1H-NMR CDCl3, (δ in ppm): 9.17 (2H, 
b, s, NH), 8.33 (2H, b, s, NH), 4.85 (m, 16H, Fc-CO), 4.64 (m, 8H, Fc-N) 4.46 (m, 16H, 
Fc-CO), 4.01(m, 8H, Fc-N), 3.84 (6H, s, COOCH3).  13C{1H} NMR (CDCl3, δ in ppm) 
172.8, 172.3  CONH, 162.7 COOCH3, 96.2, 78.8, 73.2, 72.6, 72.4, 72.2, 70.2, 69.8, 
65.7, 65.2, 63.8, 63.2 Fc, 52.4 OCH3.        
 
5.4.6.3. Characterization of Compound 14 
TOF-MS (m/z): calc for C80H68N6O10Fe7 [M]+: 1664.3747; found: 1664.0452. 
FT-IR (KBr, υmax/cm-1): 3267 (m, N-H), 1717, (s, C=O). UV-vis (CH2Cl2; λ in nm (ε in 
Lmol-1cm-1)): 446 (781). m. p 183-187 ºC. 1H-NMR CDCl3, (δ in ppm): 9.33 (2H, b s, 
NH), 8.86 (2H, br s, NH), 8.41 (2H, b s, NH), 4.93-4.01 range (m, 68H, Fc), 3.83 (6H, 
s, COOCH3).  13C{1H} NMR (CDCl3, δ in ppm) 173.6, 173.1, 172.4 CONH, 162.8 
COOCH3, 93.7, 78.8, 73.2, 73.5, 72.6, 72.3, 71.9, 69.8, 65.7, 65.3, 64.3Fc, 52.4 OCH3.        
 
5.4.6.4. Characterization of the Polyferrocene Peptide 15 
TOF-MS (m/z): found: 2.8 x 104, FT-IR (KBr, υmax/cm-1): 3307 (m, N-H), 3000 
(v b, υ(OH)). UV-vis (CH2Cl2; λ in nm (ε in Lmol-1cm-1)): 448 (512). m. p >200 ºC. 1H-
NMR DMSO-D6, (δ/ppm): 9.11 (124 H, m, NH, b, NHCO), 4.76 (m, Fc), 4.68 (m, Fc), 
4.41 (m, Fc), 4.03 (m, Fc).  
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 5.6. Supplemental Material 
 
Table 5.S1. Summary of selected 1H-NMR spectroscopic data for compounds 9, 11-15, 
chemical shifts in ppm. 
 
Compd. δ  (NH) Fc-H’s Substituents 
8a 8.19 (2H, s, NH) 4.87 (4H, t, JH-H = 4.0 Hz), 4.82 
(4H, s), 4.59 (4H, b s), 4.51 (4 H, t, 
JH-H = 4.0 Hz), 4.42 (4H, m,), 4.15 
(4 H, m).  
3.84 (6H, s) 
10a 9.07 (2H, s, NH, 
NHCO), 6.49 (2H, s, 
NH, NHBoc) 
4.82 (4H, s, Fc), 4.58 (4H, s, Fc), 
4.44 (4H, s, Fc), 4.42 (4 H, t, JH-H 
= 4.0 Hz, Fc), 4.13 (8H, m, Fc). 
1.52 (18H, s, C(CH3)3). 
12a 7.06 (1H, s, NH, 
NHCO), 6.57 (1H, s, 
NH, NHBoc), 
4.86 (2H, s, Fc), 4.81 (2H, s, Fc), 
4.51 (4H, s, Fc), 4.41 (4 H, s, Fc), 
4.14 (4 H, m, Fc) 
3.37 (3H, s, COOCH3), 
1.39 (9H, s, C(CH3)3). 
13a 9.17 (2H, b, s, NH), 
8.33 (2H, b, s, NH), 
4.85 (overlapping, 16H, Fc-CO), 
4.64 (overlapping, 8H, Fc-N) 4.46 
(overlapping, 16H, Fc-CO), 
4.01(overlapping, 8H, Fc-N) 
3.84 (6H, s, COOCH3). 
14a NH), 8.86 (2H, br s, 
NH), 8.41 (2H, br s, 
NH), 
9.33 (2H, br, 4.93-4.01 range 
(overlapping, 68H, Fc). 
3.83 (6H, s, COOCH3). 
15b 9.11 (overlapping, 
NH, b, NHCO), 
4.76 (overlapping, Fc),  
4.68 (overlapping, Fc),  
4.41 (overlapping, Fc),  
4.03 (overlapping, Fc).  
 
[a] In CDCl3,  [b] In DMSO-d6 
 
 
 
Table 5.S2.  Summary of selected IR (KBr, cm-1) spectroscopic data for compounds 8, 
10, 12-15. 
 
                   υ(C=O) 
Compounds υ(NH) COOR CONH δ(NH) 
8 3406 b 1709 s  1651 1542 s 
10 3340, 3286 b 1697 s 1639 1554 s 
12 3302 m 1720,1697 s 1645 s 1547 s 
13 3278 m 1771, 1717 s 1642 1547 s  
14 3267 m 1717 s 1641 1547 s  
15 3307 m  1640 1548 s 
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Table 5.S3. Some characterization and Physical properties of compounds 8, 10, 12-15. 
 
Compounds Color Mol. Formula (M.Wt) Yield% MP (°C) 
8 Orange C36H32N2O6Fe3(756.0305) 88 172-178 
10 Yellow C42H46N4O6Fe3 (870.1450) 56 173-177 
12 Orange C28H30N2O5Fe2 (586.0862) 3 158-163 
13 Orange C58H50N4O8Fe5 (1210.0376) 5 168-174 
14 yellow C80H68N6O10Fe7 (1664.0452) 7 183-187 
15 Yellow  (Av. 2.8 x 104 ) 11 >200 
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 CHAPTER 6 
 
 
SYNTHESIS AND ELECTROCHEMICAL INVESTIGATION OF 
OLIGOMERIC AND POLYMERIC FERROCENYL-AMIDES 
HAVING CYCLOHEXYL, PHENYLENE AND LYSYL SPACERS 
 
6.0. Connecting Text 
This chapter expands on the hypothesis demonstrated in Chapter 5 and discusses 
the use of disubstituted Fc-derivatives as precursors for the synthesis of a series of novel 
Fc-polyamides. The synthesis and electrochemical analysis for a series of different 
polymeric and oligomeric ferrocenyl amides having different spacer groups is 
described. The solution voltammetric analysis performed on the oligomeric ferrocene 
amides (Chapter 5) revealed very little electronic communication between the iron 
centres. The main theme of this chapter is the electronic effect of different linker groups 
connecting the ferrocene units in these polymers and the effect on the electronic 
communication between the redox centres. This chapter will be showing that varying 
the distances between the iron centres and altering through-bond conjugation has an 
effect on the electronic properties of these polymers.     
This manuscript is to be published material and will be co-authored by H.-B. Kraatz. All the work 
described in this manuscript, in terms of the experimental study, hypothesis, and writing of the 
manuscript was carried out by me.    
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 6.1. Introduction 
Ferrocene (Fc)-based polymers and copolymers are of great interest because of their 
potential electrical, optical, and catalytic applications.[1, 2] Fc-polyester and polyamides 
having the metallocene in the backbone and being derived from bifunctional Fc 
derivatives by condensation reactions are of particular interest due to their ease of 
preparation from convenient starting materials and the potential to vary the properties of 
the polymer by introducing linker groups that connect the Fc groups.[3, 4] In addition, 
such systems may allow the development of macromolecular conjugates systems which 
may have interesting electronic properties and may find applications in optoelectronic 
devices and chemical sensors.[5]   
Controlling the extent of the electronic communication between the Fc sites 
through a spacer that separated the electroactive sites is particularly important and 
significant efforts have been made to control and modulate the extent of such electronic 
communication by varying the distances between the iron centers and altering through-
bond conjugation. Several investigations of Fc-oligomers showed that the linkers 
between Fc units modulate the interaction between the iron centers by changing the Fc-
Fc distances and by tuning through-bond orbital conjugation.[6-10]  In an attempt to 
enhance the electronic communication between the Fc centers, Curtis and coworkers 
reported poly(ferrocenylenearylene)s (I).[11, 12] Electrochemical measurements on these 
systems showed significant interactions between the iron centers. Nishihara and others 
presented oligo- and poly-ferrocenylenes (II) as representative class of polymers that 
showed a promising electronic communications between the metal sites. The 
electrochemical studies showed redox waves that are corresponding to the ferrocene 
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 units of the molecule due to the formation of mixed valence state.[13-15] Similar 
electronic properties were observed by Manners and coworkers in oligo- and poly-
ferrocenylsilanes (III),[10, 16] in which the high molecular weight polymer displays two 
redox waves, rationalized by an initial oxidation at alternating iron sites as a result of 
interactions between the iron atoms.[16] 
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On the other hand, several linear Fc-containing polyesters and polyamides 
derived from organic diols and diamines (IV) do not display any electronic 
communication between the Fc groups. These systems display a single redox event in  
the differential pulse voltammetry (DPV), suggesting simultaneous oxidation of all 
ferrocenyl moieties.[17, 18] This suggests that such a spacer having large insulating 
organic groups will reduce the electronic interaction, effectively isolating the Fc 
groups.[17] Chao prepared Fc-polyamides having oligoaniline spacers (V).[19] The 
polymers were lacking the communication between the Fc units and showed week 
electrical conductivity compared to HCl-doped polyaniline. Similarly, the 
electrochemical investigation by Deck on perfluorinated biphenylene-linked Fc 
oligomers (VI) revealed a lack of the interaction between the adjacent iron centers.[20-22]  
Recently, we have reported the polycondensation of 1,1'-diaminoferrocene with 
1,1'-ferrocene acid chloride and on the isolation of a series of oligomeric and polymeric 
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 Fc-polyamide systems.[23] The electrochemical investigations performed on these 
polyamides also show insignificant electronic communications between the Fc units. 
The cyclic voltammetry measurements revealed two distinct redox waves which are 
clearly assigned to the two Fc environments (Fc(CO-)2 and Fc(NH-)2). 
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In this paper, we focus our attention on the spacer material linking the Fc-
diamine units and report the synthesis of a series of Fc-backbone oligomers and 
polymers by polycondensation.  In addition, model oligomers are reported that help us 
in the assignment and characterization of the polymeric materials.   
We are using three spacer materials for our study that vary in their electronic 
properties, ranging from a phenylene spacer, which should enhance the Fc to Fc 
communication, [24, 25] to a cyclohexylene spacer, which should give the polymer more 
flexibility but should reduce the interaction between the Fc groups, to a lysyl spacer, 
where we do not expect any interactions between the Fc groups. In all three systems, the 
presence of the amide group as an internal polar function within the polymeric structure 
should play a crucial role in influencing the properties of these systems.[18]                   
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 6.2. Results and Discussion 
6.2.1. Synthesis and Characterization  
For a more detailed investigation of the electronic communication between the 
Fc groups in Fc-containing polymers, various Fc-containing polymers and oligomers 
were prepared by polycondensation reactions between Fc-diamine and the acid 
chlorides, terephthaloyl chloride (2) and 1,4-cyclohexyldicarboxylic chloride (4).  
At first, two model compounds were synthesized to help in the characterization 
of the polymers. These model compounds are derived from a ferrocene amino acid 
derivative, in which the amino group can be selectively coupled with a diacid chloride, 
resulting in the formation of well-defined symmetrical bis-Fc systems linked by the 
desired spacer. Model compounds 3 and 5 were prepared from Boc-protected Fc amino 
acid methylester (1) and terephthaloyl chloride and 1,4-cyclohexylenedicarboxylic 
chloride, respectively (Scheme 6.1).  
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Scheme 6.1. Schematic overview of the synthesis of compounds 3 and 5 from ferrocene 
amino acid derivative 1 and terephthaloyl chloride (2) and 1,4-cyclohexyldicarboxylic 
chloride (4). 
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 After purification by flash column chromatography, compounds 3 and 5 were 
obtained in good yields and characterized spectroscopically. In the IR, both compounds 
display a strong Amide A band around 3283, 3252 cm-1 indicative of hydrogen bonding 
in the solid state. In addition, a strong C=O stretching vibration is observed at 1694 cm-1. 
The 1H-NMR spectrum in DMSO-d6 showed significant differences in the chemical 
shift of the amide NH of compound 3 (δ 7.82) and that of compound 5 (δ 9.16).  
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Scheme 6.2. Schematic overview of the synthesis of compounds 7 – 12 from the 
ferrocene diamine derivative 6 and terephthaloyl chloride (2) and 1,4-
cyclohexyldicarboxylic chloride (4). 
 
As a next step, we carried out reactions of the Fc-diamine, derived from the 
Boc-protected derivative 6 and the diacid chlorides 2 and 4 (Scheme 6.2). The Boc 
groups were removed from the starting material 6 by treatment with trifluoroacetic acid, 
followed by the addition of Et3N prior to reaction with the diacid chlorides. This needs to be 
done under an inert atmosphere and at low temperatures. 
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 In the case of the reaction with terephthaloyl chloride and immediately after 
mixing, polymer 10 starts to precipitate and is isolated by filtration, followed by 
washing and recrystallization from methanol. The remaining solutions from filtrations 
and successive washings were combined and purified by flash column chromatography 
(EtOAc:MeOH 9:1), allowing the isolation of oligomers 7-9 as shown in Scheme 6.2.  
The polymer 10 is soluble only in DMSO and DMF, and attempts to determine the 
molecular mass of the polymer by MALDI-TOF were unsuccessful. The estimated 
molecular mass was obtained from dynamic light scattering measurements. Assuming a 
globular protein model, the average molecular was 125 ± 4 kDa and the mean 
hydrodynamic diameters were in the range of 5.5 (±0.5) nm. The size distribution 
showed a narrow unimodal pattern (Figure 6.1).  
 
Figure 6.1. Intensity size distributions of 0.1 mM of polymer 10 in DMSO 
measured by dynamic light scattering at 23°C. 
 
The IR spectrum of 10 shows a simple but expected pattern, with broad peak at 
3229 cm-1 assigned to the Amide A, and two peaks at 1641 and 1555 cm-1 assigned to 
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 amide I and II bands, respectively. A small peak for the residual hydroxyl group was 
observed around 3485 cm-1 (Table 6.1 and Figure 6.2). 
 
The 1H-NMR spectrum for the oligomers in DMSO-d6 of the compounds 
showed a downfield shift of the amide signals with increasing degree of oligomerization 
from δ 7.87 for 7, to δ 8.33, 8.28 for 8, and δ 8.53-8.20 for 9, which lending support to 
the assumption of increasing levels of intramolecular H-bonding in these systems.   
 
Table 6.1. Selected IR spectral data (KBr, cm-1) for compounds 7-10.  
 Amide-A Amide-I Amide-II CH OH COOH 
7 3372 1645 1550 3095-2850 3327 1717 
8 3284 1648 1545 3086-2850 3386 1710 
9 3279 1647 1547 3093-2853 3385 1714 
10 3229 1641 1555 3098-2960 3435  
11 3267 1656 1542 3089-2950 3427  
12 3274 1667 1542 3089-2950 3436  
 
 A representative 1H-NMR spectrum of polymer 10 is shown in Figure 
6.3 and is surprisingly simple, showing only two singlets appearing at δ 4.83 and 4.01 
corresponding to the Fc protons. The phenylene protons merge together and appear in 
the region of δ 8.10 - 7.89. The amide protons are observed in the range of δ 8.91-8.30 
indicating a strong engagement in H-bonding. 
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Figure 6.2. IR spectra (KBr) of the oligomers 7-9 and the polymer 10. 
 
 
 
Figure 6.3. 1H-NMR spectra in DMSO-d6 of the polymer 10. 
 
In contrast to the successful polymerization of Fc diamine with terephthaloyl 
chloride, the reaction with 1,4-cyclohexyldicarboxylic chloride (4) did not lead to any 
polymeric product. Even upon increasing the reaction time or reaction temperature, we 
were able to isolate only two oligomeric products 11 and 12, having two and five repeat 
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 units, respectively (Scheme 6.2). The two oligiomers are soluble in common organic 
solvents such as CH2Cl2 and CH3CN were fully characterized by MALDI-TOF, NMR, 
and IR spectroscopy. Figure 6.4 shows the IR spectra for both compounds. Amide I and 
II bands are observed at 1660 and 1542 cm-1, respectively. In addition, broad CH 
stretching signals are observed in the range of 3089-2950 cm-1 (Table 6.1).  
 
Figure 6.4. Selected regions from FT-IR spectra (KBr) of the oligomers 11 and 12. 
 
The 1H-NMR spectra of these oligomers in DMSO-d6 shows amide NH signals 
at δ 7.78 for compound 11 and at δ 7.97-7.75 for compound 12. The NMR and IR 
spectra also provide evidence for the presence of carboxylic OH groups at around δ 9.8, 
and in the IR with an OH stretching vibration shoulder observed as a shoulder around 
3437 cm-1 (Figure 6.4). 
Next, a polymer based on the reaction of Fc diacid chloride with lysine 
methylester was synthesized. As a first step in the synthesis of the polymer, the 
conjugate 1,n'-bis(Lys(Boc)-OMe)ferrocene 14 was prepared by amide coupling of Fc-
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 acid chloride with the amino acid in the presence of Et3N.' Next, the polymer Fc-Lys 
polymer 15 was prepared by solution polycondensation of equimolar ratios of Fc diacid 
chloride with Boc-deprotected 1,1´-bis(Lys-OMe)Fc in the presence of Et3N (Scheme 
6.4).  
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Scheme 6.4. Schematic overview of the synthesis of compounds 14 and 15. (i) Et3N, 
CH2Cl2, 0 °C, H-Lys(Boc)-OMe; (ii) a) TFA, CH2Cl2 , b) Et3N, CH2Cl2, c) Fc[CO-Cl]2. 
 
The IR spectra of compounds 14 and the polymer 15 are shown in Figure 6.5 
and are very similar. The IR spectrum of compound 14 has Amide A absorption bands 
at 3378 and 3260 cm-1. In the case of polymer 15, this region is shifted to lower energy 
and registered at 3127-2864 cm-1 indicating more engagement in hydrogen bonding. 
Both compounds showed similar absorptions around 1710 cm-1 for the ester C=O and at 
1634, 1545 cm-1 for Amide I and II bands, respectively. The 1H-NMR spectrum of 
compound 14 has a single signal for the methoxy group at δ 3.66 and for the amide NH 
protons at δ 8.10 for the Fc-NH and at δ 6.79 for the Boc-NH. Polymer 15 was 
completely soluble in water and partially soluble in DMSO. Its 1H-NMR spectra, 
recorded in D2O, showed similar spectra to those of 14. However, in this case the 
majority of the signals are unresolved multiples reflecting the presence of a polymeric 
species.       
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Figure 6.5. FT-IR spectra of compounds 14 and 15 recorded as KBr disk. 
 
 
Figure 6.6. Intensity size distributions of 0.1 mM of polymer 15 in H2O measured by 
dynamic light scattering at 23°C. 
 
It was not possible to determine the molecular mass of the polymer 15 by 
MALDI-TOF. DLS measurements were used to estimate the molecular mass, assuming 
globular protein model, which gave an average of 79.4 ± 3 kDa and the mean 
hydrodynamic diameters was 6.5 (±0.5) nm. Similar to the polymer 10, the size 
distribution is narrow (Figure 6.6). 
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 Figure 6.7 shows the circular dichroic spectra of compounds 14 and 15. The 
axial chirality about the Fc group can be evaluated by the band in the 440 nm region.[26]
 
Both compounds displayed a CD signal with a positive Cotton effect at 495 nm, 
indicating P-helical chirality about the Fc group. Surprisingly, the intensity of the 
absorption decreases for the polymer, indicating that the polymer does not adopt a 
helical conformation but rather a random coil.      
 
Figure 6.7. CD spectra of compounds 14 and 15  (1 mM in CH3CN). 
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6.2.2. Electrochemistry 
In order to assess the electronic interactions between the oligoferrocenyl amides 
prepared here, and evaluate the role of the linker group, we carried out a series of 
electrochemical studies in acetonitrile solution. The results of our study are summarized 
in Table 6.2.  
The cyclic voltammograms (CVs) and differential pulse voltammograms 
(DPVs) of the precursor compounds 3, 5 and of the oligomers 7-9 are shown in Figure 
6.8. The two ferrocene amino acid derived model complexes 3 and 5 both exhibit a 
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 single redox wave with peak separations indicating a reversible one-electron oxidation, 
indicating that both Fc groups are functioning as isolated units. The halfwave potential 
E1/2 of phenylene-bridged compound 3 is shifted anodically by 75 mV compared to that 
of the cyclohexyl-bridged compound 5. The phenylene spacer appears to enable 
delocatization of electrons into the aromatic ring, but does not appear to facilitate the 
electronic communication between the two Fc groups, in which case, we would have 
expected to see two distinct redox waves.         
 
Table 6.2. Solution electrochemical results for compounds 3, 5, 7-12, and 14 and 15. 
Compound E1/2(mV) ∆Ep (ia/ic) 
3 573 ± 5 65 1 
5 498 ± 5 75 1 
7 327 ± 5 88 0.9 
8 316 ± 5 76 0.8 
9 300 ± 5 67 0.7 
10 308 ± 4 57 1.1 
11 200 ± 3 195 0.8 
12 207 ± 5 412 0.9 
14 782 ± 5 265 1.1 
15 754 ± 3 456 1.4 
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Figure 6.8. Cyclic voltammetry (left) and differential pulse voltammetry (right) of 
compounds 3, 5, 7-9 in CH3CN. All solutions contain 0.1 mM of the compounds and 
0.1 M TBAP. GCE vs. Ag/AgCl. Scan rate = 100 mV/s. The E1/2 of the 
ferrocene/ferrocenium redox couple under the experimental conditions was 449(±5) 
mV (vs. Ag/AgCl). 
 
The CVs and DPVs of compounds 7-9 are shown in Figure 6.9 Similar to what 
was observed for the compound 3, the oligomers exhibit a single reversible to 
quasireversible redox wave.  These results suggest unresolved or no interaction 
between the ferrocene groups among the oligomers. One has to point out that upon 
increasing the length of the oligomers, the E1/2 for the systems is shifting cathodically 
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 and signals undergo significant peak broadening. This may indicate increasing but small 
electron delocalization between the ferrocene and the spacer group from 7 to 8 to 9. 
Thus, the phenylene group allows only a week and unresolved electronic 
communication between the relevant ferrocenyl subunits,[27, 28] and may be due to a 
mismatch between the phenylene spacer group and the ferrocene units as was suggested 
by Swager for other compounds.[29] In addition, the peak current decreases, as would be 
expected for systems with increasing oligomeric chain length.[30]              
Next, we investigated the electrochemical properties of the polymer 10 as a thin 
film on a glassy carbon electrode. The results are shown in Figure 6.9. Interestingly, 
two redox waves were observed.               
 
Figure 6.9. Cyclic voltammetry (left) and differential pulse voltammetry (right) of 
deposited film of the polymer 10 on glassy carbon electrode. All solutions contain 0.1 
M TBAP in CH3CN. GCE vs. Ag/AgCl. Scan rate = 100 mV/s. The E1/2 of the 
ferrocene/ferrocenium+ couple under the experimental conditions was 449(±5) mV (vs. 
Ag/AgCl). 
 
The first one recorded at E1/2 = 308 mV with peak separation 57 mV was stable 
and reproducible after many sweeps. Another irreversible oxidation wave was observed 
at 847 mV, which it decreased with repeat scans. Nguyen and co-workers reported for 
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 polymer films that the reduction of in peak current may be attributed to loss of 
electroactivity rather than loss of material from the electrode surface.[31] The broad 
characteristic of this second peak was resolved to at least three waves in DPV. Different 
studies on polymer film electrodes suggested that the charge transfer between redox 
centers among the polymer matrix could happen via different mechanisms such as 
electron hoping, counter-ion diffusion, and diffusion of electroactive species.[32-35]  
Like the phenylene-spaced systems, the cyclohexyl-spaced oligomers 11 and 12 
exhibited a single redox wave, which compared to compounds 7-9, are shifted to lower 
potential and located at 200 and 207 mV respectively (see Figure 6.10).  
 
  
Figure 6.10. Cyclic voltammetry (left) and differential pulse voltammetry (right) of 
compounds 11 and 12 in CH3CN. All solutions contain 0.1 mM of the compounds and 
0.1 M TBAP. GCE vs. Ag/AgCl. Scan rate = 100 mV/s. The E1/2 of the 
Ferrocene/Ferrocene+ couple under the experimental conditions was 449(±5) mV (vs. 
Ag/AgCl). 
 
This is in line with the observation of a cathodic shift for the cyclohexylene 
systems 5 compared to the phenylene system 3. However, it is interesting to note that 
the reversibility of the redox events in compounds 11 and 12 is significantly reduced. 
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 Both systems exhibit large peak separations and a ratio of the peak current that is 
significantly removed from unity. 
Lastly, we investigated the electrochemical properties of the lysyl systems 14 
and 15. Figure 6.11 shows the CVs and DPVs of monomer 14 and the polymeric 15. 
Both systems display a single quasi-reversible redox waves with large peak separations. 
However, the peaks shapes are significantly different. The polymer 15 has significantly 
broader peaks. In addition, the peak separation increases by 191 mV compared to the 
monomer 14, which may indicate very week and unresolved electronic interaction 
between the Fc centers.    
  
Figure 6.11. Cyclic voltammetry (left) and differential pulse voltammetry (right) of 
compounds 14 and 15 in CH3CN. All solutions contain 0.1 mM of the compounds and 
0.1 M TBAP. GCE vs. Ag/AgCl. Scan rate = 100 mV/s. The E1/2 of the 
Ferrocene/Ferrocene+ couple under the experimental conditions was 449(±5) mV (vs. 
Ag/AgCl). 
 
 
6.3. Conclusion 
 
We have successfully synthesized a series of oligomeric and polymeric Fc-
amides with different spacer groups, aimed at changing the electronic coupling between 
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 the Fc units. Lysyl, cyclohexylene, and phenylene groups were used as the spacer 
groups. In our study, we isolated two polymeric materials. In both materials, electronic 
interactions between the Fc groups are weak. For the phenylene polymer 15, clear 
evidence for some weak electronic interactions is obtained from our electrochemical 
studies. However, since the redox peaks are unresolved, we are unable to evaluate the 
magnitude of the electronic interactions. The same is true for the Lys polymer 15. In 
this system, electronic interactions are even weaker leading to a distortion of the redox 
signal only. The next step in our study is to evaluate systems with alkene and alkyne 
spacers in the hope to increase the coupling between the Fc groups. 
 
 
 
6.4. Experimental 
 
 
6.4.1. General Procedure 
All syntheses were carried out under dry nitrogen gas  unless otherwise 
indicated. CH2Cl2 (BDH; ACS grade) used for synthesis was dried (CaH2) and distilled 
prior to use. CDCl3 (Aldrich) was dried (CaH2), and stored over molecular sieves (8-12 
mesh; 4Å effective pore size; Fisher) before use. THF was dried over 
benzophenone/sodium, and stored over molecular sieves (8-12 mesh; 4Å effective pore 
size; Fisher) before use. 1'-methoxycarbonyl Ferrocene-1-carboxylic acid and 1`-Boc-
aminoFerrocene-1-OBt  were prepared according to literature procedures, 
hydroxybenzotriazole (HOBt) (Nova), NaSO4, and NaHCO3 (VWR) were used as 
received. For column chromatography, a column with a width of 2.7 cm (ID) and a 
length of 45 cm was packed 18-22 cm high with 230-400 mesh silica gel (VWR). For 
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 TLC, aluminum plates coated with silica gel 60 F254 (EM Science) were used. NMR 
spectra were recorded on a Bruker Avance-500 spectrometer using a 5-mm broadband 
probe operating at 500.134 MHz (1H) and 125.766 MHz (13C{1H}). Peak positions in  
1H spectra are reported in ppm relative to TMS. All, unless otherwise described 13C{1H} 
spectra are referenced to the CDCl3 signal at δ 77.23. Mass spectrometry was carried 
out on a VG Analytical 70/20 VSE instrument. Infrared spectra were obtained with a 
Perkin-Elmer model 1605 FT-IR. Dynamic light scattering experiments were carried 
out on a Dynampro-MS800 instrument using a 20 µL sample in a quartz cuvette. Cells 
with a diameter of 10 mm were carefully flushed using distilled acetone and were dried 
before being filled with sample solutions. Samples were filtered into the cells using 0.45 
µm PTFE filters. 
 
6.4.2. Preparation of Bis-(1'-Methoxycarbonylferrocenyl-1'-Amide)-1,4-
Terephthaloyl (3) 
 
1'-Boc-aminoferrocene-1-OMe (Fca) 1 (2.1 mmol, 0.78 g) was dissolved in 
CH2Cl2 and treated with TFA (3 ml) in CH2Cl2 (3 ml) for 30 min. The TFA and CH2Cl2 
were subsequently removed in vacuo. The resulting residue was redissolved in CH2Cl2 
and cooled in ice bath prior to the dropwise addition of Et3N (0.45 ml). To this was 
added a solution of terephthaloyl chloride 2 (0.99 mmol, 0.20 g) in CH2Cl2 with 
vigorous stirring for 1 hour. The residue was chromatographed by (CHCl3: MeOH 9:1) 
to give yellow crystals of compound 3 (0.48 g, 74%): m. p. 130-138 °C; UV-vis 
(CH3CN; λ in nm (ε in Lmol-1cm-1)): 448 (610); FT-IR (KBr, υmax/cm-1): 3283 (m, N-
H), 1694 (s, C=O). 1H-NMR DMSO-d6, (δ in ppm): 8.20 (4H, s. Ph’s), 7.82 (2H, s, NH, 
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 NHCO), 4.90 (4H, s, Fc), 4.71 (4H, s, Fc), 4.42 (4H, s, Fc), 4.08 (4 H, s,  Fc), 3.52 (6H, 
s, COOCH3); 13C{1H}-NMR DMSO-d6, (δ in ppm): 172.3 (CONH), 162.7 (COOCH3), 
138.7, 127.3 (Ph’s), 99.9, 72.6, 71.0, 65.9, 62.45 (Fc), 52.3 (OCH3); TOF-MS (m/z): 
calc for C32H28N2O6Fe2 [M]+: 648.0641; found: 648.0665. 
 
6.4.3. Preparation of 1,4-Cyclohexyldicarboxylic Chloride (4) 
  1,4-cyclohexyldicarboxylic acid (8.61 g,  0.05 mol) was suspended in freshly 
distilled thionyl chloride (30 mL, 0.5 mol). Under stirring, one drop N, N-
dimethylformamide (DMF) was added as a catalyst, and the solution was refluxed for 3 
h. At this point dry toluene was added in excess and the mixture was fractionally 
distilled at 50 °C under vacuum to drive of thionyl chloride. Needle like white crystals 
of 1,4-Cyclohexyldicarboxylic acid chloride were obtained. The crystals were purified 
by recrystallization from n-hexane with a yield of 8.53 g (82%). m. p. 68-70 °C 1H-
NMR CDCl3, (δ in ppm): 2.78 (2H, m, CH), 2.35 (4H, m, CH2), 1.61 (4H, m, CH2). 
 
 
6.4.4. Preparation of Bis-(1'-Methoxycarbonylferrocenyl-1'-Amide)-1,4 
Cyclohexyldicarbonyl (5)  
 
 Compound 1 was treated as per 3 to remove the Boc group prior the mixing 
with solution of cyclohexanedicarbonyl chloride in CH2Cl2. The reaction was 
vigorously stirred for 1 hour at room temperature. The crude product was purified by 
flash column chromatography (SiO2, 95:5 EtOAc:MeOH) to give yellow crystals of 
compound 5 (78%).  m. p. 80-84 °C; UV-vis (CH3CN; λ in nm (ε in Lmol-1cm-1)): 448 
(712); FT-IR (KBr, υmax/cm-1): 3252 (m, N-H), 1696 (s, C=O). 1H-NMR DMSO-d6, (δ 
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 in ppm): 9.16 (2H, s, NH, NHCO), 4.67 (4H, s, Fc), 4.63 (4H, s, Fc), 4.38 (4H, s, Fc), 
4.00 (4 H, s,  Fc), 3.70 (6H, s, COOCH3), 2.37 (2H, m, cyclohexane), 1.94 (4H, m, 
cyclohexane), 1.59 (4H, m, cyclohexane). 13C{1H}-NMR DMSO-d6, (δ in ppm): 174.1 
(CONH), 163.4 (COOCH3), 99.9, 72.8, 70.9, 65.8, 62.0 (Fc), 51.8 (OCH3), 44.3, 28.8 
(cyclohexane); TOF-MS (m/z): calc for C32H28N2O6Fe2 [M]+: 654.1110; found: 
654.1108. 
 
6.4.5. Polycondensation of 1,1'-bis(Boc-amino)Ferrocene and terephthaloyl chloride 
1,1'-bis(Boc-amino)ferrocene[36] 6 (0.30 g, 0.75 mmol) was dissolved with 
stirring in CH2Cl2 (2.0 mL) and after cooling to 0 ºC with an ice bath, TFA (2.0 mL) 
was added dropwise under a nitrogen atmosphere. Then the ice bath was removed and 
stirring was continued. After 30 min, CH2Cl2 (10 mL) was added and the solution was 
cooled to 0 ºC before an excess Et3N was added dropwise. To this, a solution of 
terephthaloyl chloride 2 (0.67 g, 2.2 mmol) in dry CH2Cl2 was added. And the reaction 
mixture was allowed to stir for 1 hour. The content of the flask was added to 200 mL 
cyclohexane and the precipitated polymer 10 (0.23 g) was filtered off and washed by a 
mixture of cyclohexane/dichloromethane. The remaining solutions from filtration and 
successive washings of polymer 10 were combined and evaporated to dryness, and then 
the crude residue was purified by flash column chromatography (EtOAc:MeOH 9:1). 
Oligomers 7 (0.09 g, Rf = 0.56), 8 (0.13 g, Rf = 0.41), 9 (0.06 g, Rf = 0.28) were 
successfully isolated for further characterizations.  
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6.4.5.1. Characterization of Compound 7 
  m. p. 171-184 °C; UV-vis (CH3CN; λ in nm (ε in Lmol-1cm-1)): 447 (604); FT-
IR (KBr, υmax/cm-1): 3360 (m, N-H), 17063, 1661 (s, C=O). 1H-NMR DMSO-d6, (δ in 
ppm): 9.76 (2H, COOH), 8.10 (12H, m, Ph’s), 7.78 (2H, s, NH, NHCO), 4.93 (4H, 
overlapping, Fc), 4.72 (4H, overlapping, Fc), 4.43 (4H, overlapping, Fc), 4.07 (4 H, 
overlapping, Fc); 13C{1H}-NMR DMSO-d6, (δ in ppm): 190.1 (COOH), 172.3 (CONH), 
145.9, 138.7, 128.7, 127.4, 127.2 (Ph’s), 100.0, 7.3.1, 72.6, 72.5, 71.0, 65.9, 62.1 (Fc); 
TOF-MS (m/z): calc for C44H34N4O8Fe2 [M]+: 858.1070; found: 858.1064. 
 
6.4.5.2. Characterization of Compound 8 
m. p. 198-201 °C; UV-vis (CH3CN; λ in nm (ε in Lmol-1cm-1)): 447 (601); FT-
IR (KBr, υmax/cm-1): 3425 (m, N-H), 3374, 3114 (s, N-H), 1717, 1644 (s, C=O). 1H-
NMR DMSO-d6, (δ in ppm): 9.77 (1H, s, COOH), 8.33 (2H, s, NH, NHCO), 8.28 (4H, 
s, NH, NHCO), 8.02 (16H, m, Ph’s), 4.94 (6H, overlapping, Fc), 4.73 (6H, overlapping, 
Fc), 4.45 (6H, overlapping, Fc), 4.09 (6 H, overlapping, Fc); 13C{1H}-NMR DMSO-d6, 
(δ in ppm): 190.2 (COOH), 172.3 (CONH), 145.9, 138.7, 128.7, 127.4, 127.2 (Ph’s), 
100.0, 73.1, 72.6, 72.5, 71.0, 66.0, 62.9, 62.01 (Fc); TOF-MS (m/z): calc for 
C62H48N6O10Fe3 [M]+: 1204.1475; found: 1204.1508. 
 
6.4.5.3. Characterization of Compound 9 
  m. p. > 300 °C; UV-vis (CH3CN; λ in nm (ε in Lmol-1cm-1)): 447 (598); FT-IR 
(KBr, υmax/cm-1): 3495, 3295, 2978 (m, N-H), 1690 (s, C=O). 1H-NMR DMSO-d6, (δ in 
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 ppm): 9.78 (2H, s, COOH), 8.53-8.29 (11H, range of NH, NHCO), 8.10 (28H, 
overlapping, range of Ph’s protons), 4.94-4.01 (48H, overlapping, range of Fc protons); 
13C{1H}-NMR DMSO-d6, (δ in ppm): 190.2 (COOH), 172.3, 172.1, (CONH), 145.9, 
138.7, 138.5, 128.7, 128.2, 127.4, 127.2 (Ph’s), 100.0, 73.1, 72.6, 72.5, 71.0, 69.9, 66.0, 
62.9, 62.01 (Fc); TOF-MS (m/z): calc for C116H90N12O16Fe6 [M]+: 2242.2689; found: 
2242.2694. 
 
6.4.5.4. Characterization of Polymer 10 
 m.p. > 300 °C; FT-IR (KBr, υmax/cm-1): 1H-NMR DMSO-d6, (δ in ppm): 9.80 
(2H, s, COOH), 8.91-8.30 (range of NH, NHCO), 8.10-7.69 (overlapping, range of Ph’s 
protons), 4.83 (Fc protons), 4.01 Fc protons). 13C{1H}-NMR DMSO-d6, (δ in ppm): 
190.2 (COOH), 172.3, 172.1, 171.8, 164.7 (CONH), 145.9, 138.7, 138.5, 137.17, 128.7, 
128.2, 127.6, 127.4, 127.2 (Ph’s), 100.0, 73.1, 72.6, 72.5, 71.0, 69.9, 66.0, 62.9, 62.01 
(Fc); DLS: average Mw = 1.25 x 105. 
 
6.4.6. Polycondensation of 1,1'-bis(Boc-amino)Ferrocene and 1,4-Cyclohexyldi- 
carboxylic Chloride.  
 
After deprotection of Boc group from 1,n'-bis(Boc-amino)Ferrocene 6 (0.30 g, 
0.75 mmol) as described above, it was mixed with equimolar amount of 1,4-
cyclohexyldicarboxylic chloride (0.53 g, 2.2 mmol) in dry CH2Cl2. After stirring for 8 h 
the content of the flask was diluted with CH2Cl2 and washed consecutively with 10% 
aqueous citric acid and saturated NaHCO3. The organic phase was separated and 
evaporated to dryness then chromatographed by (CHCl3, MeOH 9:1) to extract the 
oligiomers 11 (0.19 g, 30%, Rf = 0.68) and 12 (0.21 g, 18%, Rf = 0.41). 
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6.4.6.1. Characterization of Compound 11 
m.p. 146-151 °C; UV-vis (CH3CN; λ in nm (ε in Lmol-1cm-1)): 448 (626); FT-IR 
(KBr, υmax/cm-1): 3267 (b, m, N-H), 3089, 2950, 1696, 1542. 1H-NMR DMSO-d6, (δ in 
ppm): 9.26 (2H, COOH), 7.78 (2H, s, NH, NHCO), 4.64 (4H, overlapping, Fc), 4.38 
(4H, overlapping, Fc), 4.17 (4H, overlapping, Fc), 3.99 (4H, overlapping, Fc), 2.17 ( 2 
H, m, cyclohexane), 1.80 (4H, m, cyclohexane), 1.34 (4H, m, cyclohexane); 13C{1H}-
NMR DMSO-d6, (δ in ppm): 203.7 COOH, 175.5 (CONH), 99.9, 73.8, 73.6, 71.2, 71.1, 
70.9, 66.1, 65.9, 61.9 (Fc), 44.3, 34.3, 39.6, 28.8, 25.5, 21.1 (cyclohexane); TOF-MS 
(m/z): calc for C44H52N4O8Fe2 [M]+: 876.2478; found: 876.2516.  
 
6.4.6.2. Characterization of Compound 12 
m.p. 173-179 °C; UV-vis (CH3CN; λ in nm (ε in Lmol-1cm-1)): 448 (626); FT-IR 
(KBr, υmax/cm-1): 3274 (b, m, N-H), 3089, 2950, 1667, 1542. 1H-NMR DMSO-d6, (δ in 
ppm): 9.85 (2H, COOH), 7.94-7.75 (8H, range of NH, NHCO), 5.03-4.00 (32H, 
overlapping, range of Fc protons), 2.23-1.28 (50H, overlapping, range of Cyclohexane 
protons). 13C{1H}-NMR DMSO-d6, (δ in ppm): 203.6 COOH, 175.4, 175.1, 174.7 
(CONH), 99.9, 73.8, 73.6, 72.6, 71.2, 71.2, 71.0, 69.3, 66.1, 65.9, 61.9 (Fc), 49.2, 44.3, 
39.6, 34.3, 28.8, 25.6, 24.8, 21.1 (cyclohexane); TOF-MS (m/z): calc for 
C98H112N10O14Fe5 [M]+: 1700.4227; found: 1700.4231. 
 
6.4.7. Preparation of 1, n’-bis(Lys(Boc)-OMe)Ferrocene (14) 
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 H-Lys(Boc)-OMe.HCl (4.00 g, 13.5 mmol) was dissolved in CH2Cl2 (20 mL) 
and cooled in an ice path prior to the dropwise addition of Et3N (15.0 mmol). The 
mixture was added to a stirred solution of Fc-1,1'-dicarbonyl chloride 13 (2.00 g, 6.43 
mmol) in CH2Cl2 (30 mL) and left to stir for two hours. The reaction completion was 
checked by TLC. The crude product was purified by flash column chromatography 
(SiO2, 1:2 EtOAc-hexane) and recrystallized from CHCl3 to yield yellow crystalline 
compound (4.49 g, 92%). m. p. 112-117 °C; UV-vis (CH3CN; λ in nm (ε in Lmol-1cm-
1)): 449 (719); FT-IR (KBr, υmax/cm-1): 3378, 3260 (b, m, N-H), 2971, 2932, 2637, 2557, 
1703, 1634, 1545; 1H-NMR CDCl3, (δ in ppm): 8.10 (1H, d, J = 7.3 Hz, Lys α NH), 6.79 
(1H, m, Lys εNH), 4.87 (1H, s, Fc-H), 4.81 (1H, s, Fc-H), 4.41 (1H, s, Fc-H), 4.36 (1H, 
s, Fc-H), 4.32 (1H, m, Lys α CH), 3.66 (3H, s, COOCH3, 2.92 (2H, m, Lys CH2), 1.76 
(2H, m, Lys CH2), 1.40 (4H, m, Lys CH2), 1.34 (9H, s, Lys NHBoc); 13C{1H}-NMR 
CDCl3, (δ in ppm):  175.5, 174.3, 156.4, 100.0, 72.0, 71.5, 70.8, 70.0, 69.9, 66.9, 66.2, 
65.9, 63.3, 62.8, 52.9, 52.5, 33.4, 30.0, 29.7, 28.8, 25.7, 14.2; TOF-MS (m/z): calc for 
C36H54N4O10Fe [M]+: 758.3184; found: 758.3210.
 
6.4.8. Reaction of Compound 14 and Ferrocenediacid Chloride 
After Boc deprotection of 1,1'-bis(Lys(Boc)-OMe)ferrocene by TFA/CH2Cl2 the 
product was reacted with ferrocene 1,1'-dicarboxilic acid chloride in equimolar 
quantities with stirring in dry CH2Cl2 for two hours. The polymeric product which 
precipitated was filtered off. Successive washings with methanol then acetone produced 
the polymeric compound 15 (0.26 g). m.p. 235-238 °C; UV-vis (CH3CN; λ in nm (ε in 
Lmol-1cm-1)): 449 (629); FT-IR (KBr, υmax/cm-1): 3127-2864 (b, m, N-H), 2650, 2567, 
 184
 1717, 1636, 1543; 1H-NMR D2O, (δ in ppm): 4.90-4.53 (overlapping, Fc), 4.52-4.37 
(overlapping, Lys α CH), 4.3 (overlapping, Fc), 3.69 (s, COOCH3 groups), 3.37, 3.23, 
2.80, 1.86, 1.72, 1.60, 1.37 (Lys CH2’s); 13C{1H}-NMR CDCl3, (δ in ppm): 174.6, 
173.1, 99.9, 74.6, 71.2, 70.2, 69.9, 53.0, 52.7, 47.1, 39.1, 29.6, 26.2, 22.4, 18.3; DLS: 
average Mw = 7.94 x 104.  
 
6.4.9. Electrochemical Measurements 
The electrochemical measurements were performed using a CHI 660B 
electrochemical analyzer (CH Instruments, Inc., Austin, Texas). A conventional three 
electrodes system consisting of glassy carbon disk working electrode (φ = 3 mm, 
geometrical area = 0.071 cm2), a platinum wire counter electrode, and Ag/AgCl (3M 
KCl) reference electrode were used. The experiments were carried out with a 1 mM 
solution sample in dry CH3CN containing 0.1 M tetrabutylammonium perchlorate 
(TBAP) as supporting electrolyte. All measurements were carried out at room 
temperature. The working electrode surface was hand-polished to a mirror finish with 
0.05 µm Al2O3 before it was used and was cleaned after each run.  Polymer 10 coated 
electrode was prepared by the pipetting of methanolic solution of the polymer onto 
glassy carbon disk electrode. The solvent was allowed to evaporate at room temperature 
to form the film electrodes.  
 185
 6.4. References 
 
[1] I. Manners, Pure Appl. Chem. 1999, 71, 1471-1476. 
[2] B. Alonso, B. Gonzalez, B. Garcia, E. Ramirez-Oliva, M. Zamora, C. M. 
Casado, I. Cuadrado, J. Organomet. Chem. 2001, 637-639, 642-652. 
[3] A. S. Abd-El-Aziz, P. O. Shipman, in Frontiers in Transition Metal-Containing 
Polymers (Eds.: A. S. Abd-El-Aziz, I. Manners), John Wiley & Sons, Inc., 
Hoboken, NJ., 2007, pp. 45-133. 
[4] K. A. Mahmoud, H.-B. Kraatz, in Frontiers in Transition Metal-Containing 
Polymers (Eds.: A. S. Abd-El-Aziz, I. Manners), John Wiley & Sons, Inc., 
Hoboken, NJ., 2007, pp. 473-498. 
[5] J. P. Launay, Editor, Molecular Electronics, Gauthier-Villars, Paris, 1991. 
[6] J. Alvarez, A. E. Kaifer, Organometallics 1999, 18, 5733-5734. 
[7] T. Hirao, M. Kurashina, K. Aramaki, H. Nishihara, J. Chem. Soc., Dalton Trans. 
1996, 2929-2933. 
[8] A.-C. Ribou, J.-P. Launay, M. L. Sachtleben, H. Li, C. W. Spangler, Inorg. 
Chem. 1996, 35, 3735-3740. 
[9] T.-Y. Dong, C.-H. Huang, C.-K. Chang, H.-C. Hsieh, S.-M. Peng, G.-H. Lee, 
Organometallics 1995, 14, 1776-1785. 
[10] R. Rulkens, A. J. Lough, I. Manners, J. Am. Chem. Soc. 1994, 116, 797-798. 
[11] G. E. Southard, M. D. Curtis, Organometallics 1997, 16, 5618-5620. 
[12] G. E. Southard, M. D. Curtis, Organometallics 2001, 20, 508-522. 
[13] G. M. Brown, T. J. Meyer, D. O. Cowan, C. LeVanda, F. Kaufman, P. V. 
Roling, M. D. Rausch, Inorg. Chem. 1975, 14, 506-511. 
[14] M. Sato, S. Tanaka, K. Kaeriyama, J. Chem. Soc., Chem. Commun. 1986, 873-
874. 
[15] T. Shimura, H. Funaki, H. Nishihara, K. Aramaki, T. Ohsawa, K. Yoshino, , 
Chem. Lett. 1992, 457-460. 
[16] D. A. Foucher, B.-Z. Tang, I. Manners, J. Am. Chem. Soc. 1992, 114, 6246-
6248. 
[17] C. M. Casado, M. Moran, J. Losada, I. Cuadrado, Inorg. Chem. 1995, 34, 1668-
1680. 
[18] M. Cazacu, A. Vlad, M. Marcu, C. Racles, A. Airinei, G. Munteanu, 
Macromolecules 2006, 39, 3786-3793. 
[19] D. Chao, X. Lu, J. Chen, X. Liu, W. Zhang, Y. Wei, Polymer 2006, 47, 2643-
2648. 
[20] P. A. Deck, M. J. Lane, J. L. Montgomery, C. Slebodnick, F. R. Fronczek, 
Organometallics 2000, 19, 1013-1024. 
[21] W. Gary Hollis, Jr., T. F. Bonsall, V. L. Cuba, P. A. Deck, F. R. Fronczek, 
Transition Met. Chem. 2006, 31, 246-249. 
[22] C. B. Hollandsworth, W. G. Hollis, Jr., C. Slebodnick, P. A. Deck, 
Organometallics 1999, 18, 3610-3614. 
[23] K. A. Mahmoud, H. B. Kraatz, J. Inorg. Organomet. Polym. 2006, 16, 201-210. 
[24] E. E. Bunel, P. Campos, J. Ruz, L. Valle, I. Chadwick, M. S. Ana, G. Gonzalez, 
J. M. Manriquez, Organometallics 1988, 7, 474-476. 
 186
 [25] K. Ma, F. F. d. Biani, M. Bolte, P. Zanello, M. Wagner, Organometallics 2002, 
21, 3979-3989. 
[26] S. I. Kirin, H. B. Kraatz, N. Metzler-Nolte, Chem. Soc. Rev. 2006, 35, 348-354. 
[27] R. Jain, H. Choi, C. A. Lalancette, J. B. Sheridan, Organometallics 2005, 24, 
1468-1476. 
[28] N. J. Long, A. J. Martin, R. Vilar, A. J. P. White, D. J. Williams, M. Younus, 
Organometallics 1999, 18, 4261-4269. 
[29] S. S. Zhu, P. J. Carroll, T. M. Swager, J. Am. Chem. Soc. 1996, 118, 8713-8714. 
[30] R. Pyati, R. W. Murray, J. Phys. Chem. 1994, 98, 11129-11135. 
[31] M. T. Nguyen, A. F. Diaz, V. V. Dememnt'ev, K. H. Paennl, Chem. Mater. 
1994, 6, 952-954. 
[32] H.-z. Bu, A. M. English, S. R. Mikkelsen, J.Phys. Chem. B 1997, 101, 9593-
9599. 
[33] H. Nishihara, Y. Shimano, K. Aramaki, J. Phys. Chem. 1987, 91, 2918-2921. 
[34] C. R. Martin, I. Rubinstein, A. J. Bard, J. Am. Chem. Soc. 1982, 104, 4817-
4824. 
[35] P. Daum, J. R. Lenhard, D. Rolison, R. W. Murray, J. Am. Chem. Soc. 1980, 
102, 4649-4653. 
[36] S. Chowdhury, K. A. Mahmoud, G. Schatte, H.-B. Kraatz, Org. Biomol. Chem. 
2005, 3, 3018-3023. 
 
 
 
 
 187
 CHAPTER 7 
GENERAL CONCLUSION 
 
In my present research, I reached my objective of exploring the preparative and 
structural properties of Fc-peptide conjugates and I successfully explored their 
applications as biosensors and as polymeric materials. Five scientific questions 
followed by three major goals listed at the beginning of my research journey were 
addressed.  
 
7.1. Ferrocene-Peptide Conjugates 
 Peptide-derived bioconjugates are well recognized potential ligands as part of 
biomolecular recognition systems for probing of biological processes.[1, 2] These 
systems are also of a more fundamental interest for the construction of well-defined 
scaffolds. Fc-peptide conjugates occupy a special position in that they allow for 
additional control over the structural properties by choosing the appropriate 
organometallic group. Disubstituted Fc systems, in which both cyclopentadienyl rings 
are substituted, provide control over the supramolecular structure of the assemblies by 
controlling the Cp-twist, as well as providing a starting point for the design of electronic 
biomaterials.[3] This has been demonstrated in the literature and work by Kraatz, Hirao 
and others have utilized Fc as reliable organometallic scaffolds for constructing self-
assembled structures, via intramolecular H-bonding, in which the interaction of the 
conjugated peptide strands are regulated in appropriate dimension.[4-10] Recently, the 
artificial amino acid 1'-amino-ferrocene-1-carboxylic acid (Fca) was recognized as a 
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 useful tool in bioorganometallic chemistry. A series of peptides incorporating Fca have 
been synthesized by using solution phase methods.  Initial investigations show that Fca 
imposes specific secondary-structural elements onto the peptide.[11-13]        
  I was successful in applying amide-coupling methods to investigate the 
capability of Fca to conjugate with amino acids and peptides. In Chapter 2, I was able to 
synthesize  and fully characterize a new active ester benzotriazol-1-yl 1-(tert-
butyloxycarbonylamino) ferrocene-1-carboxylate, which is a key intermediate in the 
coupling of Fca to amino acids and peptides.[14] During the synthesis, I was able to 
discover a transformation of this active ester into inactive N-oxide derivative, 3-{[1-
(tert-butyloxycarbonylamino)ferrocen-1-yl]carbonyl}-benzotriazole 1-oxide. Given the 
importance of Fc-OBt active ester intermediates in the preparation of Fc-bioconjugates 
and as potential intermediate for the stepwise synthesis of ferrocenamide-based 
polymers, our finding is significant. Importantly, N-oxide side product is “non-
productive” resulting in the loss of the organometallic label.[14] 
The next step in my investigation was to properly address the initial 
investigations by Rapić and Metzler-Nolte who proposed that Fca can induce the 
formation of a peptide turn,[12] and demonstrate the ability of Fca to impose specific 
secondary structural elements onto peptides. Thus, Fca was incorporated into oligo-
peptides with D- and L-amino acid residues attached to the carboxy and amino terminals 
of Fca.  
In a collaborative study with Rapić and Metzler-Nolte groups, I demonstrated 
that Fca invariably induces a turn-like structure, which is stable in solution and the solid 
state.[13] The axial chirality of the Fca group was readily evaluated by CD spectroscopy.  
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 Our result showed different behaviour for Fca peptides depending on the 
chirality and position of the attached amino acid. The axial chirality of the Fca is 
completely dependent on the chirality of the first amino acid attached to the amino 
terminal of the Fca group. Thus, my systematic work described in Chapter 3 lays a solid 
foundation for the rational design of such unique Fc peptides.[13]  
 
7.2. Applications in Biosensors  
In addition to the important consequences of utilizing ferrocene as an 
organometallic scaffold for building well organized supramolecular structures, this 
molecule was widely exploited as part of molecular recognition systems because of its 
reversible redox properties. Fc-peptide conjugates combine the ability of Fc to mediate 
electron transfer with the molecular recognition potentials of peptides. However, 
labelling the peptide recognition site in an electrochemical biosensor was potentially 
problematic since it may interfere with the biomolecular recognition processes.  
In an attempt to approach this problem, I was successful in attaching a peptide 
recognition sequences to a redox probe and exploit the resulting conjugates for the 
electrochemical detection of papain. The idea was to place a surface-bound redox probe 
in close proximity to the electrode surface. Diffusive processes will not affect the redox 
signal. Furthermore, the interaction between the recognition sequence and electrode 
surface will not be hindered by the interaction with the target protein. In addition, the 
redox-active Fca label will be part of the recognition site but will not interfere with the 
recognition process. 
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 In my work, three thiol modified Fca-peptide conjugates Thc-Fca-Gly-Gly-
Tyr(Bzl)-Arg(NO2)-OH, Thc-Fca-Gly-Gly-Arg(Mtr)-Tyr-OH and Thc-Fca-Gly-Gly-
Arg-Tyr-OH were synthesized and full characterized.[15] The three peptide sequences 
were specifically chosen as potential inhibitors for papain.[16-18]  
The work described in Chapter 4 clearly shows the utility of this approach, and 
the system was able to detect papain at low concentrations with good selectivity for the 
target analyte.  
My work represents a truly important proof of concept for establishing this 
novel bioorganometallic approach for the electrochemical detection of important 
biological targets. My sensor provides an attractive alternative for the electrochemical 
detection of non-labelled non-redox active proteins, which under current detection 
schemes remains a significant challenge.[15]       
 
7.3. Application in Material Science 
The idea of incorporating organometallic moieties into polymer structures has 
been under investigation for almost 50 years. However, in many cases, these polymers 
are sparingly soluble, which limits their characterization.[10] Pioneering work by Manners 
allowed for exploiting the ring strain in silaferrocenophanes to develop high molecular weight 
Fc-backbone polymers by ring-opening metathesis.[10-12] Despite these pioneering efforts by 
different excellent research groups, oligomers and polymers that have peptide-like 
characteristics and possess a Fc in their backbone were not known up to date.  
The major problem in this research is the difficulty to obtain suitable building 
blocks. For example, peptide-like organometallic polymers can be obtained by facial 
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 condensation of two active building blocks such as 1,1'-ferrocene dicarboxylic acid 
chloride Fc[COCl]2 and 1, 1'-ferrocene diamine Fc[NH2]2. Although Fc[COCl]2 is 
widely available little efforts have been made to synthesize Fc[NH2]2.[19-21]  None of the 
existing methods to synthesize Fc[NH2]2 appeared attractive because of poor overall 
yield and inconvenient reaction conditions. Furthermore, the explosive nature of 
diazoferocenes intermediate and the instability of the product were of major 
challenge.[22]  
Having this in mind, I was able recently to develop a very convenient method to 
synthesize 1,1'-bis(tert-butoxycarbonylamino)ferrocene as a stable derivative of 
Fc[NH2]2. This new synthetic approach has circumvented the problems encountered 
with the explosive diazide.[23] The material is stable in solution and in the solid state and 
does not decompose in solution even after several months.  
Building on this successful achievement, I tested the ability of 1,1'-bis(tert-
butoxycarbonylamino)ferrocene, after acid deprotection of Boc groups, to undergo 
facial condensation reaction with Fc[COCl]2. This approach was met with success and a 
series of novel ferrocene-oligomers and polyferrocenyl peptide were obtained.[24]  
Preliminary measurements on the polymeric materials indicate a globular 
structure in aqueous solution. Surprisingly, the electrochemical investigation on these 
oligomers and polymers showed no evidence of electronic communication between the 
neighbouring iron centres. Our results are in sharp contrast to results obtained in other 
oligmeric systems in which separate oxidation waves were observed in the triferrocenes, 
indicating significant electronic communication.[25, 26] 
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 This unexpected observation inspired me to expand on this study in Chapter 6 
and explore the effect of incorporating different linkers having different electronic 
environments, such as phenylene, cyclohexylene and lysyl groups on the electronic 
properties of their oligomers and polymers.  
Several investigations of Fc-oligomers showed that the linkers between Fc units 
modulate the interaction between the iron centers by changing the Fc-Fc distances and 
by tuning through-bond orbital conjugation.[27-31] It was expected that a phenylene 
spacer enhances the Fc to Fc communication via strong conjugation system.[32, 33] On 
the other hand a cyclohexyl spacer should give the polymer more flexibility but should 
reduce the interaction between the Fc groups.  In addition, a lysyl spacer may not allow 
any interactions between the Fc groups. All three systems are linked to the Fc centers 
via an internal polar amide group which should play a crucial role in influencing the 
properties of these systems.[34]   
More surprisingly, the electrochemical results described in Chapter 6 again 
suggested unresolved or no interaction between the ferrocene groups in all systems. 
Only the phenylene polymer displayed some weak electronic interactions. However, it 
was not possible to evaluate the magnitude of the electronic interactions since the redox 
peaks are unresolved. These results reveal the influence of the amide groups to suppress 
the electronic interaction between the iron centers in our polymer. 
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 7.4. Final Remarks and Future Directions 
Overall, in my research, I contributed to three major scientific fields: structural 
design of Fc-peptide conjugates, electrochemical biosensors, and organometallic 
materials. First, I was successful in demonstrating that Fca is a turn inducer and 
discovered the ability of this artificial amino acid to impose specific secondary 
structural elements on peptides. These studies should expand to larger molecules in 
order to understand naturally occurring biochemical processes such as protein folding. 
Studies on our novel systems may give important results with relevance to naturally 
occurring systems.       
Second, my efforts for developing a novel biorganometallic-based sensor for 
proteins have met with a great success. After optimizing the sensor platform and 
expanding our studies to improve the selectivity, a reliable and cheap electrochemical 
sensor for proteins could be developed. This may include the multiplexed detection of a 
series of proteins, making this valuable detection platform for clinical applications.       
Finally, my approach of obtaining oligomeric and polymeric ferrocenyl-peptides 
has met with success. At this point, the electronic properties of these materials are not 
promising. The next step is to investigate and understand the structure of these polymers 
in order gain control over their electronic properties. With patient, advanced synthesis 
and characterization of these materials will open the door for practical and 
commercially valuable applications.       
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